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Primary care providers such as general practitioners (GPs) and midwives are con-
sidered gatekeepers of specialized care; in general they are the ones who initially 
deal with patient’s concerns and questions. Because of the increasing availability 
of DNA-based tests (http://www.ncbi.nlm.nih.gov/sites/GeneTests/?db=-
GeneTests) and the growing possibilities for genetic screening, primary care pro-
viders need to be prepared for patients asking for information or advice on genetic 
testing.1 Moreover, increasing knowledge of genetics of common disorders (diabe-
tes, cancer, cardiovascular diseases), and its monogenic subtypes (e.g. Maturity 
Onset Diabetes of the Young (MODY), hereditary breast cancer (BRCA 1/2) and 
Lynch syndrome (hereditary nonpolyposis colorectal cancer (HNPCC), familial 
hypercholesterolemia (FH) and long QT syndrome) asks for urgent genetic literacy 
of primary-care providers. 2-4 It has been shown that physicians lack knowledge of 
genetics relevant for daily practice, lack oversight of genetic testing and concerns 
about privacy and discrimination, and report inadequacy to deliver genetic ser-
vices. 5,6 For genetics to have an effect on clinical practice that is comparable to its 
impact on research, will require integration of genetic medicine in daily health-
care.4 In a previously held large European study, GPs mentioned “genetics of com-
mon disorders” as a first teaching priority.7 GPs’ willingness to carry out genetic 
tasks showed 61% would take a family history themselves but only 38% would 
explain an inheritance pattern and 16% would order a genetic test.7 To overcome 
barriers, it was argued emphasis should be on genetics of common disorders and 
on how to deal with genetic risk in daily practice, rather than on ethics, basic con-
cepts or new technologies.7 Country specific approaches however should be kept 
in mind, when genetics education aiming at these affecting factors is organized. In 
this thesis we will explore primary care workers’ genetics educational needs and 
priorities, followed by determining the effectiveness of needs-based genetic train-
ing for GPs, taking oncogenetics as an example.  
Primary care in the Netherlands: a phenomenon 
Primary care (synonymous with primary healthcare) was defined in 2004 by the 
Dutch Health Council Committee, with regard to organisation and significance. 8 
Primary care is considered to be generalist care. It consists of general medical, 
paramedical and pharmaceutical care, nursing and supportive care and non-
specialized mental and social healthcare, including preventive and health educa-
tional activities. Additionally, care should be provided as close to home as possible, 
in the middle of the community. Primary care is provided in collaboration with 
other primary care providers such as midwives and physiotherapists and, if neces-
sary, with secondary care. The Health Council also stated the healthcare system, as 
a whole, will function more effectively and efficiently with purposely functioning 
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primary care with the general practitioner as a central gatekeeper in the Nether-
lands. Although there are some differences internationally to how primary care is 
defined, a stronger primary care system leads to more effective and efficient health 
care.8 
 
Unlike in many other countries, general practice in the Netherlands is an open 
access full-time service for every patient with any medical complaint, request, or 
question. The service includes a list system, implying that every person (with or 
without a disease) is on the list of one GP, thus guaranteeing optimal continuity of 
care. The GP handles more than 90% of all presented complaints and diseases.8 All 
referrals to secondary specialized care, including to the nine Dutch clinical genet-
ics centers, and most referrals to other primary care services are managed by the 
GP. Therefore, the GP is the first to whom a patient will turn when he/she has 
questions on prevention, diagnosis, and treatment of disease. They are highly in-
volved in care for patients with common disorders such as cardiovascular disease, 
diabetes mellitus, and cancer.6 It has been argued that the greatest public health 
benefit of advances in understanding the human genome may be realized for these 
diseases.6 Realistically however, translation into clinical practice is still in the early 
stages. 6,9 Family history taking, thus understanding mode of genetic transmission 
and counselling, predictive DNA-based testing, knowledge of relevant guidelines 
and timely referral to clinical genetics for disease prevention and reproductive 
decision making are currently understood to possibly be of great value in primary 
care practice.10 Messy translation of genetic advances into the clinic and unrealistic 
promises are limiting potential preventive treatments and improved medical 
care.11 
Role of genomics in primary care 
Genomics is defined by the World Health Organisation (2002) as “the study of 
genes and their functions, and related techniques”. 
Genomics addresses “all genes and their interrelationships in order to identify 
their combined influence on the growth and development of the organism”, 
whereas genetics “examines the functioning of a single gene”.12 
 
In the age of genomics both genetics of common disorders and large-scale applica-
tions in screening will become increasingly important, and primary care health 
workers (GPs, midwives) will have to be prepared to discuss these issues with 
their clients accordingly. 1, 3, 6, 13-16 GPs may get more involved in preventive check-
ups and develop a more flexible way to deal with patients’ requests for DNA-based 
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tests, in addition to the original role in an open access full time service for every 
patient. 
 For the assessment of possibilities for predictive testing (positive family his-
tory of common genetic disorders, in particular its monogenic subtypes, and DNA-
based test results) and its implementation in preventive check-ups, other public 
health workers in primary care (well baby clinics, occupational health care and 
policy makers) need to increase their genetic skills and knowledge. Therefore, 
genomics could change the roles of all actors in the field of primary care for recog-
nition and validation of patterns of possible familial common disorders through 
family history taking, registration of this information in Electronic Patient Records 
(EPR), timely referral to clinical genetics departments, counseling its familial con-
sequences and vital support. The question is how primary care providers them-
selves view the role of genetics in primary care.  
Creating an agenda for effective genetic educational strategies:  
needs assessment and prioritization in primary care 
Training needs can be assessed both based on perceived needs by the target group 
of the training and on the challenges related to future applications expected by 
genetic experts. The target group will only participate in training if they feel that 
the training could be useful for them, and suit in their learner-focused needs-led 
plans. Modules that fit in their regular training programs and have been approved 
by or co-developed with their professional organization might be better accepted 
than initiatives superposed. Changes will only be effective if they suit routine prac-
tice, including the EPR and GP information system (HIS: huisarts-informatiesysteem 
in GP practice). A developing routine practice, the prevention consultation, might 
include genomics. Organizers of education must be responsive to work patterns in 
planning training sessions, encourage supporters from previous courses and spe-
cialist areas to promote genetics education.14 
 Primary health care professionals increasingly perceive an urgency to deliver 
genetic training needs based on their every day practice. These needs concern 
knowledge on a diversity of topics (genetics of common disorders, psychosocial 
and counseling issues, ethical, legal and public health issues, techniques and inno-
vations in genetics), as well as skills (identifying sources of information, drawing 
up pedigrees, referring to specialist genetics services, communicating genetic in-
formation). 
 Stakeholders to be engaged in facilitating agenda setting and attunement 
could be clinical genetics professionals (clinical geneticists or genetic counselors), 
primary care educators, and representatives of patient advocacy groups. Stake-
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holders are therefore considered experts to have a broad view of the role of genet-
ics in primary care and the need for genetics education i.e. what is needed, what 
works and what does not work. In this thesis the views of these stakeholders and 
primary care workers regarding primary care workers’ needs for genetics educa-
tion and the role of genetics in primary care is addressed. This information could 
help to develop effective genetics education as well as effective integration of ge-
netics in primary care. 
Urgent need for genetics training for non-genetic healthcare providers: 
development and evaluation of genetic educational training for general 
practitioners  
The rapid development of (also commercially available direct-to-consumer) genet-
ic tests changes the role of the GP from a gatekeeper for the medical field. 17-19 The 
possibility of a more flexible role in patient requested genetic tests must be inves-
tigated. Informed medical care should also imply informing patients about the pros 
and cons of genetic tests. GPs are confronted with clients entering their consulting-
room with a high-risk estimate provided by a genetic company and based on a 
whole genome scan.19 A detailed consumer report of a genome map will almost 
certainly be beyond current physicians skills. The current development of preven-
tive counselling sessions (e.g. PreventieConsult) in primary health care might be a 
good moment for this, to facilitate engagement of multidisciplinary stakeholders 
involved in genetic education development.8 
 
In curricula of Dutch medical schools, postgraduate training for GPs and public 
health professionals as well as the master program for midwives, genetics and 
genomics are not very well represented.5, 16 Both in the domain of reproductive 
medicine (e.g. risks related to consanguinity, carrier screening, prenatal screen-
ing), and in diagnosis, therapy and prevention of common disorders, fast develop-
ments in genomics research increasingly make large scale health care applications 
in the near future possible. It is estimated, each GP has about 40 to 50 asympto-
matic patients with relatively young first-degree relatives with common forms of 
cancers (breast, ovarian, uterine and colorectal cancer) who should pre-
symptomatically be counseled by a clinical geneticist and screened according to 
recent guidelines.19-23 Women carrying a BRCA1 or BRCA2 mutation (a familial 
breast cancer gene), for example, have a lifetime-risk of 60-80% of developing 
breast cancer and 36-63% and 10-27% to develop ovarian cancer in case of re-
spectively BRCA1 or BRCA2 mutation. Timely identification and referral to the 
clinical geneticist could obviously enable them to benefit from otherwise unex-
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ploited life-saving “risk-management options”, such as salpingo-oophorectomy 
and/or mastectomy, annual screening, and pharmaceutical chemo preventive op-
tions.9, 24 Timely referral may benefit not only the individual patient but also other 
family members who might be at risk. 
 
To prepare clinical practice for the rapid advances in genomics, education is ur-
gently needed. Genetic literacy allows health care workers to engage in the debate 
on hopes and hypes, and to be able to distinguish between useful and useless ap-
plications in health care. Untimely implementation of DNA-based test results in 
genetic medicine takes place by commercial companies that refer to health care 
workers, who are not prepared for this task.19, 26 Several of the tests offered, lack 
clinical utility.26 In the Netherlands, however, patients only sporadically request 
DNA-based tests. Focus on two tracks of possible applications of genetics and ge-
nomics in daily practice is essential; one will be a proactive and the other will be a 
reactive track. The proactive track primarily supports GPs in their preventive work 
of timely recognition of common genetic disorders and its monogenetic subtypes 
throughout their daily problem based work, when a proactive initiative is request-
ed. The reactive track primarily supports the patient when he/she asks the GP a 
certain question related to genetics or genomics.  
 
Defining genetic core competences for non-genetic health care workers was con-
sidered prerequisite for implementing genetics education for general practice. 
6,28,29 Such education programmes should be based on an educational needs as-
sessment of GPs referring to the three domains of educational activities: cognitive 
(knowledge), psychomotor (skills) and affective (attitude). Despite competence 
frameworks and increasing demands, GP educators are struggling to respond ade-
quately. 15 This thesis was designed to investigate whether effective and sustaina-
ble education for primary care physicians (GPs) can be organized and developed, 
taking oncogenetics as an example. The following paragraph describes the concep-
tual models used in the studies performed in this thesis. 
Conceptual model 
The shared goal of improving patient care and health outcomes are not met: 30-
40% of patients do not receive care informed by best evidence and 20-50% re-
ceive inappropriate care.8, 9, 11 Improving educational strategies to enhance appli-
cation of evidence in practice, through Continuing Professional Development 
(CPD) is essential if new clinical evidence is to lead to improved patient care and 
health outcomes, whether it is innovations in genetics or otherwise. The accredit-
ing bodies now require medical professionals not only have to increase their 
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knowledge through CPD, but also their performance in daily practice through im-
proved skills and attitude. Online Continuing Professional Development (eCPD) 
and other more traditional CPD activities (Printed Educational Materials (PEMs) 
and live CPD activities) are widely used to inform healthcare professionals.29 In-
ternet based CPD potentially reaches many users and showed to be similarly effec-
tive and could therefore be cost effective.30, 31 
 The conceptual model presented here is based on Kern’s CPD curriculum 
design, derived from general education theory and practice and entails a six-step 
circular guide.32, 33 Similar to research outcomes, learner outcomes should be con-
sidered when the curriculum is defined (learning goals and objectives, teaching 
methods, content and assessment). Developing effective training, each step must 
show congruence with the other steps, which is demonstrated on the figure based 
on Kern’s design. Kern described the steps to come to the ultimate goal of CPD 
through education and learning: improved patient health and outcome. Actually, 
Kern’s six-step guide should rather be called seven-step guide, since this processes 
sustainable curriculum maintenance and enhancement. 
 
 
Figure 1. Conceptual model for genetic CPD curriculum development, evaluation and maintenance 
based on Kern 32, 33 
Step 1: 
Problem 
identification
Step 2: 
Genetic 
educational Needs 
assessment
Step 3: 
Prioritization of genetic 
educational needs and 
objectives
Step 4: 
Multifaceted genetic 
educational strategies 
Step 5:
Implementation of 
genetic training 
Step 6:
Evaluation and 
feedback; improved 
genetic patient 
health and outcome 
Step 7: Curriculum 
maintenance and 
enhancement driving 
revision and refining the 
curriculum
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The goal of CPD interventions is not necessarily change in translation of 
knowledge, but rather learning at various levels. Levels of educational outcomes 
can be demonstrated by Kirkpatrick’s framework for evaluating educational out-
comes, originally presented in 1967. 32, 34 The framework proposes four levels of 
outcome for educational interventions: valuation (level 1; satisfaction), learning 
(level 2; knowledge and knowledge retention), behaviour (level 3: applied 
knowledge on timely recognition of patients at risk and referral) and ultimately 
effects on patient health and organization and therefore impact on society (level 4: 
change in actual practice performance, results and effects on patient health and 
organization).  
 
 
Figure 2. Genetic educational framework. Based on Kirkpatrick’s Evaluation Framework for 
Educational Outcomes 32, 34 
 
GENERAL INTRODUCTION AND OUTLINE OF THE THESIS 
17 
In this thesis these four levels of Kirkpatrick’s are assessed due to oncogenetics 
CPD activities organized for GPs. The format used to develop oncogenetic CPD 
training (online and live) and a website to use as a supporting tool for GPs 
(www.huisartsengenetica.nl). Evaluation is done on all four levels of Kirkpatrick: 
satisfaction with the oncogenetic training organized, usability and user-friend-
liness of a supportive website, knowledge and communication skills and change in 
daily practice performance (referral rates to departments of clinical genetics).  
Outline of the thesis 
This thesis describes the development and evaluation of oncogenetic CPD modules 
as a thematic example for general practitioners in collaboration with and joining 
The Dutch College of General practitioners (Nederlands Huisartsen Genootschap, 
NHG) based on previous assessments of educational needs and prioritisation of the 
genetic educational topics. Three genetic training modules endorsed by The NHG 
were developed: an online and a live interactive CPD module on oncogenetics and 
a new developed easily accessible website for daily use in practice (www.huis-
artsengenetica.nl). The effectiveness of educational outcomes of needs-based ge-
netics training was examined according to Kirkpatrick’s four levels.  
 
Unfortunately training alone is often not effective to change clinical practice. Addi-
tional measures and actions targeting obstacles to change at the level of teams or 
organisations are needed when plans are developed enabling daily practice 
change. 4,35-38 We also investigated key factors (e.g. collaboration with key actors in 
general practice) for successful future genetics training. Ultimately, gained 
knowledge, skills and attitude on genetics and cancer in family medicine could lead 
to better referral strategies to clinical genetics according to clinical guidelines. This 
would make recognizing familial forms of cancers, improved risk stratification in 
clinical practice, life saving “risk-management options” and timely referral feasi-
ble. The results may serve as a model for future GP genetics training on other 
common disorders (diabetes, cardiovascular disease), but may also serve as a 
model for genetics training for other primary and secondary care professionals 
and to improve the medical curriculum and biology lessons in high school curricu-
la. 
 
The results from this thesis could therefore serve for a step-by-step roadmap pro-
posal, to effectively integrate genetics in daily general practice to its full potential. 
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The following research questions will be addressed in this thesis: 
 
Q1. What are the current primary care educational needs with regard to 
genetics/genomics? 
 
a.  What is the role of genetics/genomics in primary care according to primary 
care health workers and different stakeholders (i.e. clinical genetics profes-
sionals, primary care educators, and patient advocacy groups)? 
b. What are the genetic/genomics educational priorities according to primary 
care health workers and stakeholders? 
 
Q2. Can effective and sustainable oncogenetics education for primary care 
physicians (GPs) be organized and developed? 
 
a. Is an online oncogenetic CPD training module (G-eCPD) effective in improving 
GPs’ knowledge? 
b. Is a live oncogenetic CPD training effective in improving skills and attitude? 
c. Is there a change in actual practice performance (i.e. (self-reported) change in 
patient referral to the department of clinical genetics) as a result of the onco-
genetic education modules organized 
d.  Is a practice-based website for GPs (www.huisartsengenetica.nl) used as a 
supporting tool during daily primary care practice? 
 
Q3. Is it possible to integrate genetics step by step in daily genetic primary 
care and therefore make operationalization possible?  
 
Chapter 2 presents the results of a focus group study among GPs, midwives and 
experts and enables the exploration of the meaning and significance of the role of 
genetics and the need for education in that area as perceived by different stake-
holders (Q1a). 
 Chapter 3 describes a Delphi study on prioritisation of topics in a “Top 10” for 
genetics education for general practice after exploring the themes found through 
the previously held focusgroup transcript analysis (Q1b).  
 Chapters 4 and 5 will answer whether useful and effective CPD modules on 
genetics for non-genetic healthcare workers in general practice can be organised 
and whether genetic competences and actual performance in daily general prac-
tice can be improved (Q2a and b). 
 Chapter 6 will give an overview of the results of the evaluation of effective-
ness of all the genetics CPD modules organised and developed. This will answer 
the last research question (Q2c and d) and will determine whether changes in the 
organization of genetic health care have been achieved and whether new designs 
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of CPD can sustainably be developed that turn primary health workers in to learn-
ers. 
 Chapter 7 describes a 5-step roadmap, which will make it possible to integrate 
genetics information in the Electronic Patient Record (Q3). Through effective im-
plementation of genetics education, operationalization of genetics innovation 
through adding relevant ICPC codes for simple registry of family history, could 
finally become reality. The next step in future research: improved genetic medical 
care in everyday medical practice. 
 Chapter 8 starts with a critical evaluation of the outcome of the studies, focus-
ing on the established changes in the organization of genetic health care, followed 
by recommendations for possible changes and suggestions for implementation of 
genetics education both nationally and internationally and future research pro-
jects. 
 Chapter 9 summarizes the studies and conclusion presented in this thesis. 
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Abstract  
Background  
Available evidence suggests that improvements in genetics education are needed 
to prepare primary care providers for the impact of ongoing rapid advances in 
genomics. Postgraduate (physician training) and master (midwifery training) pro-
grammes in primary care and public health are failing to meet these perceived 
educational needs. The aim of this study was to explore the role of genetics in pri-
mary care (i.e. family medicine and midwifery care) and the need for education in 
this area as perceived by primary care providers, patient advocacy groups and 
clinical genetics professionals. 
Methods 
Forty-four participants took part in three types of focus groups: mono-disciplinary 
groups of general practitioners and midwives, respectively and multidisciplinary 
groups composed of a diverse set of experts. The focus group sessions were audio-
taped, transcribed verbatim and analysed using content analysis. Recurrent 
themes were identified. 
Results 
Four themes emerged regarding the educational needs and the role of genetics in 
primary care: (1) genetics knowledge, (2) family history, (3) ethical dilemmas and 
psychosocial effects in relation to genetics and (4) insight into the organisation 
and role of clinical genetics services. These themes reflect a shift in the role of 
genetics in primary care with implications for education. Although all focus group 
participants acknowledged the importance of genetics education, general practi-
tioners felt this need more urgently than midwives and more strongly emphasized 
their perceived knowledge deficiencies. 
Conclusion 
The responsibilities of primary care providers with regard to genetics require 
further study. The results of this study will help to develop effective genetics edu-
cation strategies to improve primary care providers’ competencies in this area. 
More research into the educational priorities in genetics is needed to design 
courses that are suitable for postgraduate and master programmes for general 
practitioners and midwives. 
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Background 
In the age of genomics, the genetics of common chronic disorders, pharmacogenet-
ics and large-scale applications in screening are becoming increasingly important. 
Primary care providers (e.g. general practitioners and midwives) will have to dis-
cuss these issues with their patients, who are becoming increasingly aware of ge-
netic contributions to disease and also have high expectations of genetic testing.1 
Consequently, primary care providers need to be educated to meet the needs of 
their patients that are created by rapid advances in genomics.2 Genetics literacy 
among primary care providers needs to be improved to enable their participation 
in the debate on the hopes and hypes of genomic medicine and to distinguish be-
tween useful and useless practical applications in health care.3 Currently, genetics 
and genomics are rather underrepresented in postgraduate (physician) training 
programmes in general practice (here, the terms general practice and family medi-
cine (commonly used terms in the Dutch health care system) are considered syn-
onymous to the more commonly used term family practice in the U.S. healthcare 
system) as well as in master programmes in midwifery and public health.4, 5 It is 
widely recognized that medical professionals and medical students should be edu-
cated about genetics.2, 5-7  
 Research into the perspectives of general practitioners and midwives on the 
educational priorities and attitudes in relation to genetics revealed a need for ge-
netics education for primary care providers in areas like psychosocial issues and 
screening, assessment of the risk of genetic malformations and basic genetics.8-16 
However, the educational needs of primary care providers and their views on the 
role of genetics in family practice are still under investigation, and international 
efforts to translate these needs into education programmes are still in their early 
stages.17, 18 
 Primary care providers have a unique role in the Dutch health care system 
and general practitioners are easily accessible to all patients for any complaint, 
request or question. Midwives provide obstetric and perinatal care and give advice 
and guidance to patients on pregnancy and childbirth. Genetics could have an ef-
fect on daily primary care practice if basic and clinical science advances in ge-
nomics of common chronic diseases in practice and midwifery care are successful-
ly translated.2, 3, 19 Changes will only be effective, however, if they fit well into prac-
tice routines. It is therefore important to understand how these key professional 
groups conceive of their responsibilities and experiences in relation to genetics. 
For the implementation of genetics training in daily practice to be successful, it is 
important to identify factors that can enhance or inhibit effective genetic primary 
care. 
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Up till now, most studies of educational needs concerning genetics have been lim-
ited to the perspectives of target groups.1, 4-14 Professional training needs can be 
derived from those studies and from challenges posed by new applications as fore-
seen by experts. This study explored the views of general practitioners, midwives, 
patient advocacy groups and others involved in genetics in health care and educa-
tion regarding their need for genetics education and the role of genetics in primary 
care. This information was collected to help develop effective genetics education 
and training as well as effective integration of genetics in primary care. 
Method 
Design 
We used a qualitative study design with focus groups because this enables the 
exploration of the meaning and significance of the role of genetics and the need for 
education in that area as perceived by different stakeholders. A discussion with 
members of the research team and primary care providers revealed that general 
practitioners and midwives were the primary care providers most likely to be 
confronted with issues of genetics and genomics in their practices. 
Participants 
We used purposive sampling to recruit specific groups of professionals for focus 
group interviews in order to obtain rich, relevant and diverse data. 
 The participants were expected to provide complete and possibly comple-
mentary perspectives on genetics in primary care practice and education. Potential 
participants were named by key persons and network contacts at academic de-
partments of general practice and the midwifery academies in Amsterdam and 
Maastricht, the Netherlands.  
 We convened three types of focus groups, (1) two groups of general practi-
tioners, (2) two groups of midwives, and (3) three multidisciplinary groups com-
posed of clinical genetics professionals (clinical geneticists or genetic counsellors), 
primary care educators, and representatives of patient advocacy groups. The par-
ticipants in the multidisciplinary groups were considered experts who were ex-
pected to have a broad view of the role of genetics in primary care and the need for 
genetics education i.e. what is needed, what works and what does not work. 
 For each focus group, ten to fifteen professionals from one region were invit-
ed by email or telephone. Those who responded positively received an invitational 
letter, informing them that the purpose of the study was to explore their percep-
tions of the role of genetics and genomics in primary care and the related educa-
tion needs. The term ‘genetics’ was commonly used during the focus group discus-
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sions, and the term ‘genomics’ was used to denote a broad definition (e.g. common 
complex disorders and rapid technological developments). 
Focus groups 
Table 1 provides an overview of the participants. The interviews lasted approxi-
mately two hours and were held between March and August 2009. The discussions 
were facilitated by an independent and experienced moderator (SL), who encour-
aged the participants to participate actively and to openly state their viewpoints 
and engage in discussion. An assistant (IH) took notes and all the sessions were 
attended by one observer (LH). Participation was voluntary and participants re-
ceived €100 plus travel expenses. 
 The study was approved by the Medical Ethics Committee of VU University 
Medical Center, Amsterdam and Maastricht University. All participants gave in-
formed consent at the start of their focus group session. 
 
Table 1. Characteristics of the participants in the focus groups 
Type of focus group N Female
(N) 
Mean age in 
years (SD) 
Mean work 
experience in 
years (SD) 
Professional background 
General practitioner group 1 7 3 40.6 (8.1) 11.6 (7.8) general practitioner 
General practitioner group 2 6 3 49.3 (10.2) 19.2 (12.3) general practitioner 
General practitioner group 
total  
13 6 45 (8.7) 15.4 (9.7)  
Midwife group 1 8 8 39.3 (6.1) 13.5 (6.2) midwives 
Midwife group 2 6 6 32.2 (7.9) 7.8 (6.6) midwives 
Midwife group total 14 14 35.7 (6.7) 10.6 (6.1)  
Multidisciplinary group 1 6 5 52.2 (8.3)  3 midwives-midwifery 
teachers, 1 medical doctor-
midwifery teacher, 1 
researcher, 
1 medical psychologist 
Multidisciplinary group 2 7 5 49.7 (6.0)  2 patient organisation 
representatives, 
2 medical doctors, 1 
midwife-midwifery teacher, 
1 policy advisor, 1 clinical 
geneticist 
Multidisciplinary group 3 4 3 47.8 (14.6)  2 patient organisation 
representatives, 
1 genetic counsellor, 1 
policy advisor 
Multidisciplinary group total 17 13 49.9 (8.7)   
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Interview guide 
An interview guide with open-ended questions was developed to ensure coverage 
of the major topics (table 2). The moderator opened each focus group interview 
with an introduction and a round-robin open question: “What are your experienc-
es with genetics/genomics in primary care?” Further probing by the moderator 
was rarely required, since each group spontaneously talked about genetics educa-
tion needs and the role of genetics in primary care. When needed, asking for clari-
fication of the answers was sufficient to elicit ample additional information. 
 
Table 2. Interview guide for the focus group discussions 
Genetics in primary care; assessment of need for inclusion of genetics in primary care education 
What comes to mind when you think of genetics in primary care? 
Do you think primary care workers are capable of answering questions about genetics? Why (not)? 
Genetics in primary care; assessment of the role of genetics in primary care 
In your opinion, what is the role of genetics/genomics in primary care today and what will it be in the 
near future? 
What is your opinion about the genetic knowledge and skills currently available to primary care 
providers to fulfill this role?  
In your opinion, what are the most important genetic topics for the education of general practitioners 
and midwives? 
 
Data analysis 
The focus groups were audio recorded and transcribed verbatim. Member check-
ing entailed sending a summary of the sessions to all participants and inviting 
their comments, which were then incorporated in the transcripts. Using Atlas.ti5.2 
for data analysis, two of the researchers (IH and LH) independently coded the 
themes that emerged from the transcripts. They compared their coding for relia-
bility and reached consensus on differences through discussion. Through a process 
of discussion and deliberation, connections between the codes were identified and 
categories and themes developed. The transcripts were read repeatedly to check 
the accuracy and completeness of the themes and subthemes. In the results sec-
tion, representative quotes from the focus groups, translated from the Dutch, are 
presented to illustrate the themes. 
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Results  
All participants acknowledged the importance of genetics education for primary 
care providers. A need for education was expressed more urgently by the general 
practitioners than by the midwives, while members of the multidisciplinary group 
generally indicated that both groups were deficient in genetics knowledge and 
skills. The extent and focus of the discussions differed between the general practi-
tioners and the midwives, because the general practitioners saw themselves as 
generalists while perinatal care was the primary focus for the midwives. This dif-
ference was reflected in their priorities for education. 
 Four distinct themes emerged: (1) the need for genetics knowledge, (2) taking 
a family history, (3) ethical dilemmas and psychosocial effects related to genetics, 
and (4) insight into the organisation and role of clinical genetics services (table 3). 
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Table 3. Themes and subthemes identified regarding the genetic educational needs of general 
practitioners and midwives 
Themes General practitioners Midwives 
1. The need for genetic 
knowledge 
Perceived need for genetic 
knowledge 
Aware of lack of knowledge 
Cannot know everything 
Knowledge should be aimed at 
prevention of common diseases  
Want to know where to find 
genetic information 
No perceived need of genetic 
knowledge 
Not aware of lack of knowledge 
Knowledge should be aimed at 
prevention of perinatal diseases  
Want to know where to find genetic 
information 
2. Taking a family history Taking a family history and 
pedigree drawing is not routine 
Systematically taking a family 
history could be improved 
Registering family history is 
complicated  
Taking a family history is routine 
Pedigree drawing is not routine; 
infrequently carried out and therefore 
skill not maintainable 
 
3. Genetic ethical dilemmas 
and psychosocial effects 
Increasingly confronted with 
genetic dilemmas and 
psychosocial issues 
Privacy issues and genetics 
complex  
Questions on what should be 
genetically identified and what 
should not 
Perceived difficulty of non-
directiveness in consultations 
Discussing consanguinity is 
difficult  
Genetic developments in perinatal 
screening are rapid; raises more 
ethical questions  
Discussing consanguinity is difficult  
Discussing preconceptional and 
prenatal screening is difficult due to 
inter-cultural differences 
4. Insight into the 
organisation and role of 
clinical genetics services 
Do not know when to refer to 
clinical genetics services  
Prefer to sort things out by 
themselves first 
Little insight into the organisation 
of clinical genetics centres and 
clinical trajectory  
Consult clinical geneticists easily 
Little insight into the organisation of 
clinical genetics centres and clinical 
trajectory  
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1. The need for genetics knowledge 
General practitioners perceived deficiencies in their basic understanding of genet-
ics, since they had never been taught this or because their knowledge had faded. 
They experienced their lack of knowledge as a barrier to the use of genetics in 
diagnosis, treatment and in consulting clinical geneticists, and they expressed a 
strong need for this knowledge, as reflected in the words of one general practi-
tioner (male, 37 years): 
“I think it’s essential to know the basics [of genetics].... You should know what a 
gene is, that there are deviant genes and that genes can be turned on and off... 
These are basics that clarify genetics and make it understandable so that it can 
be translated to patients in relation to diagnosis or treatment or to advise them 
to refrain from something, smoking, for example.” 
Other participants acknowledged this need and argued that general practitioners 
should have more knowledge in order to provide general genetic information. 
Primary care providers wondered how much they really needed to know about 
such a complex field. All groups shared the view that primary care providers can-
not be expected to know everything. Since many genetic diseases are rarely seen in 
primary care, there is no urgent need for them to be included in training pro-
grammes. 
 General practitioners appeared to be generally aware of their lack of 
knowledge, which made them ill equipped to identify genetic problems in their 
patients. In response to the question about experiences with genetics/genomics, 
one general practitioner (male, 52 years) said: 
“I desperately hope the midwife or obstetrician will think of [prenatal diagnosis 
for women of advanced maternal age], because I don’t always think of 
bringingit up. Also, I tend to think the specialist will consider all the genetic as-
pects of a clinical problem, but this often is not the case.” 
Midwives did not perceive a lack of genetics knowledge and said the midwifery 
master programme provided sufficient education on this topic. Multidisciplinary 
group members, however, said that both general practitioners and midwives 
needed education to increase their knowledge, as they observed a lack of 
knowledge in both groups. 
 There was a discrepancy in the content of the required knowledge as per-
ceived by the participants. General practitioners mentioned a need for knowledge 
about prevention of common genetic diseases, whereas the midwives were pri-
marily interested in prevention of perinatal diseases. To meet these educational 
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needs, general practitioners and multidisciplinary experts believed that genetics 
education should address family history and inheritance patterns. 
 Both general practitioners and midwives were interested to know where they 
could find more genetic information. There appeared to be a general need for easi-
ly accessible sources of information such as web-based education or websites with 
short and easy to understand information that could be applied in daily practice. 
2. Taking a family history  
Primary care providers believed that taking a family history was extremely im-
portant as it allows for familial risk stratification and identification of hereditary 
conditions. For midwives the importance of family history was limited to perinatal 
disease. The need to increase awareness of familial diseases in primary care was 
discussed by a midwifery educator (female, medical doctor, 56 years): 
“We agree on when to think of some familial diseases. I mean, it’s clear when 
speaking of colon carcinoma or breast cancer that you realize [as a general 
practitioner] that it can be inherited. There should be a clinical guideline to help 
one decide when to consult a clinical geneticist for further diagnosis. Today, 
more general practitioners should realize this [colon carcinoma or breast can-
cer] could be familial.” 
An educator, allied to a postgraduate general practice programme, thought that 
taking a family history was well covered during postgraduate training, but the 
general practitioners were not quite so sure. Although family history was part of 
some consultations, most general practitioners said that family history and pedi-
gree drawing were not part of their daily routine. The midwives said that family 
history was something they did every day, but they lacked the skills for pedigree 
drawing. They thought this was not important, however, because they did not do it 
often enough to maintain this skill. They thought the main thing was to be able to 
recognize high-risk factors in a family history 
“Midwives generally lack sufficient knowledge to draw a pedigree. I think the 
same applies for general practitioners, but it is more important for them [gen-
eral practitioners] to detect high-risk family history criteria. How and when is 
something important? The signalling function, that is important and it should 
be taught. Counselling is important for both general practitioners and midwives. 
But above all it is important to be clear on when something is important, how 
important it is for you, what you want to do about it, and once this is clear you 
can take the next step” (a female GP and midwifery educator, 39 years).  
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General practitioners were uncertain about recording information from family 
history in the Electronic Patient Record. Participants said that measures should be 
taken to improve the Electronic Patient Record to include information from family 
history. 
3. Ethical dilemmas and psychosocial effects related to genetics 
Most primary care providers expressed concern about the surge of genetic testing 
which confronted them with ethical dilemmas and more profound psychosocial 
effects of genetics in their daily practice. One participant said he was faced with 
“an increasing amount of vague, worrying and inexplicable genetic information”. 
He referred to information about genetic risks provided to consumers by commer-
cially available Personal Genome Services. Primary care providers felt unqualified 
to deal with these issues and thought that genetic ethical dilemmas should be part 
of genetics education. 
 General practitioners also wondered whether it was beneficial to their pa-
tients and themselves to know everything about a patient’s genetic background. 
They voiced concern about the possibility of unauthorized dissemination of genet-
ic information and related privacy issues if it were to become obligatory for them 
to take a family history and record the information derived from it. They asked: 
“Who should you inform about genetic information and who should you not in-
form if you want to keep your patient’s best interest at heart, for example when a 
patient wants to take out life insurance or needs a mortgage to buy a new house?” 
 Midwives thought that developments in genetics were moving at a very rapid 
pace, giving rise to feelings of insecurity both in midwives and their patients. They 
discussed whether following the protocol for perinatal screening might be inap-
propriate and therefore not uniformly applicable. They preferred to adapt the 
application of genetic protocols to individual patients, because test results could 
have important genetic and personal consequences. One midwife, (female, 40 
years) explained: 
“Surely because this child is already in the uterus, the basic question is rather 
what do you really want to know? Because what are you going to do with this 
[genetic] information?” 
Clear guidelines as to when a general practitioner should be proactive and bring 
up the subject of familial disease to patients and their families were non-existent 
but considered necessary. General practitioners were unclear about how to guide 
patients in their decisions around prenatal and genetic testing. As a result they 
perceived non-directive counselling as difficult because it was influenced by their 
personal opinions and sense of urgency. One general practitioner (male, 52 years) 
explained: 
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“I used to discuss prenatal screening with patients at first when it was a hot 
item. Everybody wanted the triple test, but this seems to change when you ex-
plain that it gives a probability that doesn’t offer any certainty and things can 
also happen after the baby is born or you cannot always see things on the out-
side and people then pull back automatically. I try to counsel nondirectively, be-
cause it promotes shared responsibility. I like to hold on to this nice shared re-
sponsibility, because it doesn’t make me feel that I am solely accountable.” 
General practitioners and midwives alike mentioned consanguinity as a complex 
issue to discuss with patients and they raised the problem of how to deal with a 
potentially increased risk of congenital disease. One general practitioner (female, 
52 years) said: 
“When cousins get married, they are blissfully happy when presenting this news 
to their doctor. As a general practitioner I find it complicated, when there is a dis-
ease in the family, to confront these people with this problem in today’s society.”  
Inter-cultural differences were considered a source of difficulties in discussing 
prenatal or preconceptional screening. Midwives sensed urgency early on in preg-
nancy when recommending this type of screening to members of ethnic minorities 
in order to prevent congenital disease. This feeling of urgency was sometimes 
enhanced by language barriers and time constraints. 
4. Insight into the organisation and role of clinical genetics services 
General practitioners expressed a need for education with regard to indications for 
referral to clinical genetics services. Some general practitioners preferred to first 
gather information from other sources (such as online websites) before turning to 
a clinical geneticist. Other general practitioners said it was better to refer than to 
do it all yourself. Midwives, on the other hand, said it was easy for them to consult 
clinical geneticists, whom they regularly telephoned for advice. 
 Some general practitioners and midwives said it was not clear to them what 
clinical geneticists do and what the clinical trajectory would be once a patient was 
referred to such a service. General practitioners mentioned their lack of familiarity 
with this type of service as a cause of inappropriate consultation strategies, which 
could result in untimely referrals. Geneticists argued that general practitioners 
should consult them more often, and that this should be stimulated by education. 
“The relation between primary and secondary care is sometimes difficult. Once 
the clinical geneticist has diagnosed a certain genetic disease, which means 
more specialised information, the patient’s family members find themselves in a 
pickle together with the GP and then the whole process (of consulting) starts all 
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over again. […] I hope education of primary care providers will result in acces-
sible consultation services. Because I don't think the general practitioner should 
know everything about everything ... but they should at least know that help is 
easily available.” (Clinical geneticist, female, 45 years).  
The role of genetics in primary care 
The role of genetics in primary care was perceived to be unduly limited as a result 
of care providers’ inadequate genetics knowledge and skills. Although care provid-
ers might show some interest in improving their knowledge, representatives of 
patient advocacy groups indicated that primary care providers were “not suffi-
ciently proactive” in this area. They perceived an urgent need for inclusion of ge-
netics in primary care guidelines in order to make genetics a “hot item”. General 
practitioners and midwives said they were unsure about their responsibilities in 
relation to genetics, perhaps because they lacked insight into the genetic back-
ground of diseases and its possible consequences. A representative of a patient 
advocacy group (male, 59 years) said:  
“No knowledge (of genetics) and no interest (in genetics). It’s not a hot item. It 
seems as if general practitioners are not interested in identifying patients with 
familial hypercholesterolemia (FH). We have an excellent screening programme 
for this in the Netherlands, which threatens to go under because too few index 
patients are put forward by general practitioners. General practitioners do not 
alert patients that they might have FH when there is a positive family history 
and high cholesterol levels, and patients are not advised to take part in a brief 
screening programme […]. General practitioners often say they don’t have the 
time or they’re not interested or they see no benefit.” 
Primary care providers noticed a change in their experiences with and views of the 
role of genetics in primary care, which led to an increased need for basic 
knowledge of genetics and family history taking. General practitioners felt their 
current knowledge was insufficient to meet these needs. Participants also said 
they noticed an increase in patients’ questions about genetic issues. They per-
ceived a change in the responsibilities of primary care providers that prompted 
increased attention for genetics. They also saw an urgent need for a description of 
the responsibilities of different disciplines in relation to genetic issues. A clinical 
geneticist (female, 40 years) put it as follows:  
“When I think of genetics I think of monogenetic disorders, but of course disor-
ders (seen in primary care) are often complex disorders or multigene or gene 
environment interaction disorders. Of course, clinical genetics cannot deal with 
all those problems, it’s simply impossible. […] I think it is the task of the general 
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practitioner, but I find this difficult... is it really the task of the general practi-
tioner to deal with such complicated problems?” 
Overall, participants were positive about the changed role of genetics in primary 
care. They said this change emphasized their role as an easily accessible source of 
information. However, there was also some criticism. General practitioners saw 
even more work coming their way, which caused some concern. Taking a family 
history, non-directive counselling, and unfamiliarity with recording information 
from family history in their electronic patient record were said to take up a great 
deal of time. 
 General practitioners indicated that they were aware of rapid developments 
in genetics and the subsequent lag in its application in primary care. They regard-
ed this as important and pointed to two aspects of this change. Firstly, they said it 
was urgent for limits to be set in relation to required genetics-related knowledge 
and responsibilities in primary care. Secondly, education should include the clini-
cal application of genetic developments and ways to communicate genetic infor-
mation. A midwifery educator (female, medical doctor, 56 years) clarified these 
aspects: 
“Highly educated people develop national genetics guidelines. Even the ethical 
issues involved in these problems and how to deal with them are prescribed. In 
primary care you are in close contact with patients and it can be difficult some-
times to apply theory-based guidelines in a way that can be understood by pa-
tients, it is difficult to do this appropriately.” 
Suggestions for strategies for effective genetic education 
At the end of each focus group interview, the participants were asked to briefly 
consider effective strategies for teaching genetics in primary care education (table 
4). 
 The following general considerations emerged: programmes should be rele-
vant to primary care practice, participants in the multidisciplinary group empha-
sized the importance of assuring the quality of educational strategies and suggest-
ed that programmes should range in duration from brief sessions to ten-day pro-
grammes. Finally, strategies should be added to existing programmes or could be 
integrated with other topics, such as cardiovascular risk management or familial 
breast cancer as examples of common diseases. 
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Table 4. Suggested strategies, including details, for effective ways to incorporate genetics into primary 
care education 
Strategies Details 
A short internship in the clinical genetics department 
to familiarise students with the specialty 
Suggested by clinical genetics professionals, 
primary care educators and younger general 
practitioners 
E-learning Younger participants were in favour  
Lectures Preferred by older participants 
New guidelines which should be easily accessible on a 
website 
A decision tree should be attached to help GPs 
and midwives with busy schedules to quickly 
find genetic information about how, when and 
to whom to refer. 
Workshops Learning by discussing clinical cases with 
colleagues and attending clinical geneticists, 
paediatricians or other specialists depending 
on the topic under discussion. 
Basic genetic knowledge, skills, such as 
drawing a pedigree, and attitude, through 
discussing medical ethical topics, could be 
included. 
Continuing Professional Development CPD genetics sessions repeated yearly and 
accredited with CPD credits to promote 
attendance.  
CPD = Continuing Professional Development 
Discussion 
The results of this study indicate that Dutch primary care providers need, and 
would welcome, more extensive education in genetics. Four major themes 
emerged in relation to the role of genetics in primary care and the related educa-
tional needs: lack of basic knowledge, need for education on family history taking 
and the potential clinical consequences, ethical dilemmas and psychosocial effects 
related to genetics and insight into the organization of regional genetics services 
and the referral system. There was general agreement that increased genetics 
knowledge and family history taking by primary care providers would require a 
better understanding of the organization of genetics services in order to promote 
more appropriate and timely referrals. In summary, the results point to a need for 
courses in genetics for master programmes in midwifery and postgraduate pro-
grammes in family medicine. 
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A similar need for genetics education in primary care was also found in other stud-
ies. The identified needs are in line with the learning outcomes and core compe-
tencies in genetics proposed by genetics experts for non-genetic health care pro-
fessionals.17,18 Since there is little published research on the extent to which the 
need for genetics education matches the core competencies, we used a qualitative 
approach to explore the views of the target group. In this way we gained insight 
into the educational needs of this group with regard to genetics; general practi-
tioners indicated that a paucity of knowledge can lead to poor recognition of and 
unresponsiveness to genetic problems in daily patient care. 
 The results of this study are in line with some studies and differ from others 
with regard to the need for increased genetics knowledge among midwives and 
general practitioners.5, 8, 10, 12, 13, 14, 16, 19, 20 The midwives in our study seemed more 
confident of their basic knowledge and did not perceive as strong a need to adapt 
existing educational programmes as was expressed by midwives in studies by 
Benjamin et al. and Metcalfe et al..8, 13 This difference may be due to differences 
between master programmes in midwifery or between health care systems. 
 Our results support the outcomes of the afore mentioned studies regarding 
deficiency in skills (e.g. taking a family history, referral to appropriate regional 
genetics services and non-directive counselling).8, 13 It may be problematic for 
primary care providers to take appropriate steps in response to the perceived shift 
in the importance of genetics in primary care, such as taking enough time to dis-
cuss the family history or non-directive counselling. Another step to take would be 
to improve the Electronic Patient Record in order to achieve accurate documenta-
tion of family history information. 
 Martin and Wilikofsky reported on general practitioners’ perceptions of their 
role in genetic counselling and their unwillingness to accept this role due to time 
and organizational constraints.21 Representatives of patient advocacy groups and 
genetic counsellors in our study emphasized the need to increase acceptance of the 
importance of genetics and genetic counselling in primary care. The responsibility, 
on the part of the patient or the doctor, to report data from the family history re-
mains a topic of debate, however, even though the importance is clear and primary 
care seems well suited to include this role in daily practice routines.22 Perhaps a 
joint effort by all stakeholders would be realistic and useful. 
 
General practitioners and other participants in our focus groups recognized the 
important role of genetics in primary care. This is in contrast to a study conducted 
by Fetters et al. in 1999, which found general practitioners reluctant to invest in 
self-education in genetics, because they felt genetic problems were not clinically 
relevant.12 Our study suggests that today’s primary care providers are aware of a 
progressive impact of genetics on primary care and therefore increasingly con-
scious of what they don’t know. They recognize the need for attention to genetics 
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in educational programmes. Perhaps this is a reflection of family medicine finally 
becoming aware that genetics and genomics are an integral part of primary care. 
 Clinicians were seen to be uncomfortable in applying genetics in their daily 
practice, which resulted in difficulties in referring adult patients for genetic coun-
selling.7 Our study showed similar results. Some general practitioners were reluc-
tant to consult a clinical geneticist, whereas midwives seemed to be more comfort-
able with this. Representatives from patient organizations were also aware of this 
barrier and urged more genetic education for primary care providers, general 
practitioners in particular. Taylor et al. also suggested that insurance coverage of 
genetic consultation can be a problem. There is currently a paucity of published 
research on the clinical value of genetic evaluation in primary care.23-25 Genetic 
counselling could be of greater value and might be integrated in periodical check-
ups more often if its results had greater practical applicability. 
 The educational strategies suggested by general practitioners and midwives 
in this study appear to be supported by Gaff et al., who concluded “Program logic, 
adult learning theory, and evaluation theory together provide a useful and relevant 
theoretic framework for the development of genetics education programs for 
health professionals.”26 
Limitations 
The use of focus groups has engaged primary care providers of a potential genetics 
education programme in the Netherlands. A variation in concepts is possible, be-
cause it is unknown how far the themes reach in their contribution and interaction 
in real practice. The aim of this study was intended to yield results regarding the 
participants’ particular views on knowledge, skills and attitudes in relation to ge-
netics education in primary care. Apart from homogenous groups of general prac-
titioners and midwives, we included participants from a variety of backgrounds to 
obtain input on broader and future developments in genetics in primary care. 
However, it remains to be investigated if the results have relevance beyond the 
Dutch health care system, since the nature of the sample was drawn from this 
particular health care system. 
 Together with previously published studies on various aspects of genetics in 
primary care education, our study offers a broad perspective on genetics educa-
tion. We believe this information can be used to develop genetics education pro-
grammes in the near future. The inclusion of multidisciplinary focus groups which 
could provide meta views can be considered a strength but also a weakness of this 
study because of the unequal representation of different fields of expertise in these 
groups. Another limitation is that purposive sampling can result in self-selection, 
which can introduce bias. Our study revealed four major themes concerning the 
role of genetics in primary care. In order to ensure that our picture is complete and 
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usable for educational purposes, and possibly for policy makers as well, consensus 
has to be sought, for example by means of a Delphi procedure. 
Conclusions 
The results of this study suggest that postgraduate training in primary care could 
be enhanced by incorporating additional training in basic clinical genetics. For 
midwives and general practitioners there should be more emphasis on counselling 
using strategies that are clinically feasible and on ethical issues relating to genetic 
conditions. Insight into the organization of regional genetics services and the re-
ferral system should be enhanced to promote interdisciplinary collaboration. 
There is an urgent need for a clear description of responsibilities and guidelines to 
enable effective use of developments in genetics in primary care. Especially de-
scriptions of the genetic responsibilities of primary care providers and their spe-
cific role in this area will have to be addressed by future research. Useful and effec-
tive application of genetics knowledge can only become a reality when genetics 
education is improved.  
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Abstract 
Purpose 
General practitioners (GPs) are increasingly expected to deliver genetics services 
in daily patient care. Education in primary care genetics is considered suboptimal 
and in urgent need of revision and innovation.  
Aim of the study was to prioritise topics for genetics education for general prac-
tice. 
Methods 
A Delphi consensus procedure consisting of three rounds was conducted. A pur-
posively selected heterogeneous panel (n=18) of experts, comprising six practising 
GPs also engaged in research, five GP trainers, four clinical genetics professionals 
and three representatives of patient organisations, participated. Educational needs 
regarding genetics in general practice in terms of knowledge, skills and attitudes, 
were rated and ranked in a Top 10. 
Results 
The entire panel completed all three rounds. Kendall’s coefficient of concordance 
indicated significant agreement regarding the top ten genetic educational needs 
(P<0.001). “Recognising signals that are potentially indicative of a hereditary 
component of a disease” was rated highest, followed by “Evaluating indications for 
referral to a clinical genetics centre” and “Knowledge of the possibilities and limi-
tations of genetic tests”.  
Conclusion 
The priorities resulting from this study can inform the development of educational 
modules, including input for case-based education, to improve GP performance in 
genetic patient care. 
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Introduction 
It has been argued that the greatest public health benefit of advances in under-
standing the human genome may be realized for common chronic diseases such as 
cardiovascular disease, diabetes mellitus, and cancer.1 International attempts to 
integrate such knowledge into clinical practice are still in the early stages, and as a 
result, many questions surround the current state of this translation.1-3 Physicians 
lack knowledge of genetics relevant for daily practice, lack oversight of genetic 
testing and concerns about privacy and discrimination, and report inadequacy to 
deliver genetic services.1, 4 For genomics to have an effect on clinical practice that 
is comparable to its impact on research will require advances in the genomic liter-
acy of health-care providers.5  
 In the age of genomics both genetics of common disorders and large scale ap-
plications in screening will become increasingly important, and primary care 
health workers will have to be prepared to discuss these issues with their clients. 
GPs may get more involved in preventive check-ups and develop a more flexible 
way to deal with patient’s requests for genetic tests, in addition to the original role 
in an open access full time service for every patient. 
 Defining genetic core competences for non-genetic health care workers was 
considered prerequisite for implementing genetics education for general practice. 
1, 3, 6, 7 Such education programmes should be based on an educational needs as-
sessment of GPs referring to the three domains of educational activities: cognitive 
(knowledge), psychomotor (skills) and affective (attitude).  
 Recently, a focus group study among participants from a variety of discipli-
nary backgrounds explored the genetic educational needs of GPs in the Nether-
lands.8 The results showed an urgent need for a genetics curriculum for postgrad-
uate and continuing general practice education. Four overarching themes were 
identified with regard to educational needs: genetics knowledge, family history, 
ethical dilemmas and the role of clinical genetics services. These themes clarified 
genetics in general practice with implications for education.  
 The aim of the present study was to obtain consensus on prioritisation of GPs’ 
educational needs regarding genetics, as identified in focus groups and focused on 
“knowledge”, “skills” and “attitudes”. The results are aimed to inform the devel-
opment of effective genetics education for GPs.  
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Materials and methods  
We used a Delphi method to operationalize the findings from our earlier focus 
group study and to obtain consensus on the prioritization of topics for GP genetics 
education. The Delphi technique has been widely used and is an accepted method 
for gathering data and achieving consensus from respondents within their domain 
of expertise.9, 10 The technique was mainly developed by Dalkey and Helmer in 
1963 at the Rand Corporation in the 1950s.11  
 A panel of experts emailed their responses to a questionnaire about GPs’ edu-
cational needs to the researchers in three rounds. The responses were fed back 
anonymously to all panel members in order to share answers and arguments 
thereby enabling the participants to reflect on different views and modify their 
own. 
Panel selection 
Eighteen purposively selected experts from the Netherlands responded to an invi-
tation to participate in the study sent to 24 experts (response rate 75%). Of the 
invited experts, three did not participate due to time constraints, and three did not 
respond at all. Recruitment was guided by the researchers’ network, and a snow-
ball method was used. Through the authors’ [researchers] network, work in general 
practice and clinical genetics (Centre for Community Genetics in the Netherlands) we 
were familiar with key persons eligible for recruitment in our expert panel. Repre-
sentatives from patient advocacy groups were asked whether they were interested 
in participating or could refer someone else. We established a heterogeneous pan-
el of experts who participated anonymously: six practicing GPs, also involved in 
research, five GP trainers, four clinical genetics professionals (one genetic counse-
lor, three clinical geneticists) and three representatives from patient advocacy 
groups (See table 1 “Characteristics of the participants in the Delphi study”). The 
participants were considered to represent a complete overview, from different 
perspectives, of the importance of genetics core competences for general practice 
and the need of genetics education in general practice, i.e. what is needed, what 
works and what does not work. Eleven experts (61%) were female, and the aver-
age age was 51.4 years (SD 9.1). Seven panelists also took part in our previous 
focus group study.  
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Table 1. Characteristics of the participants in the Delphi study 
Type of Delphi 
subgroup 
N Female 
(N) 
Mean age 
 in years 
(SD) 
Mean work 
experience in 
years (SD) 
Professional background 
General practitioners 11 6 52.0 (9.4) 17.0 (11.0) general practitioner;  
6 practicing and involved in 
research, 5 trainers 1 genetic 
counselor, 3 clinical 
geneticists individuals 
representing: public health 
organization, patient advocacy 
groups for rare conditions and 
genetics and reproduction 
advocacy groups 
Clinical genetic 
professionals 
4 3 54.5 (8.6) n.a. 
Patient/consumer 
advocacy group 
representatives 
3 2 44.7 (7.6) n.a. 
Total 18 11 51.4 (9.1)  
n.a. not available 
 
The Delphi procedure  
The initial questionnaire consisted of 29 topics describing GP educational needs. In 
order to arrive at these needs, we first transformed all previously identified educa-
tional needs within four overarching identified themes in focus groups into learn-
ing outcomes.8 We then refined the list based on the proposed learning outcomes 
from the suggested core competences for GPs in Europe.12 Topics relating to three 
domains of primary care genetics were presented to the participants: “knowledge” 
(7 topics), “skills” (12 topics) and “attitudes” (10 topics). 
 The flowchart in Figure 1 shows the phases and the (anonymous) process of 
the three consecutive Delphi rounds. After analyzing the responses to each round 
(EJFH, LH and MW) and discussing them with the other researchers (SJvL, MCC, 
GJD and CvdV), the researchers reworked the responses into a new questionnaire. 
The Delphi study was conducted between December 2009 and March 2010. At the 
start of the study, all experts were asked to complete at least three Delphi rounds. 
They received 100 Euro upon completion of the whole procedure. 
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Figure 1. Flowchart Delphi consensus and prioritization procedure on GPs’ genetic educational needs 
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Criteria for consensus 
The research group discussed criteria for consensus on genetics education needs 
before the actual study was undertaken. The purpose of the study was to obtain 
consensus on and prioritize genetics educational needs in primary care. For this 
purpose, in the first two rounds, the experts were asked to prioritize the topics by 
ranking their importance and to give their Top 3 of topics for inclusion in educa-
tional modules. In the third and final round, ten items on which consensus was 
established in the first two rounds were judged. The definition of the inclusion 
criteria in a Top 3 in favour of a topic became more rigorous in the following sec-
ond round, because in the first round at least two experts had to agree with a topic 
in the Top 3, whereas at least three experts had to agree in the second round. This 
will be explained in more detail below. 
Round 1 
In the first round, the experts were asked to rate the educational urgency for GPs 
of each of the 29 topics on a 7-point scale: “I believe that GPs have a strong need 
for education on [topic]”, (totally disagree (1) - totally agree (7)). Experts were 
asked to comment on the topics they had given the lowest (1) and the highest (7), 
rating or about which they had doubts. The responses were converted into im-
portance-based clusters of categories (low (1-2), medium (3-5) and high (6-7) 
importance category). The experts were also asked to indicate three (Top 3) of the 
29 educational needs which they thought GPs most urgently wanted to be incorpo-
rated in an educational programme to be delivered within the next twelve months. 
In the first round, consensus in favour of a topic was defined as ≥75% agreement 
regarding the “importance category” and/or inclusion among the Top 3 by at least 
two experts. 
Round 2 
The questionnaire for the second round consisted of the sixteen topics that had 
survived the first round. Some small adjustments were made to clarify topics 
which had been shown to be somewhat unclear. The inclusion criteria for the next 
round were more rigorous: ≥75% agreement on importance category and/or in-
clusion in the Top 3 by at least three experts. An exception was made for topic #15 
(“educating patients on the possibilities and limitations of genetic tests”), which 
despite 76% agreement was rejected in the second round, because the experts 
thought there was too much overlap with topic #4 (“knowledge of possibilities and 
limitations of genetic tests”), which did pass the round.  
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Round 3 
For each topic the experts received a summary of the comments from the previous 
two rounds with the number of Top 3 ratings in round 2. The experts were asked 
to list their Top 10 of genetics educational needs for GPs, and Kendall’s W (coeffi-
cient of concordance assessing agreement among raters) was computed for these 
rankings. 
Results 
After three Delphi rounds, 29 topics (table 2) were reduced to 10 priorities regard-
ing genetic educational needs (table 3). All eighteen participants completed all 
three rounds. Response was high with many comments per round (table 2), indi-
cating strong involvement of the experts. Of the 29 initial topics, ten remained 
after three rounds (text box 1 and 2). Of the 29 initial topics, three were modified 
after comments. 
 High agreement on a topic did not always imply high frequency in the Top 3. 
In fact, the reverse was true for some topics, which led to some unexpected results. 
Topic 1 (“Refreshing knowledge of basic genetic principles”), for example, showed 
only 39% agreement, but nevertheless made it through to the third round, because 
four experts placed it in their Top 3. In support of topic #1, some experts com-
mented: “I think there are great differences [in competency] between younger and 
older GP generations” (active GP) and “without a proper knowledge basis, every-
thing else will be futile”. These comments underscored the notion improving ge-
netics knowledge will pave the way for successful improvement of skills and atti-
tudes for all GPs. 
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Table 2. Number of comments (n), consensus (%) per round, frequency of inclusion in Top 3 (N) and 
final result (accepted/rejected) in terms of agreement or disagreement with the proposed topics 
Topic Round 1 Round 2 Result In round 
 n % N in Top 3 n % N in Top 3   
Knowledge         
1 18 39 4 18 39 4 Accepted  
2 17 53 1    Rejected 1 
3 17 76 5 18 83 4 Accepted  
4 18 89 10 18 89 8 Accepted  
5 16 69 5 17 71 3 Accepted  
6 17 65 2 18 72 5 Accepted  
7 16 50 0    Rejected 1 
 
Skills 
        
8 18 78 2 18 100 6 Accepted  
9 16 56 1    Rejected 1 
10 17 71 4 18 50 3 Accepted  
11 16 75 3 17 71 7 Accepted  
12 18 61 1    Rejected 1 
13 16 44 3 18 39 3 Accepted  
14 18 61 0    Rejected 1 
15 18 61 2 17 76 2 Rejected 2 
16 17 53 0    Rejected 1 
17 16 56 2 18 61 0 Rejected 2 
18 17 76 1 18 72 1 Rejected 2 
 
Attitude 
        
19 18 56 0    Rejected 1 
20 18 33 2 18 33 3 Accepted  
21 17 29 0    Rejected 1 
22 16 50 0    Rejected 1 
23 16 56 0    Rejected 1 
24 18 61 1    Rejected 1 
25 18 61 2 17 71 1 Rejected 2 
26 17 71 2 18 56 1 Rejected 2 
27 17 41 0    Rejected 1 
28 18 67 0    Rejected 1 
29 17 76 1 18 72 2 Rejected 2 
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Table 3. Overview of mean rank order1 (Top 10) and Kendall’s coefficient of concordance assessing 
agreement among experts 
Topic # Mean rank 
order 
General 
Mean rank 
order 
Active GPs 
Mean rank 
order 
GP trainers 
Mean rank order 
Clinical genetic 
professionals 
Mean rank order 
Representatives 
patient organizations 
11 2.9 3.0 4.4 1.5 2.3 
8 3.1 3.7 3.8 1.8 2.7 
4 3.2 4.7 1.2 4.3 2.3 
6 4.6 5.3 4.4 5.0 2.7 
3 5.2 4.9 5.6 4.5 6.0 
1 6.1 5.3 6.6 7.5 5.0 
5 6.6 6.0 6.0 7.5 7.0 
10 7.3 6.6 5.0 10 8.7 
13 8.0 7.5 8.6 7.3 9.0 
20 8.1 8.0 9.2 5.8 9.3 
      
N 18 6 5 4 3 
Kendall’s W 0.433 0.271 0.595 0.779 0.919 
Chi-square2 70.208 14.660 26.760 28.036 24.818 
df 9 9 9 9 9 
Sig 0.000 0.101 0.002 0.001 0.003 
1 The lower the score in mean rank order, results in higher ranking in the Top 10. 
2 Comparing score for topics within the group.  
 
An example of a topic that was accepted in the first round (76% agreement, N=1 in 
Top 3) but rejected in the second round (72% agreement, N=1 in Top 3) is topic 
#18 (“Explaining the consequences of a genetic test for a patient and his or her 
family”). According to a Clinical genetic professional: “This task should be specifi-
cally assigned to the genetic counsellor. GPs should be able to generally evaluate 
whether a patient should be referred” and “The consequences [of genetic test re-
sults] are diverse. Generalization would be dangerous and might lead to misinfor-
mation. It seems therefore wiser for this kind of specific information to be deliv-
ered by a clinical genetics professional”. 
 After round 2, there was consensus on ten topics, which increased for most 
after modification of the wording. In the end, it was not difficult to distinguish 
between accepted and rejected topics. The prioritized topics at the end of round 3 
supports the development of educational modules with the main focus on skills 
and knowledge (Kendall’s W=.43, P<0.001).  
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Text box 1. Accepted topics  
Knowledge 
1 Knowledge of basic genetic principles (round 1) 
Refreshing knowledge of basic genetic principles (round 2 and 3) 
3 Knowledge of the most important genetic disorders in the Netherlands (round1) 
Knowledge of the prevailing (most common) genetic disorders in the  
Netherlands (round 2 and 3) 
4 Knowledge of the possibilities and limitations of genetic tests 
5 Knowledge of the wide array of referral possibilities concerning genetics 
6 Knowledge of the most important sources of genetic information 
 
Skills 
8 Evaluating indications for referral to a clinical genetics centre 
10 Discussing genetic risks with patients (risk communication) 
11 Recognising signals potentially indicative of a hereditary component of a disease 
13 Taking and interpreting a family history 
 
Attitude 
20 Being aware of the fact that many symptoms/disorders can have a  
genetic component (round 1) 
Being aware of the possibility of a genetic/hereditary component of  
symptoms and disorders (round 2 and 3) 
 
 
Although Kendall’s W showed significant agreement among the respondents, there 
were also differences of opinion between subgroups of experts on different topics. 
For example participants from the active GP subgroup and Clinical genetic profes-
sionals subgroup commented differently on topic #10 (“Discussing genetic risks 
with patients (risk communication”). Active GPs (mean rank order 6.6) comment-
ed “Risk communication is difficult, certainly in the case of genetic diseases” and 
“Risk communication is becoming more important, most GPs are not educated on 
this topic.” Clinical genetic professionals however commented less supportive of 
adding this topic to the Top 10 of educational topics (mean rank order 10) “I think 
it depends on the [genetic] disease and the degree of difficulty. I prefer the GP to 
leave this up to the Clinical geneticist” and “If risk communication is meant as a 
means to support the patient in handling their genetic risk, this could be a GP’s 
responsibility. However, if is meant the GP should be capable of calculating a cer-
tain genetic risk and discuss this with the patient, additional education would be 
necessary.” 
 Relatively high agreement was found within the subgroup of GP trainers 
(Kendall’s W=0.60, P=0.002), clinical genetics professionals (Kendall’s W=0.78, 
P=0.001) and representatives of patient organisations (Kendall’s W=0.92, 
P=0.003), whereas agreement was relatively low among practising GPs (Kendall’s 
W=0.27, P=0.101).   
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Text box 2. Rejected topics 
Knowledge 
2 Knowledge of different hereditary patterns 
7 Knowledge of the consequences of genetic testing for obtaining a  
mortgage and insurance 
 
Skills 
9 Discussing with patients how to cope with (an increased risk for) a  
genetic disorder 
12 Explaining genetic information in a way that is adapted to the patient’s level of knowledge 
14 Drawing and interpreting a pedigree 
15 Educating patients on possibilities and limitations of genetic tests 
16 Explaining the genetic aspects, except lifestyle, of multifactorial  
disorders  
17 Informing parents about the possibilities and limitations of prenatal and 
neonatal screening 
18 Explaining the possible consequences of a genetic test for a patient and  
his or her family 
 
Attitude 
19 Recording a family history in such a way that it can be easily retrieved 
21 Guiding patients with genetic issues in a non-directive way 
22 A medical practitioner’s role in (actively) suggesting the possibility  
of having a genetic test 
23 Demarcating tasks in the field of genetics in comparison with other 
caregivers 
24 A GP’s role in decisions about discussing (the chances of) a genetic  
disorder with the patient’s family 
25 Offering support to patients with (an increased risk for) a genetic  
disorder 
26 Dealing with the choices relating to genetics, made by people from  
different cultures 
27 Dealing with sensitivities surrounding genetic disorders in families 
28 Informing patients about genetic risks in consanguine marriages 
29 Dealing with ethical dilemmas in genetics 
Discussion 
Our study generated consensus on a Top 10 of prioritized topics for GPs’ genetics 
education. The highest ranking topics were concerned with skill and knowledge 
competences: “Recognizing signals that can indicate a hereditary component of a 
disease”, “Evaluating indications for referral to a clinical genetics center”, and 
“Knowledge of the possibilities and limitations of genetic tests”. These priorities 
could, in particular, be met by case-based education.  
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Strengths and limitations of the study 
The Delphi procedure included eighteen selected experts, who completed all 
rounds. Despite the experts’ differing backgrounds, it remains to be investigated if 
the results have relevance beyond the Dutch health care system, since the nature 
of the sample was drawn from this particular health care system. General practice 
in the Netherlands is an open access full-time service for every patient with any 
medical complaint, request, or question. The service includes a list system, imply-
ing that every person (with or without a disease) is on the list of one general prac-
titioner (GP), thus guaranteeing optimal continuity of care. The GP handles more 
than 90% of all presented complaints and diseases. If genetic counseling as a pri-
mary care service is available in their particular region, the GP manages most re-
ferrals to this service as to most other primary care services and to all secondary 
care services. Therefore, the GP is the first to whom a patient will turn when 
he/she has questions on prevention and treatment of disease. 
 The results of this study are in line with some studies and differ from others 
with regard to the need for increased genetics knowledge in general practition-
ers.5, 12-16 This difference may be due to differences between health care systems. 
However, our previous focus group results are supported by the outcomes of the 
afore mentioned studies regarding deficiency in skills (e.g. taking a family history, 
referral to appropriate regional genetics services and non-directive counselling).8, 
17, 18 It may be problematic for primary care providers to take appropriate steps in 
response to the perceived shift in the importance of genetics in primary care, such 
as taking enough time to discuss the family history or non-directive counselling.  
 Another possible weakness of our study is regression to the mean, although 
this is inherent to this consensus method: experts are inclined to adjust their opin-
ions during a consensus process.15 Nevertheless, there was a high degree of 
agreement on the ten final topics, while nineteen topics were not accepted despite 
several adjustments. The procedure started with topics based on our earlier focus 
group research, and some experts were aware of these results although they were 
unaware of each other’s identity.8 Although this may have biased their opinions, 
the validity of the focus group results was checked by comparing them with the 
results of the consensus procedure, a process commonly referred to as triangula-
tion.19 Compared with the results of the focus groups, this study strengthened the 
prioritization of genetic educational topics for general practice. Also, the transpar-
ency of the way we dealt with comments and ratings and adjusted or rejected top-
ics is expected to have improved the validity and reliability of the resulting con-
sensus.  
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Comparison with existing literature 
Our study resulted in a Top 10 of genetic educational topics in primary care 
through consensus and prioritization. 1, 5, 7, 12, 13, 16, 20-22 The results also support the 
learning outcomes and core competences in genetics for non-genetic health care 
professionals as specified by genetic experts.6 A previous paper described the ab-
sence of genetics educational objectives for Dutch non-genetic health care provid-
ers.13 This Delphi study has laid a firm foundation, supported by experts’ opinions, 
for the development of more appropriate genetics education for GPs. 
 In addition to the perceived inadequacy of primary care workers to integrate 
genetics in daily practice, Scheuner et al. identified deficiencies in primary care 
workers’ basic genetic knowledge and ability to interpret familial patterns.1 This is 
in line with our prioritized educational topics, which include knowledge of basic 
genetic principles, (the most common) genetic disorders and family history skills. 
Taylor and Edwards stated primary care should be encouraged to invest more 
time in family history data.20 However, they also stressed identified barriers (e.g. 
time constraints) and the need to develop strategies to overcome difficulties pre-
venting GPs from routinely obtaining family history information.20 These barriers 
and strategies are still under construction, and may explain why topic #13 “Taking 
and interpreting a family history” ended ninth in the Top 10 list of genetic educa-
tion priorities. In this study, we did not elaborate on these difficulties, but they 
should definitely be considered during the development of education modules 
concerning the integration of family history skills according to referral criteria.  
 Topic #8 (“Evaluating indications for referral to a clinical genetics centre”) is 
similar to one of the priorities mentioned in Scheuner et al.’s systematic review, 
namely “referral guidelines would improve referral patterns”, while (computer-
ised) decision support might be helpful in familial risk assessment for common 
cancers (e.g. breast, ovarian and colon cancers) and would render many other 
genetics referrals more consistent with guidelines.1 These results support the im-
plementation of genetics education aimed at enhancing effective referral indica-
tions and options. 
 The results of this Delphi study differ from those of the GenEd study of 2004 
by Calefato et al. and of previous focus groups.8, 12 Competences relating to atti-
tudes received more attention in these studies, such as “ethical, legal and public 
health issues” and “psychosocial and counselling issues”. This difference may be 
attributed to the fact the GenEd study was not limited to the Netherlands but en-
compassed five European countries with differing health care systems. In our 
study, the experts commented genetics education should first focus on 
“knowledge” before moving on to “attitudes”. Some comments on this issue were 
rather ambivalent: “Attitude is not specific to genetics” and “A good attitude 
should be an intrinsic component of the GP’s role”. Thus, although it seems the 
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“attitude” domain is considered essential for GP genetics education (i.e. case based 
learning with medical ethical problems), effective implementation of genetics edu-
cation may be jeopardized if too much attention is paid to this area.  
 The higher than expected number of topics in the Top 10 referring to 
“knowledge” (5 out of 7) exceeded the number of “skill” topics (4 out of 11). This 
may be explained by the experts’ perceptions genetic knowledge should be 
brought up to date before related skills can be learned. This unexpected result 
needs further research and probably explains a relatively low agreement among 
practicing GPs since some may find their genetic knowledge or skills sufficient and 
others not.  
Implications for future research and clinical practice 
Unless a scientific, logistical and ethical framework for the appropriate and effec-
tive use of genomic information is in place, the primary care workforce is unlikely 
to be adequately prepared to provide such information in general practice. 1, 3, 5-7, 12, 
20, 22-24 If GPs stay genetically uneducated and therefore incompetent related to the 
use of genomic information in general practice, individual genetic medical care 
provided will likely be unhelpful and possibly even harmful. We believe the results 
of this study should be used in the near future to guide the implementation of ge-
netics education in the Netherlands and perhaps even internationally. Although 
the majority of the issues investigated cover genetics-related knowledge, skills and 
attitudes essential for every medical care provider, further studies will have to 
determine whether the results are relevant to other medical specialties as well.  
 We are currently working on developing genetics education for general prac-
titioners in collaboration with the Dutch GP society. This entails a written educa-
tional module aiming for improving genetics knowledge, an informative website 
specifically aiming on genetics in general practice in the Netherlands and a live 
Continuing Professional Development module aiming for improving genetic skills 
and attitude. Hopefully this will improve (genetic) medical care in the Netherlands 
and will meet the needs expressed by GPs and experts in our previous work and 
the Top 10 of genetic educational topics presented in this paper.8 
 Preparation of health care providers for the future of genetic medicine, with 
personalized genomic information and education, will lead to effective use of ge-
netics in daily primary care.  
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Abstract 
Medical professionals are increasingly expected to deliver genetic services in daily 
patient care. However, genetics education is considered to be suboptimal and in 
urgent need of revision and innovation. We designed a Genetics e-learning Contin-
uing Professional Development (CPD) module aimed at improving general practi-
tioners’ (GPs’) knowledge about oncogenetics, and we conducted a randomized 
controlled trial to evaluate the outcomes at the first two levels of the Kirkpatrick 
framework (satisfaction, learning and behavior). Between September 2011 and 
March 2012, a parallel-group, pre- and post-retention (6-month follow-up) con-
trolled group intervention trial was conducted, with repeated measurements using 
validated questionnaires. Eighty Dutch GP volunteers were randomly assigned to 
the intervention or the control group. Satisfaction with the module was high, with 
the three item’s scores in the range 4.1–4.3 (5-point scale) and a global score of 7.9 
(10-point scale). Knowledge gains post test and at retention test were 0.055 
(P<0.05) and 0.079 (P<0.01), respectively, with moderate effect sizes (0.27 and 
0.31, respectively). The participants appreciated applicability in daily practice of 
knowledge aspects (item scores 3.3–3.8, five-point scale), but scores on self-
reported identification of disease, referral to a specialist and knowledge about the 
possibilities/limitations of genetic testing were near neutral (2.7–2.8, five-point 
scale). The Genetics e-learning CPD module proved to be a feasible, satisfactory 
and clinically applicable method to improve oncogenetics knowledge. The educa-
tional effects can inform further development of online genetics modules aimed at 
improving physicians’ genetics knowledge and could potentially be relevant inter-
nationally and across a wider range of potential audiences.  
 
Trial registration trialregister.nl Identifier: NTR3322 
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Introduction 
Although the dramatic surge in the volume and potential applicability of genetics 
knowledge in medical care is set to continue, there appears to be a marked un-
deruse of this knowledge, in particular among primary-care physicians.1,2 This is 
probably largely because of physicians lacking sufficient knowledge about genetics 
for daily practice and failing to keep up with recent developments in genetic test-
ing.3-9 It is therefore not surprising that there are inadequacies reported in the 
delivery of genetic services.10 In view of the ongoing rapid developments in genet-
ics research, it is important that genomic literacy among healthcare providers be 
enhanced to ensure optimal translation to health-care delivery of research on 
common complex diseases, including familial cancers, such as breast and colon 
cancer. Previous studies have shown that as far as genetics is concerned non-
genetic healthcare workers require not only education but also clear guidelines 
and definitions of their responsibilities.11-13 
 Continuing Professional Development (CPD) seems the obvious vehicle for 
remedying deficiencies in practicing physicians’ genetics knowledge and skills. In 
addition, e-learning appears to offer a cost-effective and time-efficient method of 
keeping physicians informed of new developments. In CPD, e-learning and other 
modalities (printed educational materials and face-to-face activities) are widely 
used and have been shown to be equally effective.14-16 In 2010, the Accreditation 
Council for Continuing Medical Education in the United States reported online 
(enduring materials) activities accounted for 28% of all CPD activities, with 4.6 
million US physician participants (activity attendees). Online CPD (eCPD) activities 
represent by far the most popular form of CPD in the United States (40% of all CPD 
credits).17,18 Between 2003 and 2010, the number of physicians receiving credit for 
online CPD increased by 800%, compared with an 89% increase for all CPD pro-
grams.18 These findings and reported improvements in knowledge and clinical 
decision making following online case vignette courses suggest that online educa-
tional activities can offer ‘a searchable, credible, available on-demand, high-impact 
source for physicians.’19,20 So far, however, there is a paucity of research into opti-
mizing eCPD and its relevance to everyday primary care, with two small studies 
evaluating eCPD being methodologically weak and of uncertain clinical signifi-
cance.16,21 Nevertheless, considering that eCPD is easy to deliver on a large scale 
and is relatively inexpensive to develop, it is important to determine the feasibility 
and effectiveness of accredited Genetics eCPD (G-eCPD) in keeping physicians 
abreast of new genetics developments affecting the delivery of (preventive) cancer 
care. We therefore conducted a randomized controlled trial (RCT) to investigate 
the effectiveness and applicability in daily practice of an oncogenetics eCPD mod-
ule. We aimed to measure the educational outcomes of the module at the first two 
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levels of Kirkpatrick’s four-level framework for evaluating educational outcomes 
(satisfaction, knowledge and knowledge retention, behavior, and actual practice 
performance and results).22-24 We investigated participant satisfaction (level 1), 
participants’ gain in knowledge about oncogenetics and participants’ self-reported 
application of newly acquired oncogenetics knowledge in daily practice (level 2). 
To our knowledge, the online module we developed was the first of its kind to be 
based on assessment of primary-care physicians’ educational needs and priorities 
in relation to genetics knowledge and on core competencies for genetics education. 
Primary-care physicians’ gains in knowledge about oncogenetics in family medi-
cine are expected to improve referral strategies to clinical genetics services and 
adherence to clinical guidelines. This would increase the feasibility of identifica-
tion of familial forms of cancer by primary-care physicians, which in turn would 
improve risk stratification in clinical practice and ultimately reduce morbidity and 
mortality. 
Materials and methods 
Experimental design 
We designed an RCT to assess the outcomes of a G-eCPD module for primary-care 
physicians at the first two of Kirkpatrick’s levels of educational outcomes. The 
intervention consisted of an oncogenetics eCPD module written by The Dutch Col-
lege of General Practitioners (NHG; FJ) and the first author of this manuscript 
(EJFH). Two clinical geneticists and an educationalist (SvL) supported the devel-
opment of the module. The trial was conducted between September 2011 and 
March 2012. To control for external effects, a control group was included and, to 
detect any changes over time, educational outcomes were measured by a pre- and 
post-test and a retention (6 months) evaluation trial. The study protocol was ap-
proved by the ethical review board of the Netherlands Association for Medical 
Education and the medical ethical review boards of the Maastricht University Med-
ical Center and the VU University Medical Center in The Netherlands. Participation 
was voluntary and participants gave written informed consent before the start of 
the trial. 
Study participants 
General practitioners (GPs) working full time or part time in family practice were 
eligible for inclusion in the study. Out of 600 Dutch GPs who met the inclusion 
criterion according to the NHG, 80 responded to participate in the study. Two 
groups of 40 participants were estimated to be sufficient to detect a medium-to-
large effect with a power of 90% and a significance level of 5%.25 Figure 1 shows 
the randomization scheme and participation flow. Participants were recruited by 
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online mailings, informing them about the study and requesting informed consent. 
CPD accreditation points were awarded for completion of the module, the online 
knowledge tests and the online questionnaires. A book on genetics in general prac-
tice or a book voucher of equal value was offered as an extra incentive. 
 For sampling and random assignment of participants to the intervention and 
control group, a pseudo random number generator was used for which the opera-
tor was not otherwise involved in the intervention or data analysis. The results of 
the randomization were communicated to the NHG but not to the researchers. 
  
 
Figure 1. Randomization Scheme and Participation Flow of the online Genetics Continuing Professional Development  
(G-eCPD) study groups 
 
CHAPTER 4 
70 
Educational design and content 
The module contained several didactic components with multimedia presenta-
tions, interactive cases with feedback, enabling tools (for referral, family history 
and online information searches) and other resources, such as step-by-step clinical 
practice guides and employable NHG guidelines. Common forms of oncogenetic 
diseases were presented in patient cases. The contents of the module were de-
signed to include 10 items prioritized in a multidisciplinary Delphi study on core 
competencies of health professionals endorsed by the NHG.13, 26 A multidisciplinary 
team consisting of FJ and EJFH who wrote the module, educationalists SvL and 
CvdV, and a clinical geneticist familiar with genetics in primary care, constructed 
the module and selected practical genetics information on common forms of can-
cer (such as breast and ovarian cancer, and colon cancer). 
 The aim of this module was to provide physicians with sufficient knowledge 
and skills to: 
• Identify patients with an inherited predisposition to cancer. 
• Draw a family tree as a tool for identifying patients at risk for hereditary can-
cer. 
• Describe the most common types of hereditary cancer (ie, breast cancer and 
colon cancer) and the likely genetic mutations involved. 
• Apply oncogenetics guidelines in identifying patients for whom referral is indi-
cated or not, and find relevant information online. 
• Explain the possibilities and limitations of oncogenetic testing. 
• Discuss with patients periodic examinations and risk-reducing surgical options 
that are available to patients with hereditary cancer. 
 
The online module provided access to didactic presentations, such as ‘a clinical 
genetic cancer consultation in daily practice’; interactive cases on breast cancer 
due to BRCA mutations and on colon cancer (eg, Lynch syndrome) due to 
APC/mismatch-repair gene mutations; and enabling tools, such as information 
about regional possibilities for referral and consultation. The educational sections 
were presented in the style the NHG usually uses when presenting online CPD 
modules for optimal recognition. The participants were free to revisit program 
sections as desired. The module was designed to enable completion within 2 h. The 
online administration tools afforded monitoring of participant progress, including 
test and survey completion. 
Data collection 
Data were collected using four online instruments: online-only material contents 
section eTable 1, Questions and Answer Options of the Multiple-choice Knowledge 
Test; eTable 2, Satisfaction Questionnaire; eTable 3, Applicability Questionnaire; 
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and eTable 4, Demographics and Practice Characteristics Questionnaire. The test 
questions were based on a validated questionnaire that identified the genetic 
learning objectives and covered the oncogenetics topics of the G-eCPD.6 The in-
struments were developed and validated in collaboration with content experts 
(experts in daily clinical genetics, a GP, and an expert in education and question-
naire development) and pilot tested. 
 The knowledge test contained 20 multiple-choice items. Oncogenetics 
knowledge was measured as the proportion of correct answers. The satisfaction 
questionnaire contained 3 items (5-point scale: 1=completely disagree; 
5=completely agree) (In the questionnaires, the coding was directed oppositely 
(1=completely agree, 5=completely disagree) in accordance with the conventions 
of the NHG. For ease of interpretation in the current paper, the ratings were recod-
ed to comply with international conventions (1=completely disagree, 
5=completely agree), related to different aspects of satisfaction, a global grading of 
the module on a 10-point scale (1=no value; 5=insufficient; 6=sufficient; 8=good; 
10=excellent) and a question about the amount of time spent doing the module. 
The applicability questionnaire contained six five-point Likert scale items about 
the application of the newly acquired knowledge in daily practice and a multiple-
choice question about the application frequency. The demographic survey asked 
about participants’ general characteristics (eTable 4). 
 The interventions and measurements were conducted at and between time 
points T0, T1 and T2 (table 1). At T0, the intervention and the control group com-
pleted the demographics survey and the knowledge test. Between T0 and T1, the 
intervention group undertook the G-eCPD module, whereas the control group 
were free to spend the 2-h break any way they wanted, except by doing the mod-
ule. At T1, both the intervention and the control group again completed the 
knowledge test in which the question and answer options had been randomly 
changed to correct for recall bias, and the intervention group completed the satis-
faction questionnaire also. At T2, 6 months after T1, retention of knowledge was 
measured by administering the knowledge test to both groups, whereas the inter-
vention group also completed the applicability questionnaire. After T2, in order to 
stimulate compliance the online module was made available to the control group, 
which also completed the satisfaction questionnaire. 
Analysis 
Knowledge gain immediately after the module was examined using regression 
analysis, with Knowledge Test Score at T1 (ScoreT1) as the dependent variable, 
test score at T0 (ScoreT0) as predictor and Training (0=no, control group; 1=yes, 
intervention group) as the indicator variable. In order to allow for different slopes 
for the relation ScoreT1 and ScoreT0, the interaction of Training and ScoreT0 
(TrainingxScoreT0) was also included as an independent variable. To improve the 
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interpretation and numerical stability, the independent variable ScoreT0 was cen-
tered, and the resulting variable ScoreT0c, equal to ScoreT0−Mean(ScoreT0), was 
used in the analysis. In a similar analysis, retention of knowledge was analyzed 
using ScoreT2 as a dependent variable. The regression coefficient corresponding 
to Training represents the net gain in knowledge (proportion correct) after the 
intervention, and the standardized regression coefficient indicates the effect size. 
According to Cohen’s categorization, 0.1, 0.3 and 0.5 indicate small, moderate and 
large effect sizes, respectively.25 The final model included only predictors with a 
statistically significant contribution (P<0.05). 
 The mean test scores and corresponding 95% confidence intervals (95% CIs) 
for the two groups at T0, T1 and T2 were calculated, and Student’s t-tests were 
conducted to determine between-group differences. To determine satisfaction, 
mean scores, 95% CIs and SD were calculated for the pooled data of the interven-
tion and control groups. For the applicability data (intervention group only), the 
same statistics were calculated. All statistical analyses were performed using the 
statistical package SPSS version 19 (SPSS, Chicago, IL, USA). 
 
Table 1. Time table of the RCT 
Instrument Group Time 
    0   2 h 6 months 
    Pre-test 
(T0) 
  Post-test  
(T1) 
Retention test 
(T2) 
Knowledge test Intervention Xa Online 
oncogenetics 
training 
X X 
  Control X   X X 
Satisfaction 
questionnaire 
Intervention     X   
Applicability 
questionnaire 
Intervention       X 
Demographics 
questionnaire 
Intervention & 
Control 
X       
Abbreviation: RCT, randomized controlled trial. 
Time table of the RCT showing scheduled measurement times (columns 3–6), instruments (column 1) and 
measurements made (indicated with X in columns 3–6) in the intervention and control groups (column 2). 
a Measurement made with the instrument indicated in column 1 in the group indicated in column 2. 
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Results 
Randomization and dropout comparisons 
Of the total of 80 participating physicians (40 intervention group and 40 control 
group), 44 (20 intervention, 24 control group) completed all the learning activities, 
knowledge tests and questionnaires (Figure 1). Thirty-six participants were lost to 
follow-up; 22 did not participate because of time limitation or illness, and 14 did 
not respond to requests for information. 
Participant characteristics 
There were no significant differences between intervention and control group in 
age, gender, years of experience in primary care, type of practice and practice situ-
ation (eTable 5). 
Knowledge 
Figure 2 presents the results of the pre-test, post-test and retention test. The be-
tween-group difference was indifferent or in favor of the intervention group, start-
ing from 0.034 (Student’s t-test, non-significant, P=0.34) at T0, and increasing to 
0.072 (P<0.05) and 0.084 (P<0.05) at T1 and T2, respectively. More precise esti-
mations of knowledge gain were obtained by the regression analysis controlling 
for between-group differences in ScoreT0 and allowing for an interaction effect of 
intervention (group) and ScoreT0. The first numerical row of table 2 shows the 
regression results for ScoreT1. As the contribution of the interaction was found to 
be statistically non-significant, the interaction was exluded from the final model, 
leaving the intercept (Constant), and two additional independent variables (see 
second row) ScoreT0c, the centered version of the pre-test score (mean 
ScoreT0=0.66) and the indicator variable Training (0=no, control; 1=yes, interven-
tion). The resulting regression coefficient, the corresponding 95% confidence in-
terval (95% CI; low and high boundary) and the standardized regression coeffi-
cient are presented. Value B=0.70 for Constant indicates the expected proportion 
correct in the post-test for a participant in the control group with a ScoreT0 equal 
to the mean value (0.66). The regression coefficient (0.51) for ScoreT0c indicates 
the slope of the corresponding regression line for the control group, which was 
found to be statistically significant as is indicated. The effect of the intervention 
was found to be statistically significant, amounting to 0.055 on the proportion 
correct scale; the corresponding value for the standardized regression coefficient 
was 0.27, indicating an almost moderate effect size. The analysis for ScoreT2 also 
showed a non-significant interaction and in the final model the intervention effect 
was found to be 0.079 (standard regression coefficient of 0.31, moderate effect 
size), implying a further increase of the knowledge effect by 0.024 at 6 months 
after the intervention. 
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Figure 2. Knowledge test 
scores (mean and 95% CI) 
for the control group (circle) 
and the intervention group 
(triangle) at T0, T1 and T2, 
corresponding to pre-, post- 
and retention measurement, 
respectively. 
 
Table 2. Effect of the oncogenetics training (G-eCPD module) on the performance of GPs. Regression 
results are shown for immediate gain of performance (ScoreT1) and retention of performance 
(ScoreT2), using the pretest score (Score T0) as a covariate and the control group score as a reference.  
Dependent 
Variable 
 
 
Independent Variables 
  Constant  Score T0 Training 
   
regression 
coefficient 
  
regression  
coefficient 
standardized 
regression 
coefficient 
 
regression  
coefficient 
standardized 
regression 
coefficient 
    
 
value 95% 
Conf Int 
value Value 95% 
Conf Int 
value 
  low high   low high  
ScoreT1  0.70***   0.51***  0.30 0.71 0.57 0.055* 0.006 0.103 0.27 
ScoreT2  0.64***   0.68***  0.43 0.93 0.62 0.079** 0.022 0.136 0.31 
Abbreviations: G-eCPD, Genetic online Continuing Professional Development; CI, confidence interval. 
Regression results are shown for immediate gain of performance (ScoreT1) and retention of performance 
(ScoreT2), using the pre-test score (ScoreT0c) as a covariate and the control group score as a reference. 
*P<0.05; **P<0.01; ***P<0.001.***  
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Satisfaction and applicability 
Table 3 shows the results for satisfaction and applicability. The four satisfaction 
items had scores of at least 4.1 (95% CI lower boundary not <3.7) and a mean 
global score of 7.9 (95% CI lower boundary=7.5). The average time spent on the 
module (124 min) was very close to the recommended time. The applicability 
scores were more diverse: neutral scores (2.7–2.9) were obtained for self-reported 
recognition of disease, referral to a specialist and knowledge of possibili-
ties/limitations of genetic testing. The scores on increased knowledge about genet-
ic diseases, concepts and information sources were more positive (3.3–3.8). More 
than 90% of participants indicated applying newly acquired knowledge at least 
once a month, and 5% indicated a frequency of at least once a week. No participant 
reported daily application, and 5% indicated not having encountered any genetic 
problem in their practice in the last 6 months.  
 
Table 3. Satisfaction (intervention+control; N=44) and self-reported applicability (intervention only; 
N=20) as a result of training with the G-eCPD module. 
Variable  
Mean 
95% CI 
Low 
 
High 
 
SD 
Satisfaction     
 Would recommend the module to a colleague1 4.3 3.9 4.6 1.1 
 Content of the module is relevant for a GP 4.2 3.9 4.6 1.1 
 Content of the knowledge test is relevant for a GP 4.1 3.7 4.4 1.0 
 Global score (1-10) 7.9 7.5 8.3 1.3 
 Time spent on the module (minutes) 124 115 132 27 
 
Applicability 
    
 Recognize patient with genetic disease sooner 2.8 2.3 3.3 .98 
 Sooner refer to or discuss with a genetic specialist 2.7 2.0 3.3 1.2 
 More knowledge of possibilities/limitations of genetic tests 2.9 2.4 3.4 .96 
 More knowledge of genetic diseases 3.6 3.1 4.1 .98 
 More knowledge of basic genetic concepts 3.3 2.8 3.8 .96 
 More knowledge of genetic information sources 3.8 3.4 4.3 .88 
 
Proportion of trainees applying the learned knowledge (%) 
    
 Daily  0    
 Weekly  5    
 Monthly 90    
 Not (do not meet any genetic problems in our practice)  5    
Abbreviations: CI, confidence interval; G-eCPD, Genetic online Continuing Professional Development; GP, 
general practitioner. 1 if not indicated otherwise results refer to scores of 5-point Likert scale items (1: 
competely disagree, 5: completely agree)  
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Discussion 
To our knowledge, our study is the first to evaluate the outcomes of an online ge-
netics CPD module at the first two levels of Kirkpatrick’s framework, taking onco-
genetics as an example. The results indicate that presenting a case-based onco-
genetics module in an accessible online learning environment can result in sus-
tained improvement of genetics knowledge for daily medical practice. Other topics, 
such as cardiogenetics (ie, long QT syndrome or hyperthrophic cardiomyopathy) 
or diabetes (ie, maturity-onset diabetes of the young), could also be trained in this 
framework. The findings in the current study indicate that this approach may help 
to transfer urgently needed genetics knowledge on a broad array of issues, both in 
primary and secondary care. The participants were satisfied with the module and 
indicated that they actually applied their newly acquired knowledge in daily prac-
tice. However, self-reported applicability aspects focused on practice received 
neutral scores. This seems to indicate the G-eCPD mainly improved genetics 
knowledge rather than skills. A live training on oncogenetics may put more em-
phasis on these performance-oriented aspects reflected in increased consultation 
skills (ie, recognizing patient with genetic disease, how to refer to a Clinical Genet-
ics center or to be able to explain possibilities/limitations of genetic tests). 27 Of 
course, the evaluation of the G-eCPD module should be an ongoing process, which 
can sustainably help to improve effectiveness. These findings are encouraging for 
future work in this challenging area of education. 
 The results indicate that significant knowledge gains of moderate effect size 
persisted for 6 months after the 2-h educational intervention. This is consistent 
with reports in the literature that most educational interventions lead to modest-
to-moderate improvements in health care.28 In addition to knowledge gains, the 
module showed relatively good cost effectiveness in terms of both finance and 
time, and it seems likely that it could easily reach large groups of physicians and 
possibly medical students as well. 
Limitations 
A limitation is the fairly large number of non-responders. Selection bias could have 
been caused by interested GPs who voluntarily participated and received financial 
incentives. Similar baseline characteristics of the two groups and comparability of 
the 55% participation rate to those reported for postal surveys among GPs (60% 
response rate) however, indicate that the participants were representative of GPs 
likely to attend oncogenetic training in the future. 29,30 
It is possible that participating in the oncogenetics training might become a man-
datory part of training for all GPs. Participants in the control group had to wait for 
training content, possibly causing resistance to finish all measurements. No specif-
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ic reasons, such as fairly long duration of the study for drop out were reported, 
rather than general attributes (no time and sickness). It is therefore unlikely that 
self-selection in dropout negatively impacted the validity of the results. Although 
there were no significant differences in participant characteristics between inter-
vention and control group, the physicians in our study appeared to be more num-
ber of women, younger and less experienced, compared with the general profile of 
Dutch GPs.31 This possibly reflects extra interest in genetics and/or using online 
learning modules by young woman GPs who recently graduated. Whether the re-
sults can be generalized within and beyond the Dutch healthcare system needs 
further investigation. 
 Although the results show substantive knowledge gains, it might be argued 
that we did not compare the online module to any other intervention or more tra-
ditional methods, such as paper format or live CPD modules. In education evalua-
tion studies published, there may be publication bias: a wide variety of Internet-
based interventions show effectiveness in medical education, perhaps leaving 
negative studies unpublished.32 Given recent rapid developments in genetics, there 
is not enough staff to provide nationwide traditional education activities. A meta-
analysis suggested that Internet-based instruction would be similarly effective to 
non-Internet interventions. Moreover, Internet-based learning is associated with 
large positive effects compared with no intervention at all.32 Our study could there-
fore be seen as a proof-of-concept evaluation study and further research will be 
necessary to confirm comparable effectiveness on sustained knowledge. 
 Although our evaluation of the educational outcomes of the G-eCPD module 
by the questionnaire on the application of new knowledge in daily practice (eTable 
6) closely approached Kirkpatrick’s third level, assessment by observation of actu-
al behavior was absent. We are currently undertaking a study to determine chang-
es in referrals to Clinical Genetics centers after attending the G-eCPD module. An-
other study we have planned uses standardized patients to evaluate the effective-
ness of face-to-face oncogenetics modules in terms of behavioral changes (level 3), 
such as family history taking and recognizing the need for referrals to the depart-
ment of Clinical Genetics.27 By applying an effective framework for genetics educa-
tion and measuring outcome of education on various levels of Kirkpatrick, we 
might be able to initiate a change in organization (approaching level 4) and find 
barriers to implementation of genetics education.33 Despite the limitations of the 
current study, however, the results suggest that the module presents a promising 
innovative educational approach in CPD for health professionals. Despite the obvi-
ous importance of evaluation at higher Kirkpatrick levels, the results we found for 
lower outcome levels are also important to build a solid basis for an advanced 
impact. 
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Generalizability 
The results of the present study may contribute to the development of genetics 
educational programs, and online CPD in particular. Online modules once created 
could potentially reach a large group of physicians in primary and secondary care 
(non-clinical geneticists, such as oncologists, cardiologists, pediatricians, etc), and 
across large geographical areas. In addition, possibly those in nursing professions, 
medical school students and those attending biology classes could benefit from 
this framework for online genetics education. Costs are likely to be less than mul-
tiple face-to-face sessions; however, the time and expertise to create an effective 
tool is not insignificant.32 
 General practice in the Netherlands is an open-access full-time service, availa-
ble to all patients with any medical complain or question. As, under the Dutch sys-
tem, the entire population, irrespective of the presence of disease, is on the list of a 
GP, optimal continuity of care is guaranteed. If genetic counseling is available in 
the region, the GP manages most referrals to this service for healthy family mem-
bers of cancer patients. The GP is therefore likely the first healthcare professional 
to whom a patient will turn with questions about genetics. 
 It is also important to consider whether the current results can be generalized 
to future effects. Obviously, the results are representative for those GPs who par-
ticipated in the trial on a voluntary basis. It is reasonable to assume that the partic-
ipants are representative of the group of GPs who, in the future, would be willing 
to make use of online CPD modules. In other words, the results seem to be general-
izable to future users of online CPD modules. 
 Voluntary participation may have led to self-selection of participants with a 
special interest in genetics or in clinical leadership qualities. Furthermore, the 
online module may be made mandatory for all Dutch GPs in the near future. How-
ever, it seems plausible that accidental factors, such as time and health problems, 
rather than specific attributes of participants were responsible for participant 
dropout. However, specific attributes should be investigated further, for there was 
a relative high dropout rate (30%). 
 Studies have reported satisfaction and knowledge gains as a result of online 
modules on other topics and have suggested that course outcomes may benefit 
when a course is designed in accordance with a prior educational needs assess-
ment.15,19,34-36 The advantages of online CPD have also been broadly discussed and 
supported.37 Various reviews, however, have pointed to heightened effects on 
physician behavior of multiple interventions compared with single episodic inter-
ventions. Multifaceted interventions can tackle several common barriers to change 
and this combined operation may ultimately lead to improved practice perfor-
mance. This aspect deserves further study. 
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Interpretation 
Our online oncogenetics module proved to be a satisfactory and feasible method to 
achieve urgently needed knowledge improvement in a rapidly evolving field. Web-
based genetics education can be a valuable tool to provide physicians, in general, 
with applicable genomics knowledge, and the long-term educational effects show 
great promise with respect to practical and strategy implications.2,38 The results 
suggest that relatively simple and low-cost online educational activities can have a 
pivotal role in urgently needed genetic health-care improvement.  
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Online-only material contents 
eTable 1. Questions and answer options of the multiple-choice knowledge test1 
1) In an autosomal-dominant inheritance pattern, who can pass on the disorder?  
o Men  
o Women 
o Men and women 
2) In which category do the most common disorders with a genetic component fall?  
o Monogenetic 
o Chromosomal 
o Multifactoral 
Case Study: Ms. van Aalst 
Ms. van Aalst comes to your practice. Her father’s sister was diagnosed with breast cancer at age 40 and 
died of it. Her daughter (Ms. van Aalst’s cousin) recently received the same diagnosis at age 35. Answer 
questions 3, 4 & 5 using Case Study: Ms. van Aalst. 
3) What is the degree of the relationship between Ms. van Aalst and the sister of her father: 1st , 2nd , 
3rd or 4th ? 
o The sister of the father is a first-degree relative of Ms. van Aalst.  
o The sister of the father is a second-degree relative of Ms. van Aalst.  
o The sister of the father is a third-degree relative of Ms. van Aalst.  
o The sister of the father is a fourth-degree relative of Ms. van Aalst.  
4) Which possible influence does breast cancer in the family of the father have on the risk of Ms. van 
Aalst for inherited breast cancer?  
o Increased 
o Decreased 
o None 
5) Is there an indication to refer Ms. van Aalst to a clinical genetics department based on the availa-
ble information?  
o No 
Yes 
Case Study: Ms. Brederode 
Ms. Brederode comes to your practice. The father of her mother was diagnosed with colorectal cancer 
and died of it shortly after diagnosis, at the age of 50. The sister of her mother was diagnosed with 
colorectal cancer at age 39 and died of it a year later. Ms. Brederode is 30 years old and has two 
children. Answer question 6 using Case Study: Ms. Brederode.  
6) Is there an indication to refer Ms. Brederode to a clinical genetics department based on the availa-
ble information according to CBO-guidelines? 
o There is an indication to refer Ms. Brederode to a clinical genetics department 
o There is no indication to refer Ms. Brederode to a clinical genetics department  
A decision cannot be made based on the available information.  
                                                                  
1 The order of the questions and possible answers was changed from T0 to T1 to T2. 
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7) HNPCC (or Lynch syndrome) is form of inherited colon cancer in which one gene plays a great 
role, i.e. it is a monogenetic subtype. Which portion of colon cancer cases involves a recognizable
monogenetic subtype?  
o Less than 1%  
o Approximately 5%  
o Approximately 30%  
o Approximately 50%  
8) An increased chance of colon cancer caused by one gene mutation exists in other disorders as
well. In which of the following disorders is that most likely?  
o tuberous sclerosis  
o adenomatous polyposis coli 
o retinoblastoma 
multiple endocrine neoplasia 
Case Study: Ms. Crynen 
Ms. Crynen (28) has received test results from the department of clinical genetics indicating that she 
has a BRCA2 gene mutation. She considers her family to be complete. Ms. Crynenis now considering her 
options, such as breast cancer screening, mastectomy, oophorectomy and hormonal treatment. Answer 
questions 10, 11 &12 based on Case Study: Ms. Crynen.  
9) Which of the following breast examinations is the most sensitive in young BRCA2 patients (≤30)?  
o Palpation by an experienced surgeon 
o Mammagram 
o MRI 
o Sonogram 
10) And if Ms. Crynen had been 40 years old, which breast exam would be the most sensitive:  
o Palpation by an experienced surgeon + MRI 
o Mammagram + MRI 
o Sonogram +MRI 
o CT + MRI 
11) How should the Family Physician approach the options mentioned by Ms. Crynen? 
o The FP should discourage breast cancer screening and encourage postmenopausal 
oophorectomy. 
o The FP should encourage bilateral mastectomy and premenopausal oophorectomy. 
o The FP should encourage premenopausal oophorectomy. 
12) Ms. Crynen is considering prophylactic oophorectomy. BRCA2 patients have the following progno-
sis: 
o Following the oophorectomy there will be no menopausal symptoms.  
o Following the oophorectomy there will be menopausal symptoms, which can be managed 
with non-hormonal treatment. 
Hormonal treatment to limit menopausal symptoms should follow the oophorectomy.  
13) In comparison to hereditary cancer, sporadic cancer usually develops at an:  
o earlier age 
o later age 
14) Which website presents the general guidelines for referrals to clinical geneticists, for advice relat-
ed to inherited forms of cancer?  
o www.erfelijkheid.nl 
o www.oncoline.nl 
o www.kankerrichtlijn.nl 
o www.erfelijkekanker.nl 
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15) Multiple patients in the same family are diagnosed with colorectal cancer at a young age (age
≤50). Many of these patients have polyps. In the majority of cases, this indicates a mutation in:  
o One of the genes that can cause Lynch syndrome (aka HNPCC)  
o The APC gene that can cause FAP  
o The BRCA1/ BRCA2 gene 
16) Multiple patients in the same family are diagnosed with colorectal cancer at a young age (age
≤50). These patients have few or no polyps. In the majority of cases, this indicates a mutation in:  
o One of the genes that can cause Lynch syndrome (aka HNPCC)  
o The APC gene that can cause FAP  
o The BRCA1/ BRCA2 gene 
17) Multiple patients in the same family are diagnosed with endometrial cancer. When a genetic 
predisposition such as this exists, it indicates a mutation in:  
o One of the genes that can cause Lynch syndrome (aka HNPCC)  
o The APC gene that can cause FAP  
o The BRCA1/ BRCA2 gene 
18) Patients can screen themselves for increased risk of inherited breast cancer or colorectal cancer 
via one of the following websites. This screen provides an immediate initial risk estimation, but
cannot determine if hereditary cancer exists. Those who are found to have increased risk are ad-
vised to visit their family physician to discuss a referral to a clinical geneticist for further testing.
Which website is it? 
o www.erfelijkheid.nl 
o www.oncoline.nl 
o www.kankerrichtlijn.nl 
o www.erfelijkekanker.nl 
19) In a certain family a genetic disorder is passed by women to their sons and daughters, and by men
to their sons and daughters, and the chance of repetition is 25-50%. Which inheritance pattern is 
most likely? 
o autosomal dominant with increased penetration 
o autosomal recessive with increased penetration 
o autosomal recessive with decreased penetration 
o autosomal dominant with decreased penetration 
20) In a certain family with an inherited form of cancer, many family members have questions about
their chance of getting the cancer. What is the usual form of clinical genetic care in such families?  
o The first patient visits the clinical geneticist, the family members are informed via telephone 
by the clinical geneticist.  
o The first patient visits the genetic counselor, the family members are informed via telephone 
by the clinical geneticist.  
o The first patient visits the clinical geneticist, the family members are seen by the genetic 
counselor. 
o The first patient visits the genetic counselor, the family members are seen by the clinical 
geneticist.  
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eTable 2. Satisfaction questionnaire 
1. I would recommend this internet PIN to my colleagues. (On a scale of 1=Totally Agree to 5=Totally 
Disagree, 6= Not applicable/ No opinion.) 
2. In general, I judge the topics presented in the internet PIN as relevant for family practice. (On a scale 
of 1=Totally Agree to 5=Totally Disagree, 6= Not applicable/ No opinion.) 
3. In general, I judge the questions presented in the knowledge test as relevant for family practice. (On a 
scale of 1=Totally Agree to 5=Totally Disagree, 6= Not applicable/ No opinion.) 
4. Which grade would you give this internet PIN, on a scale of 1= Bad to 10= Perfect?  
5. How much time did you spend on this internet PIN?  
o Less than an hour  
o 1 – 1.5 hours 
o 1.5 - 2 hours  
o 2- 2.5 hours  
o 2.5 - 3 hours 
o More than 3 hours 
6a. Which topic(s) appealed to you the most? (Tick one or more boxes please.) 
o Genetic tests 
o Hereditary breast- and colorectal cancer  
o Referral and cooperation with specialists 
o No preference 
b. Why? …………………………. 
7a. Which topic(s) appealed to you the least? (Tick one or more boxes please.) 
o Genetic tests 
o Hereditary breast- and colorectal cancer  
o Referral and cooperation with specialists 
o No preference 
b. Why? …………………………. 
8. Space for optional extra comments: …………………………. 
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eTable 3. Applicability questionnaire 
1. I apply the knowledge gained from this internet PIN:   
o Daily 
o Weekly 
o Monthly 
o I don’t come across any genetic issues in my practice and therefore do not apply the 
knowledge from the PIN.  
2. I recognize patients with a genetic condition much earlier than I did before I completed the internet 
PIN. (On a scale of 1=Totally Agree to 5=Totally Disagree, 6= Not applicable/ No opinion.)  
3. I refer to or consult with a clinical geneticist much earlier than I did before I completed the internet 
PIN. (On a scale of 1=Totally Agree to 5=Totally Disagree, 6= Not applicable/ No opinion.)  
4. I have more knowledge about the possibilities and limits of genetic testing than I had before I 
completed the internet PIN. (On a scale of 1=Totally Agree to 5=Totally Disagree, 6= Not applicable/ No 
opinion.)  
5. I have more knowledge about the most common genetics conditions in the Netherlands than I had 
before I completed the internet PIN. (On a scale of 1=Totally Agree to 5=Totally Disagree, 6= Not 
applicable/ No opinion.)  
6. I have more knowledge about fundamental concepts of genetics than I had before I completed the 
internet PIN. (On a scale of 1=Totally Agree to 5=Totally Disagree, 6= Not applicable/ No opinion.)  
7. I have more knowledge about important sources of information about genetics than I had before I 
completed the internet PIN. (On a scale of 1=Totally Agree to 5=Totally Disagree, 6= Not applicable/ No 
opinion.)  
8. Space for optional extra comments: …………………………. 
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eTable 4. Demographics and practice characteristics questionnaire
1) You are:  
o Male 
o Female 
2) Age: … years old 
3) Number of years experience as General practitioner: …years 
4) In which type of practice do you work? 
o Solo practice 
o Duo practice 
o Group practice 
o Community Health Center 
o Other 
5) Degree of Urbanization of Practice Area: 
o Metropolitan area (>100.000 residents) 
o City (30.000 - 100.000 residents)  
o Small Town (5.000 - 30.000 residents)  
o Rural area (<5.000 residents in largest village)  
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eTable 5. Demographical and practice characteristics of participants  
 Control  
Group  
(n=24) 
Treatment 
Group  
(n=20) 
Chi-square/ 
Mann-Whitney 
Test  
(P values) 
Sex    
 Female 20 19 .23 
 Male 4 1  
Age in years    
 30-39  13 10 .70 
 40-49 7 5  
 50-59 3 5  
 60-69 1 0  
Professional experience in years     
 less than 10 13 12 .92 
 between 10 and 19 7 4  
 between 20 and 29 3 1  
 between 30 and 39 1 3  
Practice Type    
 Solo practice 4 0 .29 
 Duo practice 3 5  
 Group practice 4 5  
 Community Health Center 4 2  
 Other 9 8  
Practice Setting    
 Metropolitan area (>100,000 residents) 7 4 .82 
 City (between 30,000 and 100,000 residents) 7 5  
 Small Town (between 5,000 and 30,000 residents) 7 7  
 Rural area (<5,000 residents in largest village) 3 4  
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eTable 6. Evaluation of G-eCPD1 according to two levels of Kirkpatrick  
Instrument Item description 
Kirkpatrick level 
of 
evaluation 
Knowledge test 20 Multiple Choice items; on knowledge of basic genetic 
principles, genetic disorders, possibilities and limitations of 
genetic tests, referral possibilities concerning genetics and 
most important sources of genetic information 
KP2 1 and 2; 
evaluation of 
participation and 
learners behavior 
(effects on 
knowledge and 
skills) 
Satisfaction 
questionnaire 
3 items on user relevance with a 5-point Likert scale. KP 1; 
evaluation of 
satisfaction and 
opinions of 
participants 
 1 item global evaluation rating score (1-10).  
 1 item on amount of time spent on the online module  
 2 items on user opinion on personal preference of the topics 
with multiple choice options and explanation  
 
Applicability 
questionnaire 
1 item on frequency of application of knowledge acquired 
through the online G-eCPD with a 4-point ordinal scale. 
KP 2; 
effects on attitudes 
and 
perceptions, 
knowledge and 
skills, effects in 
change of 
behavior and 
possibly evaluation
on the effects on 
patient genetic 
Health 
 6 items on applied knowledge in daily practice (recognizing 
patients with a common genetic form of cancer, referral to 
secondary care, knowledge of genetic tests and common 
genetic diseases, basic genetic terms, usage of important 
resources of genetic information) with a 5-point Likert scale.
 
Demographics and 
Practice 
Characteristics 
Questionnaire 
5 items on age, gender, years of experience as a FP3, practice 
situation (urban/rural practice) and practice type 
(group/single practice). 
Not applicable 
 
1 Genetic online Continuing Professional Development; 2 Kirkpatrick levels of effect of Continuing Pro-
fessional Development (CPD) programs (Kirkpatrick    2006); 3 Family Physician 
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Abstract 
Purpose 
General practitioners (GPs) are increasingly called upon to deliver genetic services 
and could play a key role in translating potentially life-saving advancements in 
oncogenetic technologies to patient care. If GPs are to make an effective contribu-
tion in this area, their genetics competencies need to be upgraded.  
The aim of the study was to investigate whether an oncogenetics training for GPs 
improves their genetic consultation skills.  
Methods 
In this pragmatic, blinded randomized controlled trial, the intervention consisted 
of a four-hour training (December 2011 and April 2012), covering oncogenetic 
consultation skills (family history, familial risk assessment, and efficient referral), 
attitude (medical ethical issues), and clinical knowledge required in primary care 
consultations. Outcomes were measured using observation checklists by unan-
nounced standardized patients and self-reported questionnaires. 
Results 
Of 88 randomized GPs who initially agreed to participate, 56 completed all meas-
urements. Key consultation skills significantly and substantially improved; regres-
sion coefficient post-intervention equal to .34 and .28 at 3-month-follow-up indi-
cating moderate effectsize. Satisfaction and perceived applicability of newly 
learned skills were highly scored. 
Conclusion 
The GP-specific training proved to be a feasible, satisfactory and clinically applica-
ble method to improve oncogenetics consultation skills and could be used as edu-
cational framework to inform future training activities with the ultimate aim of 
improving medical care. 
 
Trial Registration: trialregister.nl Identifier: NTR3323 
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Introduction 
Genomics holds great promise to improve human health. Genetics of common 
disorders (diabetes, cancer, cardiovascular diseases), and monogenic subtypes 
(Maturity Onset Diabetes of the Young (MODY), BRCA 1/2, familial hypercholester-
olemia (FH) and long QT syndrome) in particular, are expected to come increasing-
ly to the forefront in primary care. Consequently, general practitioners (GPs) are 
facing a daunting informational challenge to keep abreast of the expanding body of 
genomics knowledge and attain competencies for informed use of its potential for 
personalized patient care.1 In view of increasing requests for DNA-based predic-
tive testing arising from a positive family history and GPs’ increasing involvement 
in preventive check-ups, it is important for GPs to be competent to take and inter-
pret a family history and deal appropriately with patients’ questions and con-
cerns.2 Each family practice has a substantial number of unidentified asymptomat-
ic patients with relatively young first-degree relatives with familial or hereditary 
forms of cancer (breast, ovarian, uterine, and colorectal cancer), and such patients 
should be referred to a clinical geneticist for counseling and/or screening accord-
ing to guidelines.3,4 Women carrying a BRCA1/2 mutation, for example, have a 
lifetime-risk of 60-80% of developing breast cancer (accounting for 5-10% of all 
breast cancer cases), and timely identification enables them to benefit from oth-
erwise unexploited life-saving “risk-management options”, such as salpingo-oo-
phorectomy and/or mastectomy, annual screening, and pharmaceutical chemo 
preventive options.5 Assessing familial risk by taking a family history can be a 
reliable method to improve outcomes of hereditary forms of cancer with targeted 
cancer prevention strategies.6-9 Taking an adequate family history however is diffi-
cult and takes time. Insufficient genetics knowledge and consultation skills to ac-
tually conduct an initial oncogenetics risk assessment and its interpretation pose a 
barrier to appropriately recognize and elicit details to assess the features of poten-
tial oncogenetics risk.6 This could warrant timely referral to oncogenetics services 
for further assessment and genetic testing (referral-level competences). Moreover, 
lack of computerized decision support implies that GPs themselves need to learn 
adequately interpreting family history and act on it.10 Educational innovation 
therefore seems imperative, including genetic risk ascertainment and preven-
tion.11 Unless GPs receive proper education and training, individual genetic care by 
GPs will likely be unhelpful and possibly even harmful.3,12,13 Considering the urgent 
need for and the potentially huge benefits to be gained from genetics education for 
GPs, we embarked on an educational project aimed at strengthening the role of 
genetics in family medicine. 
 Well-defined core genetics competencies for non-genetic health care workers 
are considered a precondition for the development of effective genetics educa-
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tion.14,15 Educational activities should be responsive to GPs’ assessed needs in 
respect to cognitive (knowledge), psychomotor (consultation skills), and affective 
(attitude) aspects of genetics competence. Previous studies have shown that as far 
as genetics is concerned non-genetic healthcare workers require not only educa-
tion but also clear guidelines and definitions of their responsibilities.16,17 
 This article reports a study in which GPs attended a needs-based, interactive 
oncogenetics training aimed at enhancing insight, consultation skills, and attitudes 
relevant to the identification of oncogenetic disease in family practice consulta-
tions. We evaluated the effects of the training in two ways: 1. Office visits by 
standardized patients (SPs) to determine the extent to which GPs synthesized and 
applied the newly learned behaviors; and 2. Questionnaires to determine GPs’ 
satisfaction with the training and perceived applicability of the new genetics con-
sultation skills in their practice. 
Materials and methods 
Experimental design 
We conducted a pragmatic, blinded randomized controlled trial (RCT) with paral-
lel repeated measurements using a performance checklist and questionnaires. 
Kirkpatrick’s four level framework for evaluating educational outcomes entails: 1. 
valuation (satisfaction), 2. learning (knowledge and knowledge retention), 3. be-
havior (applying knowledge about timely identification of patients at risk and 
referral), and 4. effects on patient health and organization (change in practice and 
results).18,19 The design included an innovative measurement method with office 
visits by SPs aimed at the third level. Unannounced SPs are a proven method to 
collect data about real practice in a direct and reliable way. 20 
 Participating GPs were randomly assigned to a training date: Decem-
ber/January for the intervention group (four sessions) or March/April for the 
control group (three sessions). The trial ran from December 2011 to April 2012.  
 The RCT involved an intervention (oncogenetics training) and repeated 
measurements before (T0), one month (T1) and three months (T2) after the inter-
vention (table 1). All participants completed a demographics survey at T0. Be-
tween T0 and T1 the intervention group attended the training, while the control 
group received no intervention. For the evaluation of genetic consultation consul-
tation skills at T0 (pre-test), at T1 (post-test) and at T2 (retention test), SPs com-
pleted checklists after consultations with both GP groups (level 4)21. The SPs were 
blinded to GPs’ group assignment. To measure satisfaction with the training (level 
1), the intervention group completed a questionnaire at T1. To measure partici-
pants’ perceived applicability of the training content (level x), the intervention 
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group answered a questionnaire at T2. To stimulate compliance of control group 
participants, they were invited to attend the training after T2.  
 The ethical review boards of the Netherlands Association for Medical Educa-
tion, Maastricht University Medical Center, and VU University Medical Center Am-
sterdam, the Netherlands approved the study protocol. All participants gave writ-
ten informed consent before the trial.  
 
Table 1. Time table of the randomized controlled trial showing scheduled measurement times, 
instruments, and measurements made (indicated with X) in the Intervention and Control groups. 
Instrument Group Time 
  0  2 weeks 1 month 3 months 
  Pretest 
(T0) 
 Posttest 
(T1) 
Retention test  
(T2) 
Standardized patients’ 
checklist 
Intervention  X1 Oncogenetics training X X 
Control X  X X 
Satisfaction 
questionnaire 
Intervention   X  
Applicability 
questionnaire 
Intervention    X 
Demographics 
questionnaire 
Intervention 
& Control 
X    
1 measurement made with the instrument indicated in column 1, in the group indicated in column 2. 
 
Participants 
The project team collaborated with the Dutch College of General practitioners 
(NHG) and local training providers to recruit GPs working full - or part time in 
general practice. 
 For logistic reasons, recruitment was limited to all GPs practicing in two 
Dutch provinces, who received an invitational online mailing with information 
about the aim of the study, the contents of the face-to-face training, and the evalua-
tion procedure. Accreditation points were offered to GPs completing the study. A 
book on genetics in general practice or a book voucher of equal value was offered 
as an extra incentive. Four email or telephone reminders were sent to non-
responders.  
 Eighty participants were needed to detect a medium- to large-sized effect 
with a power of 90% and significance level of 5%.22 Figure 1 shows the randomiza-
tion scheme and participation.  
CHAPTER 5 
96 
Intervention 
The intervention group attended a four-hour face-to-face evening training cover-
ing oncogenetic consultation skills (family history, familial risk assessment, and 
efficient referral), attitude (medical ethical issues), and clinical knowledge re-
quired in primary care genetic consultations. More specifically, the training com-
prised the following educational content aimed at equipping GPs to: 
• recall clinically relevant information about types of hereditary cancer (breast, 
ovarian, colon, skin) including genes associated with oncogenetics syndromes 
most commonly tested for;  
• recognize patients with features suggesting inherited predisposition to cancer; 
• draw a family tree as a tool to identify patients at risk;  
• discuss (possible) familial and hereditary cancer risks, management of poten-
tially developing hereditary cancer (i.e. surveillance and risk-reducing surgical 
options) and related ethical issues;  
• identifying patients for referral for risk assessment and find relevant infor-
mation online using oncogenetics guidelines; 
• explain the possibilities and limitations of oncogenetic testing; 
• know when to consult and/or refer to a genetics specialist. 
 
The training was developed by a multidisciplinary team consisting of an NHG edu-
cational expert (EJvdJ), GP researcher (EJFH), two clinical geneticists, and two 
educationalists (SvL, CvdV). The focus was on oncogenetic diseases with relatively 
high prevalence in family practice (breast cancer due to BRCA mutations, colon 
cancer (e.g. FAP, Lynch syndrome) due to APC/mismatch-repair gene mutations, 
and skin cancer (e.g. Familial Atypical Multiple Mole Melanoma (FAMMM) Syn-
drome due to CDKN2A (p16) gene mutations)). The training started with a one-
hour interactive theoretical session on hereditary forms of cancer lead by a clinical 
geneticist from a local academic hospital who was familiar with the aims of the 
program, followed by a one-hour session with two patients of the Dutch BRCA 
patient organization, who talked about their experiences, discussed ethical issues 
and answered questions. A short break was followed by a two-hour workshop in 
which participants in small groups engaged in three role-played consultations for 
three oncogenetic problems in the presence of experts (clinical geneticist, patient 
representatives, and two trainers). Patients and GPs were role-played by partici-
pants and the others gave feedback.  
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Measurements 
Standardized Patients 
For a detailed description of the training sessions with SPs preceding the practice 
visits, clinical case scenarios (eTable 1) and development and finalization of check-
list (eTable 2), see Supplementary Materials and Methods information. 
Questionnaires 
Three online self-reported questionnaires were used to collect data on satisfaction, 
applicability of new consultation skills, and demographics and practice character-
istics, (see eTables 3, 4 and 5). The instruments were developed and validated in 
collaboration with the research team. The questionnaires were developed and 
validated in collaboration with content experts (experts in daily clinical genetics, a 
GP, and an expert in education and questionnaire development) and pilot tested.” 
 The satisfaction questionnaire contained two items with five-point Likert 
scales (1: completely disagree; 5: completely agree) and an item with a global rat-
ing on a ten-point scale.5 The applicability questionnaire contained six items with 
five-point Likert scales and one item with a four-point ordinal scale.  
Regression analysis 
For detailed description of Regression analysis to investigate improvement of 
genetic consultation behavioral skills, see online-only material contents (Details of 
background of Methods –Analysis of Regression). 
 Satisfaction with the intervention and applicability scores were analyzed by 
calculating mean scores, 95% confidence intervals, and standard deviations for the 
pooled data from the satisfaction questionnaire.  
 All analyses were performed using SPSS version 19 (SPSS, Chicago, IL). 
Results 
Randomization and dropout comparisons 
Of 88 randomized GPs who agreed to participate in the training in Decem-
ber/January 2011/2012 (intervention group) or March/April 2012 (control 
group), 56 (38 intervention, 18 control group) completed the entire procedure, 
and 32 were lost to follow-up due to lack of time or sickness (Figure 1). 
Participant characteristics 
Participants in the intervention and control groups did not differ significantly in 
age, gender, years of experience, type of office, and office situation (See table 2). 
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Table  2. Demographics and Practice Characteristics of Participants (n) 
 Control Group 
(n=18) 
Intervention 
Group 
(n=38) 
Chi-square/ 
Mann-Whitney 
Test 
(P values) 
Sex    
 Female 12 29 .446 
 Male 6 9  
Age in years    
 30-39  3 14  
 40-49 5 6  
 50-59 7 12 .318 
 60-69 2 4  
 Unknown 1 2  
Professional experience in years     
 Less than 10 4 9  
 Between 10 and 19 3 7  
 Between 20 and 29 7 6 .679 
 Between 30 and 39 0 2  
 Between 40 and 49 0 1  
 Unknown 4 13  
Practice Type    
 Solo practice 1 5  
 Duo practice 4 7  
 Group practice 2 3 .364 
 Community Health Center 5 3  
 Other 4 12  
 Unknown 2 8  
Practice Setting    
 Metropolitan area (>100,000 residents) 10 11  
 City (between 30,000 and 100,000 residents) 1 6  
 Small Town (between 5,000 and 30,000 residents) 3 10 .145 
 Rural area (<5,000 residents in largest village) 1 0  
 Unknown 3 11  
Effects of the intervention on oncogenetics-related learned consultation skills  
Each of the 56 GPs was visited by three SPs, portraying different cases, resulting in 
168 first visits (Figure 1).  
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Figure 1. Consort Diagram of Randomization and Participation 
 
 
Figure 2 shows the raw mean performance scores (proportion correct) for the 
control and intervention groups at times T0 (pre-test), T1 (post-test), and T2 (re-
tention-test). Between-group differences were found to be non-significant for pre-
test and retention-test, but the post-test difference of 0.19 in favor of the interven-
tion group was found to be significant (t-test, p<0.0005). These estimations, how-
ever, are based on raw means and may be biased due to differences in difficulty 
between the three SP cases. More precise and unbiased estimations were obtained 
by the regression analysis (table 3). The regression results for ScoreT1 showed 
that the effect of the intervention (the coefficient for Train) was statistically signif-
icant and amounted to .14 on the proportion correct scale; the corresponding val-
ue for the standardized regression coefficient was equal to .34 indicating a moder-
ate effect size. The analysis for ScoreT2 showed that the significant intervention 
effect persisted until the retention measurement at T2 (two months later) and 
amounted to .11 (standardized regression coefficient=.28, moderate effect size). 
Hence, the performance improvement due to the intervention was still substantial 
at T2, being equal to 80% of the immediate effect at T1.  
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Effect modification of the treatment effect by baseline value was tested for the T1 
and T2 scores; for both variables, the effect modification was found to be non-
significant.  
 
 
Figure 2. Performance scores for oncogenetics consultation skills as measured by proportion correct 
on SP checklists (mean and 95% confidence interval) for control group (black) and intervention group 
(gray) at T0, T1, and T2, corresponding to pre-, post-, and retention-measurement, respectively. 
 
Table 3. Effect of the oncogenetics training on the performance of GPs. Regression results are shown 
for immediate gain of performance (ScoreT1) and retention of performance (ScoreT2), using the 
pretest score (Score T0) as a covariate and the control group score as a reference.  
Dependent 
Variable 
 
 
Independent Variables 
 Constant  Score T0  Train 
  regression 
coefficient 
regression  
coefficient 
standardized
regression 
coefficient 
 regression  
coefficient 
standardized
regression 
coefficient 
    value 95% CI Value  value 95% CI value 
  low high   low high  
ScoreT1  .58 ***  .23  -.02 .47 .23  .14 ** .05 .23 .34 
ScoreT2  .52 ***  .15  -.07 .38 .16  .11 * .03 .20 .28 
*** p<0.001; ** p<0.01; * p<0.05; CI: confidence interval  
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Satisfaction and applicability 
The satisfaction questionnaire resulted in high scores for the two items (both 4.4) 
and a global score of 7.7; when applicability is also considered, favorable scores 
were found for all six items (3.5-4.5). Overall, 65% of the trainees reported apply-
ing the newly learned skills monthly, and 35% weekly (table 4). 
 
Table 4. Satisfaction (intervention only; N=18) and self-reported applicability  
(intervention only; N=17) as a result of oncogenetics training.  
Variable Mean  95% CI SD 
 (min - max) low high  
Satisfaction      
 Would recommend the module to a colleague1 4.4 (2 - 5) 3.9 4.9 0.98 
 Content of the module is relevant for a GP 4.4 (1 - 5) 3.8 5.0 1.10 
 Content of the knowledge test is relevant for a GP  4.1 (2 - 5) 3.7 4.5 0.83 
 Global score (1-10) 7.7 (1 - 10) 6.7 8.6 1.90 
     
Applicability     
 Recognize patient with genetic disease sooner 4.1 (2 - 5) 3.6 4.5 0.90 
 Sooner refer to or discuss with a genetic specialist 3.9 (3 - 5) 3.5 4.4 0.77 
 More knowledge of possibilities/limitations of   
 genetic tests 
4.0 (3 - 5) 3.7 4.3 0.61 
 More knowledge of genetic diseases  3.7 (1 - 5) 3.2 4.2 1.00 
 More knowledge of basic genetic concepts 3.5 (2 - 5) 3.2 3.9 0.72 
 More knowledge of genetic information sources  4.5 (2 - 5) 4.0 4.9 0.87 
     
Proportion of trainees applying the learned knowledge (%)     
 daily  0    
 weekly 35    
 monthly 65    
 not (do not meet any genetic problems in our practice)  0    
CI, confidence interval; GP, general practitioner; max, maximum; min, minimum. 
1 if not indicated otherwise results refer to scores of 5-point Likert scale items (1: competely disagree, 
5: completely agree); CI: confidence interval  
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Discussion 
Summary of main findings 
To our knowledge this is the first RCT to use SPs to investigate improvement of 
GPs’ oncogenetic professional behavior after attendance of an oncogenetics train-
ing. The results show sustained improvement 3 months after the training, as well 
as high satisfaction with the training and positive perceptions of the practical ap-
plicability of training topics.  
 Immediate and long-term training effects were evaluated at Kirkpatrick’s 
level 3 (behavior showing evidence of learning), which enhances the value of the 
findings.22,23 The results indicate that case-based oncogenetics education can 
achieve sustained improvement with a moderate effect size in urgently desired 
genetics competencies for GPs, while the positive results for satisfaction and ap-
plicability may reflect a move toward a culture of genetic medical practice im-
provement. Educational interventions likely have a small to moderate effect on 
physician knowledge and performance, and patient outcomes.25 A few factors that 
were applied could have supported this result, such as active and interactive ses-
sions, single group and smaller group sessions. Whether there is a sustainable 
impact on applicability of the training in practice, including timely identification of 
patients with a possible cancer predisposition syndrome and appropriate referral, 
will need further longer-term studies. Designed to fill gaps in physicians’ compe-
tencies and boost their confidence in using basic clinical genetic principles and 
activities, the oncogenetics training addressed previously prioritized key features 
of genetic consultation skills and attitude, but not basic science knowledge.31-35 
 
SPs have been used successfully before to assess changes in clinical competence 
and performance and sustained effectiveness of behavioral training, but not to 
evaluate attitudinal factors cited as directing practice performance, such as patient 
satisfaction.21,26,27 
 After the training the participating GPs seemed to be more comfortable incor-
porating oncogenetics aspects in patient consultation skills as reflected in their 
high perceived applicability. It seems plausible that this, in turn, will enhance effi-
cient and effective referral for genetic counseling. Whether the latter effect will 
materialize, however, remains to be examined in future studies. Taylor et al. dis-
cussed barriers to effective primary care involvement in the expanding field of 
adult genetics, arguing that genetic medicine should be part of integrated medical 
care and therefore of primary care medicine. 28 We agree with this viewpoint and 
feel that the training we designed shows promise to enhance communication be-
tween GPs and the genetics community, identification of high-risk patients, and 
timely referral to genetics services. 
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Methodological considerations 
One of the aims of including real patients and simulated consultations in our train-
ing was to promote a favorable attitude among GPs to the application of genetic 
competencies. A study by Carroll et al. measured intent to use clinical genetics 
scenarios and increase competence due to a multifaceted knowledge translation 
intervention but used questionnaires and not ratings of observed practice behav-
iors.29 Patient and societal perspectives on legal consequences of DNA-based test-
ing results (for example being able to find a genetics information source or ability 
to obtain a mortgage or life insurance) however, demand that physicians’ effective 
use of genetics be demonstrated by actual performance in health care practice.7,21 
We therefore deliberately deployed trained and blinded SPs to optimize the value 
of the measurement. Repeated SP visits may have impacted the outcome of learn-
ing effects in both study groups, as the GPs would have had a higher level of 
awareness of being critiqued and could have felt a certain pressure to perform 
appropriately, but this is controlled for in the current study thanks to its RCT de-
sign.30 
 Rollnick et al. suggested that learner-directed and context-bound consultation 
skills training should be integrated in everyday practice in a way that is acceptable 
to clinicians.31 Based on this principle we had physicians identify their training 
needs and tailored our training to the practice context by patient centered consul-
tation skills training. Based on the results of our earlier studies we emphasized 
everyday genetic clinical experiences more than consultation skills and attitude 
alone.16,17 Our strategy could therefore be described as an “enriched context-bound 
consultation skills training”. Informal comments after the training by participants 
made clear that this format had a positive effect on their learning.  
 Potential oncogenetic problems are considered very personal topics to dis-
cuss between a patient and their own general practitioner (GP).16 This determined 
why it was not discussed in an incognito setting with a so-called “new” patient or 
unannounced, concealed simulated patient.32 
Strengths and limitations 
Strength of the study was measuring change in consultation skills after the training 
by using SPs in particular, as opposed to using computerized case-based testing for 
example. A variation of measurement instruments was proposed to predict prac-
tice performance.33 SP-based measurement is relatively unobtrusive, highly au-
thentic and based on patient perception. Another strength of the study is the fact 
the educational intervention was tailored to the learners’ needs.6,16 Because the 
current study is confined to one health-care setting within one country, the gener-
alizability of the results may be limited. The training’s demands on resources, facil-
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ities, and logistics may limit the feasibility of training delivery in many different 
settings. Nevertheless, SP-based assessment is a valid instrument to describe what 
happens in real practice and can therefore provide valuable information for ad-
vanced development of genetic trainings. The study design introduces the possibil-
ity of bias by virtue of each GP seeing three different case presentations in differ-
ent orders. This potential limitation was acknowledged and statistical accommo-
dations were made.  
 Using comparable case scenarios in this study, it was possible to measure 
change in checklist scores over time. However, it remains to be investigated 
whether it is possible to use different scenarios, for example based upon a family 
history alone. This would be a scenario seen in daily GP practice and the time 
when timely referral could be of benefit to the pre-symptomatic patient in regards 
to preventing or reducing familial cancer risk. Future studies could include as-
sessing the issues addressed in the study by Culver et al, namely satisfaction with 
the time to address concerns, acknowledgements of patient concerns about cancer 
risk by physician and offering reassurance.34 Using the validated checklist, the 
current study measured GPs’ genetics consultation skills, thereby reflecting that 
training outcomes’ covering the full scope of good practice consultations: key in-
gredients related to family history taking, genetic risk assessment, and referral to 
genetics specialists. The SP requested standard 10-minute appointments. This may 
seem short for a first consultation, however this is standard duration the Nether-
lands. If requested, in “real world” clinical practice, a follow up appointment could 
be made to adequately address all of the issues concerned further. However, in the 
study design, the SPs came in with a concern possibly related to an inherited form 
of cancer. The extent to which GPs synthesized and applied the newly learned 
behaviors was assessed by long-term changes in a 28-item checklist score, not by 
whether all issues would be discussed. Performance assessment is considered 
representative of a product of competence, influences of individual (e.g. health, 
relationships) and organization (e.g. facilities, practice time). GPs were therefore 
similarly assessed for performance under equivalent conditions (e.g. appointment 
time limitation focused entirely on the sole reason for visit, without distraction or 
delay). 21,27,35  
 Although the three-month study period may have been too short to detect 
sustainable practice improvement long term, repeated measurement of consulta-
tion skills predicts practice performance long term.21,26 
 Voluntary participation by interested GPs could have caused selection bias. 
However, similarity of the baseline characteristics of the two groups and compa-
rability of the 60% participation rate with that of other studies among GPs indicate 
that the participants were representative of GPs likely to attend oncogenetic train-
ing in the future.36,37 Furthermore, it is possible that participating in the onco-
genetics training might become part of standard training for all GPs. There was an 
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imbalance however between the drop out rate in the intervention and control 
group and the reason for this is not clear. Attending the training in the beginning of 
the trial period could have provided the urgent information to be able to satisfac-
torily finish all measurements long-term. Participants in the control group on the 
other hand had to wait for training content, possibly causing resistance to finish all 
measurements resulting in drop out. General reasons for drop out were reported 
(no time and sickness), not specific attributes. It is therefore unlikely that self-
selection in dropout negatively impacted the validity of the results.  
 A pragmatic and blinded study design has known limitations.38 Obviously, it is 
preferable for an RCT where participants are blinded to inclusion in the interven-
tion or control group, that those conducting the measurements are blinded as 
well.39 We achieved this by blinding the SPs to the GPs’ group allocation and by 
having two independent researchers (AMMM and SRvT) analyze the checklist 
scores in a blinded manner.  
 
The results indicate that an oncogenetics training designed to meet GPs’ educa-
tional needs can be a satisfactory and feasible method for sustained improvement 
of competencies to ensure appropriate application in family medicine of develop-
ments from the rapidly evolving field of genetics. Learner-directed and context 
bound genetics education appears to be a valuable tool to stimulate GPs to deliver 
genetic services.40 We plan to use the results to inform the design of new trainings 
on complex genetic diseases, including hereditary forms of cancer, cardiovascular 
disease, and diabetes, in our continuing efforts to improve referral strategies and 
timely recognition of high-risk genetic patients. Large-scale international random-
ized controlled trials with adequate power are warranted to further assess how 
genetics education can improve health care.  
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eTable 1. Description of Cases presented by Standardized Patients 
  Skin cancer case Colon cancer case Breast cancer case 
Biography Male or female, age 31. Born and 
raised in suburb of major city. Went 
to culinary school, works at 
restaurant. Lives in apartment 
downtown, romantic relationship 
ended two years ago.  
 
Male or female, age 
41. Born in small 
city, moved to 
outskirts 10 years 
ago. After high 
school, first worked 
in do-it- yourself 
store, past 15 years 
as taxi driver. 
Relationship with 
spouse is stable. 
 
Female, age 41.  
Lives in quiet suburb 
with husband, 
daughter age 13 and 
son age 10. After 
college began 
working at bank. 
Family situation is 
stable, spends a lot 
of time with children 
in the weekend. 
 
Medical complaint Spots on back which bleed, itch and 
are getting bigger. Last month doctor 
called it a regular birthmark. Spots 
noticeable for at least 3 months. 
Pain in lower left 
abdomen and 
watery brown 
bowel movements. 
Symptoms began 3 
weeks ago after trip 
to Thailand. 
Obesity, but 
recently lost 1 kilo.  
 
Lump in left breast, 
noticed last week. 
The 4 cm irregular 
swelling not painful 
but sensitive. The 
skin on the swelling 
is a little red and 
dimpled.  
Lifestyle Smokes half a pack of shag a day since 
age 17. Drinks heavily twice a week 
after work. No drugs, no coffee, tea 
once a day. Sunbathing vacation in 
southern France every year. 
No history of 
smoking. Drinks 
wine occasionally. 
On Mirtazipine 
(anti-depressant) 
for a year. Drinks 4 
cups of coffee and 2 
cans energy drink 
per day. Fresh 
vegetable is absent 
from diet, does eat 
2 fruit servings.  
 
Heavy smoker from 
age 16 up to 2 years 
ago. Drinks wine 
with dinner and 
social drinker in the 
weekend. Drink 2 
cups of coffee a day. 
Medical history No medical history.  
 
Family history: 
Sister: skin cancer at age 23, died two 
years later of brain tumor.  
Father: skin cancer at age 40, treated 
and cured.  
Grandfather, father’s father: skin 
cancer at age 43, died 5 years later of 
brain tumor. 
On mother’s side no one has cancer. 
Mild depression 
Obesity;BMI 35 
 
Family history: 
Father diagnosed 
with colon cancer 
at age 40, died of it 
a year later. 
No contact with 
rest of family. 
No medical history.  
 
Family history: 
Grandfather, 
mother’s father: 
unknown cancer and 
died, age 55. 
Mother: breast 
cancer at age 35 and 
is now 75. 
Sister: ovarian 
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  Skin cancer case Colon cancer case Breast cancer case 
cancer at age 30 and 
died at age 33;  
other 2 sisters seem 
healthy.  
On father’s side no 
one has cancer. 
Motivation for 
appointment 
You want a thorough examination, 
because you know how quickly 
cancer can develop. If the doctor’s 
diagnosis isn’t cancer, you will need 
convincing. You know that your sister 
had the same symptoms back then 
and it took a lot of persistence to get a 
referral and diagnosis.  
You want a solution 
to your symptoms, 
and clarity on 
whether it’s cancer 
or not. You know 
your father got 
cancer at your age 
and it killed him. 
You don’t mention 
this until later; you 
don’t like to talk 
about family. You 
don’t have much 
contact with 
relatives due to 
conflicts.  
You’re scared of 
cancer because 
there’s a lot of it in 
the family. You want 
to know whether the 
lump will get larger 
and if it’s malignant. 
You really want to be 
referred to the 
specialist. If the 
doctor doesn’t do 
this, let him or her 
know you’re really 
scared and be 
disappointed. 
Physical 
examination 
results  
 
(given in paper 
format by the SP 
to the GP during 
the visit if 
requested) 
Inspection: A lesion is visible on the 
right shoulder blade. The lesion has 
an erratic surface, irregular border 
and color, and is 2 cm in diameter.  
Inspection:  
no irregularities. 
Auscultation: 
plumbing sounds. 
Percussion: normal 
sounds in all four 
quadrants of 
abdomen.  
Palpation: no 
palpable 
irregularities. 
Rectal exam: 
normal. 
Inspection: no 
irregularities. 
Palpation: a palpable 
mass in the left 
breast. Size: 2cm. 
Consistency: solid-
elastic. Irregular 
shape. Not painful, 
no inflammation. No 
discharge from 
nipple.  
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eTable 2. Standardized patient checklist items assessing genetic consultation skills 
 Score as yes: YES NO ? 
1. Responds to my concern about possible 
genetic cancer. 
“I can imagine you are worried about 
that”, “what are you concerned 
about?”, etc.  
   
2. After expressing my concern, the GP 
confirms that this form of cancer can be 
hereditary. 
“This form of cancer can be 
hereditary”, “this form of cancer is 
often passed in families”, etc. 
   
3. Asks about cancer in my family. “Do any of your relatives have 
cancer?”, etc.  
   
4. Further asks which kinds of cancer 
occur in my family.  
“Which kind of cancer did they have?”, 
“Can you remember what kinds of 
cancer your relatives have?”, etc.  
   
5. And asks at which age the cancer was 
diagnosed. 
“At which age did the doctors discover 
that your relative had cancer?”, “How 
old were they when they got the 
diagnosis?”, etc.  
   
6. Asks who was diagnosed. “Can you remember who had this kind 
of cancer?”, “Which relatives have this 
kind of cancer?” 
   
7. Asks specifically if this kind of cancer is 
present in my children, siblings or parents 
(first -degree relatives).  
“Have your children, parents or 
siblings had this kind of cancer?” 
   
8. Draws a family tree to clarify possible 
inheritance of cancer.  
A family tree is drawn.    
9. Explains the possibilities and limits of 
genetic testing. 
“What we can/can’t determine by 
genetic testing is…”, “With genetic 
testing we can diagnose X but not Y.” 
   
10. Explains that a genetic test for this 
kind of cancer does not prevent that I may 
or may not get that cancer in the future.  
Makes it clear that interpretation of 
tests is still limited. “This test doesn’t 
offer certainty that you will or won’t 
get this form of cancer at some point 
in your life.” 
   
11. Explains what the consequences could 
be for me if a certain genetic test for 
hereditary cancer comes back positive.  
“If the test indicates that you have this 
inherited defect, then…”, “A positive 
test result would mean for you…” 
   
12. Asks about my expectations regarding 
the possibilities and limits of genetic 
testing. 
“what do you expect from the genetic 
test?”, “Do you expect to have 
certainty after having the test?” 
   
13. Explains why referral to the clinical 
geneticist is or is not useful.  
“Referral to a clinincal geneticist can 
be useful in your case”, “a referral in 
your case isn’t useful because…” 
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 Score as yes: YES NO ? 
14. Considers looking up referral criteria 
on the internet (possibly with me) 
“I’ll look online if there is an indication 
to refer you to the clinical geneticist”, 
“to be sure that it’s useful to refer you 
to the clinical geneticist, I’ll look up 
their website” 
   
15. Knows about relevant clinincal 
geneticists in the region (possibly by 
looking with me online) 
“By this department of clinincal 
genetics are the following 
possibilities…”, “Let’s together look at 
what the clinical geneticists can do for 
you.” 
   
16. Considers contacting (by phone) the 
clinical geneticist to discuss possible 
referral (possibly with me) 
“I will contact the specialist in genetics 
to discuss your situation”, “I’m calling 
the clinical geneticist to be sure we 
make the right decision” 
   
17. Explains when I would meet the 
criteria for referral to clinical genetics 
“The following criteria must be met for 
a referral …”, “If this happens, then I 
can refer you to clinincal geneticist” 
   
18. Discusses with me whether relatives 
may be informed that referral is useful for 
them 
“Perhaps it’s a good idea to inform 
your relatives and have them tested as 
well”, “It’s important that your family 
members also get tested for this 
condition” 
   
19. Discusses with me whether relatives 
should make a GP appointment, if it turns 
out it is hereditary cancer 
“Your relatives who also come to this 
practice, could also have a higher risk 
and should be tested”, “Because your 
family members could have the same 
condition, I would like to also ask 
them to have a genetic test.” 
   
20. If yes, discusses with me whether 
relatives may receive information about 
me.  
“Do you have a problem with that?“, 
“What do you think about that?” 
   
21. Indicates that cancer indeed occurs 
more often in my family than one would 
expect  
“cancer indeed occurs more often in 
your family than I would expect”, 
“Your family does have a lot of this 
kind of cancer” 
   
22. Indicates that this could point to a 
hereditary form of cancer.  
“We do see this kind of cancer in 
hereditary form”, “It’s possible that 
this kind of cancer is inherited” 
   
23. Registers the genetic risk (family 
history) of this kind of cancer in the 
computer system  
“I’m registering this genetic risk of this 
kind of cancer in your record”, “I see 
you typing, what are you entering, is it 
in my record?” 
   
  
EFFECTIVENESS OF ONCOGENETICS TRAINING ON CONSULTATION SKILLS 
113 
 Score as yes: YES NO ? 
24. Mentions possible consequences of the 
genetic risk for my children, 
cousins/nieces and nephews 
“The chance that your children get this 
condition is…”, “There’s a higher 
chance that your nieces will develop 
this condition” 
   
25. Refers me to the closest clinical 
genetics outpatient clinic 
“I would like to send you to the clinical 
genetics outpatient clinic”, “They can 
help you better at the clinical genetics 
outpatient clinic, so I’m sending you 
there.” 
   
26. When I ask for more information to 
read at home, the doctor mentions 
www.erfelijkheid.nl (a Dutch website on 
general genetics topics) or another 
website 
“If you want to read more info on the 
internet at home, you can look at 
www.erfelijkheid.nl “, “At (another 
site) you can find more info” 
   
27. Gives me a patient information letter “In this letter you can read more 
information” 
   
28. Mentions possible support from the 
relevant patient organisation when I ask 
where else I can turn to with my concerns 
“You could find support by a patient 
organisation”, “A specific patient 
group could support you with your 
condition” 
   
 
 
eTable 3. Satisfaction Questionnaire 
1. I would recommend this training to my colleagues.  
 
(On a scale of 1=Totally Agree to 5=Totally Disagree, 6= Not applicable/ No opinion.) 
2. In general, I judge the topics presented in the training as relevant for family practice. 
 
(On a scale of 1=Totally Agree to 5=Totally Disagree, 6= Not applicable/ No opinion.) 
3. Which grade would you give this training, on a scale of 1= Bad to 10= Perfect?  
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eTable 4. Perceived applicability questionnaire 
1. I apply the knowledge gained from this training:   
o Daily 
o Weekly 
o Monthly 
o I don’t come across any genetic issues in my practice and therefore do not apply the 
knowledge from the training.  
 
(On a scale of 1=Totally Agree to 5=Totally Disagree, 6= Not applicable/ No opinion.) 
 
2. I recognize patients with a genetic condition much earlier than I did before I completed the training.  
3. I refer to or consult with a clinical geneticist much earlier than I did before I completed the training.  
4. I have more knowledge about the possibilities and limits of genetic testing than I had before I 
completed the training.  
5. I have more knowledge about the most common genetics conditions in the Netherlands than I had 
before I completed the training.  
6. I have more knowledge about fundamental concepts of genetics than I had before I completed the 
training.  
7. I have more knowledge about important sources of information about genetics than I had before I 
completed the training.  
8. Space for optional extra comments: …………………………. 
 
eTable 5. Demographics and Practice Characteristics Questionnaire
1) You are:  
o Male 
o Female 
2) Age: …years old 
3) Number of years experience as General practitioner: …years 
4) In which type of practice do you work? 
o Solo practice 
o Duo practice 
o Group practice 
o Community Health Center 
o Other 
5) Degree of Urbanization of Practice Area: 
o Metropolitan area (>100,000 residents) 
o City (30,000 – 100,000 residents)  
o Small Town (5,000 – 30,000 residents)  
o Rural area (<5,000 residents in largest village) 
 
EFFECTIVENESS OF ONCOGENETICS TRAINING ON CONSULTATION SKILLS 
115 
Supplementary materials and methods  
Details of background of Materials and Methods; Measurements of genetic 
consultation skills through standardized patients and Regression Analysis 
Methods 
Measurements of genetic consultation skills 
Standardized Patients 
Visits 
Twelve experienced SPs (5 male/7 female) were trained by JJR and EJFH to each 
play one of three oncogenetic cases. All of the four SPs trained to play the breast 
cancer case were female, while one of the familial colon cancer case SPs and two of 
the melanoma case SPs were female. They received a comprehensive written 
account of the clinical scenario and a full briefing of their role. Thereafter, a 
training session with two of the researchers (EJFH and JJR) clarified the purpose of 
the project and the standardized roles. The three oncogenetic cases were 
comparably recognizable and urgent to be able to train all the SPs the first day 
together on presentation and checklist items. The second training day the SPs 
were trained separately for each one of the three cases on specific clinical history. 
In case the GP would indicate to proceed to a physical examination, the SPs handed 
over to the GP a standardized leaflet summarizing the main PE findings fitting the 
specific oncogenetic case (see eTable 1. Description of Cases presented by 
Standardized Patients). 
 At each measurement time (T0, T1 and T2) each GP was visited by one SP. 
Each SP presented a different case. The GPs were therefore confronted with three 
different standardized cases, played by three different SPs. The SPs were blinded 
to whether the GP belonged to the intervention or control group. The GPs were 
informed an SP would consult during office hours; however they were unaware of 
exact date and time. After telephoning the office assistant the SP made a standard 
ten-minute appointment, insisting that their identity would not be disclosed to the 
GP; however they revealed their identity on entering the GP’s office. At the 
beginning of each simulated encounter, the SPs gave instructions asking the GPs to 
conduct the consultation authentically. Immediately after each visit, the SPs 
completed a uniform, predefined checklist to assess GPs’ genetic consultation 
skills.  
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Cases 
Experts in family medicine, clinical genetics, and education selected the 
oncogenetic cases and wrote the clinical scenarios (EJFH, JJR, EJvdJ, CvdV) using 
the following criteria: relatively high prevalence in family practice; diagnostic 
features identifiable through family history and family tree drawing (eTable 1); 
suitability for a discussion on efficiency considerations (efficient referral to clinical 
genetics specialist and timeliness of referral); suitability for scoring with one 
uniform checklist; the presence of important features for physician education; 
feasibility of realistic SP performance; and coverage of a broad spectrum of 
oncology cases commonly presented in family practice. 23 Using comparable case 
scenarios according to the criteria mentioned, enabled comparing potential 
changes in checklist scores between the three different measurement times. 
Checklist 
The research team developed a 28-item checklist to quantify evidence judged 
necessary to assess GPs’ genetics consultation skills reflecting training outcomes’ 
covering the full scope of good practice consultations: key ingredients related to 
family history taking, genetic risk assessment, and referral to genetics specialists. 
To validate the checklist, three experts in family medicine education and four 
clinical geneticists evaluated the applicability of the items and cases (eTable 2). 
Items judged not suitable for scoring (i.e. less than 75% of experts agreed on 
inclusion) were removed. Items were rated as “yes, observed” (score=1), “no, not 
observed at all” (score=0), or “?, unclear” (not scored = missing). The scores were 
summed and the proportion of the maximum possible score (1 for each item, 
ignoring the missing items24) was determined.  
Training of standardized patients and finalization of checklist 
One month before the first office visit, 12 SPs were trained, in groups of four, to 
play the three cases (one case consistently per group of 4) and score the checklist 
on GP’s performance consistently. Training took 16 hours spread over two days. 
Realistic portrayal was promoted by SPs practicing ten-minute consultations with 
ten real GPs (not training participants) in a studio in a GP practice setting. Training 
focused particularly on the use of introductory phrases and on helping them avoid 
giving away clues as to their role. SPs were also trained to fill in the checklist, to be 
completed immediately after a consultation during the trial, and their colleague 
SPs practiced their same role. Their checklist scores were compared with those of 
the SP trainers (EJFH and JJR), the supposed “gold standard”. The practice-
consultations were videotaped, scored, and judged to have sufficient face validity 
for each SP by a panel of four GPs who did not participate in these training 
sessions and were not otherwise involved. Differences in rating between the panel 
members were discussed and final alterations made to the measurement scale and 
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checklist. The panel and the SPs independently re-rated the transcripts using the 
modified checklist. Agreement between SPs and panel ranged from 87% to 98%, 
with Cohen’s kappa 0.87, which was deemed satisfactory for commence of the 
practice visits. 
Regression Analysis 
Regression analysis was used to investigate improvement of genetic consultation 
skills immediately after the course using the checklist scores at T1 (ScoreT1) as 
dependent variable and the checklist scores at T0 (ScoreT0) and the indicator 
variable Train (0: control group; 1: intervention group) as independent variables. 
To improve interpretation and numerical stability, the independent variable 
ScoreT0 was centered and the resulting variable Score T0, equal to ScoreT0-Mean 
(ScoreT0) was used in the analysis. 
 Each participant was rated on one of the three SP cases at T0, T1, and T2. As 
the roles might vary in difficulty and the case order varied between participants, 
we corrected for these differences by extending the regression equation with four 
terms corresponding to four indicator variables (values: 0, 1), the dummy 
variables D1-D4. This suffices to represent the effects of the five possible different 
role pairs in comparisons at T1 and T0. Role pair 1 is indicated by (D1=1, 
D2=D3=D4=0), role pair 2 by (D2=1, D1=D3=D4=0), etcetera, and role pair 5, is 
indicated by (D1=D2=D3=D4=0).  
 
Thus, the effect of the intervention was assessed using the model: 
 
ScoreT1= C + b1 Train + b2 ScoreT0c + b3 D1 + b4 D2 + b5 D3 + b6 D4 + E 
 
In the model C (Constant) represents the intercept of the regression equation, i.e. 
the predicted score at T1 for a participant in the control group (Train=0) with a 
score at T0 equal to the mean score (Score T0=0), and being visited by role pair 5 
(D1=D2=D3=D4=0). Regression coefficient b1 represents the effect of the 
intervention (Train=1), i.e. the increase of the score at T0 due to a participant 
being a member of the intervention group. Coefficient b2 is the effect of the pretest 
(Score T0), b2 Score T0 being the part of the score at T1 that can be predicted from 
the score at T0. Regression coefficients b3-b6 indicate the increase of the score at 
T1 when a participant was visited by role pair 1, 2, 3, or 4, respectively, instead of 
being visited by the reference role pair (role pair 5). Term E (Error) is the part of 
the score at T1 that cannot be explained by the predictors in the regression model 
(the residual). 
 In a similar procedure, using ScoreT2 as dependent variable, retention of 
knowledge was analyzed. 
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The regression coefficient b1 corresponding to Train represents the net gain in 
performance (expressed as proportion of the maximum score) due to the 
intervention. The corresponding standardized regression coefficient indicates the 
effect size. According to Cohen’s categorization (Cohen, 1988) values 0.1, 0.3, and 
0.5 indicate small, moderate, and large effect sizes, respectively.  
 The mean checklist scores and corresponding 95% confidence intervals were 
calculated for the two groups at T0, T1, and T2. Because the raw means are not 
corrected for varying role orders, the differences of the raw means may differ 
considerably from the intervention effect found in the regression analysis. It is 
important to note that the intervention effect inferred from the raw means is 
biased, whereas the regression analysis provides an unbiased estimator.  
 Satisfaction with the intervention was analyzed by calculating mean scores, 
95% confidence intervals, and standard deviations for the pooled data from the 
satisfaction questionnaire. The data from the applicability questionnaire were 
analyzed in the same way. All analyses were performed using SPSS version 19 
(SPSS, Chicago, IL).  
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Abstract 
Purpose 
General practitioners (GPs) are increasingly called upon to identify patients at risk 
for hereditary cancers. Therefore, their genetic competencies need to be enhanced. 
Three oncogenetics modules were developed based on the priorities identified: an 
online Continuing Professional Development (G-eCPD) and live genetic CPD 
module, and a website (huisartsengenetica.nl) with supporting genetics 
information applicable in daily practice. The study aimed to determine: 1) long-
term (self-reported) genetic consultation skills (i.e. increased genetics awareness 
and referrals to Clinical Genetics centers) among GPs participating in the training, 
and 2) interests in and satisfaction with the website.  
Methods 
1. A (1-year follow-up) online questionnaire on self reported applicability of 
genetic competences and on change in referral behavior. 
2. Referral numbers from GPs to Clinical Genetics centres.  
3. Satisfaction questionnaire and visitor count analytics of genetics website.  
Results 
The genetics CPD modules achieved sustained improvement of oncogenetic 
knowledge and consultation skills. Participants reported to be more alert of 
genetic problems. 68% of the respondents who attended the live training reported 
to more frequently refer patients to the Clinical Genetics centers, compared to 
29% of those who attended the online oncogenetics training. No significant change 
in referral numbers however was reported by the Clinical Genetics centers one 
year after the training. Website visitor numbers are still increasing. The page most 
often consulted is “family tree drawing”. 
Conclusion 
Self-perceived genetic consultation skills increased long-term and there was 
interest in and satisfaction with the supportive website. The study results 
presented suggest we have provided an adaptable and effective framework to 
answer to the need for effective educational programs for non-genetic healthcare-
providers enabling improvement of genetic medical care.  
 
Trial Registration: trialregister.nl Identifier: NTR3322 and NTR3323 
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Introduction 
Genomic innovations are increasingly applicable in daily medical care. General 
practitioners (GPs) are confronted with challenging genetic information, patients’ 
requests for genetic tests and its diagnostic and therapeutic consequences. For 
successful implementation of genetic innovations several barriers have to be 
overcome, including the fact that physicians lack knowledge of genetics relevant 
for daily practice, lack oversight of genetic testing, and report inadequacy to 
deliver genetic services.1,2 For genetics to have an effect on clinical practice 
comparable to its impact on research will require genetic literacy of health-care 
providers.3  
 Physicians in general wish to be educated in a practical manner, which means 
genetics education should be applicable in daily practice through exploiting case 
based learning.4-6 Genetic core competences for non-genetic health care workers 
have been developed 7-10. Competences in three domains are needed: cognitive 
(knowledge), psychomotor (skills) and affective (attitude).11 Combining the 
educational competences in training is regarded to have more impact on a clinical 
situation than training competences separately.12  
 We set out to provide an adaptable and effective framework for genetics 
education for primary care health physicians based on multiple methods and 
assessable at the highest possible level of evaluating the learning process and its 
effects on genetic performance in daily practice. We started by exploring the needs 
and the role of genetics in primary care and assessed priorities in genetic 
education mentioned by GPs.5,6 Top three of prioritized genetic competences were 
“Recognizing signals that can indicate a hereditary component of disease”, 
“Evaluating indications for referral to a Clinical Genetics center”, and “Knowledge 
of the possibilities and limitations of genetic tests”.6 It was expected that training 
focusing on these topics would lead to higher quality consultations between 
medical professionals and patients, reflected in timely referrals to the specialized 
departments of Clinical Genetics. The genetic competences were applied in 
oncology, as this was the yearly theme of the Dutch College of General 
practitioners (NHG). 
 Based on the priorities and integrating genetic core competences we 
developed three training modules executed by the NHG (Department of 
Education): 
1. a Genetics online Continuing Professional Development on oncogenetics,  
2. a live training (interactive program taking oncogenetics as a model condition), 
and  
3. a supportive website (www.huisartsengenetica.nl, “GP and genetics”). 13,14 
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The website was developed and is kept up-to-date by the research team in collabo-
ration with the Erfocentrum (Dutch Information Center on heredity and genetic 
disorders) and NHG, with on demand supportive information to be able to work on 
the learning tasks and apply genetic competences in daily general practice. The 
easily accessible website gives GPs on demand information on e.g. basic genetics 
information and how and which Clinical Genetic center to refer to.  
 To our knowledge, this was the first time a series of oncogenetic modules 
were organized and evaluated based on prioritized topics and effects on genetic 
performance were assessed.  
Kirkpatrick’s framework for evaluation educational outcomes 
For effect evaluation we considered Kirkpatrick’s framework for evaluating 
educational outcomes, originally presented in 1967, describing four levels: 
valuation (level 1; satisfaction), learning (level 2; knowledge and knowledge 
retention), behaviour (level 3: applied knowledge and consultation skills on timely 
recognition of patients at risk ) and effects on patient health and organization 
(level 4: change in actual practice performance (i.e. referral) and results).15 Also 
the impact on society, or patient safety in genetic medical care would be part of 
level 4 (Figure 1). We used Moore’s model for CPD curriculum design identifying 
individual learning steps with its educational objectives and the Kirkpatrick 
framework as a model to evaluate our oncogenetic modules (table 1).16 
 
Table 1. Matrix levels of oncogenetics modules evaluation according to Kirkpatrick and Moore 
(Adjusted to Davis et al., 2008 4)  
Kirkpatrick/Moore 
levels of Education 
and Evaluation 
Kirkpatrick  
Definition 
Oncogenetic 
module format 
Assessment Educational objective 
I Satisfaction G-eCPD,13  
live training,14 
supportive website 
Satisfaction surveys and 
website visitor count 
Information, 
comprehension 
II Knowledge, Self-
reported applicability 
of newly learned 
consultation skills 
G-eCPD, 13  
live training14 
Multiple choice questions, 
open ended questions, 
Vignettes: Pre/post-and 
retention-test 
Information, 
comprehension 
III Behavioral change Live training14 Responses to SP- encounters 
in actual practice: Pre/post-
and retention-assessment 
Synthesis, application, 
performance, attitude 
IV Organizational  
change, health gain 
G-eCPD, 13  
live training, 14 
supportive website 
  
GP Referral data of Clinical 
Genetics centers 
Analysis, synthesis, 
evaluation: health gain 
through timely 
(increased) referral to 
Clinical Genetics centers 
123 
 
 
Figure 1. Genetic educational framework;  
Based on Kirkpatrick’s Evaluation Framework for Educational Outcomes 15,17 
 
After the needs-based development and shorter-term evaluation of our genetic 
education modules, the goal was to answer the following research questions:  
1. To determine long-term genetic consultation skills among GPs participating in 
the training by assessing self-reporting skills (i.e. increased genetics 
awareness and referrals to Clinical Genetics centers), and by comparing 
referral data from GPs to Clinical Genetics centers before and after training. 
An increase in number of referrals was expected to reduce the number of 
missed cases.18 
2 To determine interest in and satisfaction with the website, website visitor 
count was analyzed and satisfaction with the website was determined 
through a pop-up questionnaire. Visitor count was expected to increase with 
oncogenetic programs organized and increasing media attention such as links 
on social media, newsletters and newsflashes in the media.  
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Materials and methods 
Four instruments were used to answer the research questions: 
1. An online questionnaire for determining long-term self-reported genetic 
consultation skills was emailed to those who had previously attended the 
oncogenetics CPD modules. See online-only material contents for Details of 
background of Materials (Questionnaire to determine self reported 
applicability of an Online Continuing Professional Development (G-eCPD) 
module and a Live training). 
2. Referral numbers by GPs were requested from the Clinical Genetics centers, in 
the Northern and Southern parts of the Netherlands (VU University Medical 
Center (VUMC), Amsterdam and Maastricht University Medical Center 
(MUMC), Maastricht, The Netherlands) from the two years before (2010 and 
2011) and the year after (2012) launch of the oncogenetics CPD modules and 
website huisartsengenetica.nl (“GP and genetics”). Increase in referral 
numbers was presumed to estimate short-term improvement of GPs’ 
synthesis and application of the newly-learned oncogenetics knowledge and 
consultation skills with increased awareness of oncogenetics problems in 
daily practice.  
3. Website visitor analytics roughly determine GPs’ sustained interest in the 
supportive website one year after introduction, suggesting change in 
organization and consequently health gain. Visitor count was expected to go 
up with oncogenetic programs organized and increasing media attention such 
as links on social media, newsletters and newsflashes in the media.  
4. To more specifically determine whether there was an interest in and 
satisfaction with the website, an online pop-up questionnaire was requested 
for one month when visitors would visit the website. See Online Only Text for 
Details of background of Materials (Website Satisfaction questionnaire).  
 
The ethical review boards of the Netherlands Association for Medical Education, 
Maastricht University Medical Center, and VU University Medical Center 
Amsterdam, the Netherlands approved the study protocols. All participants gave 
written informed consent before the trials.  
Participants 
The project team collaborated with the NHG on providing genetics CPD 
modules.13,14 The GPs who previously participated in these studies, working full or 
part time in family practice, were all followed up to participate long term in the 
online questionnaires. Recruitment for participation in the live oncogenetic CPD 
module was limited to GPs practicing in two Dutch provinces where the previously 
held live training sessions were given (n=88). The online oncogenetics training 
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required recruitment of participants outside these two provinces to be able to 
assess effects separately (n=80).  
 Participants of the website evaluation were all recruited online, when they 
visited the website a pop-up invitation would come up. The pop-up came up dur-
ing the whole month of February 2013.  
Analysis 
The answers to the online questionnaire (effects of online and live training) and 
the pop-up questionnaire (appreciation of the website) were investigated in a 
similar way. For ease of interpretation the 5-point scales were transformed into 2-
point scales (binomial) by merging the lower three categories (disagree complete-
ly, disagree, not disagree /not agree) and the upper two (agree, agree completely). 
The proportion answers in the upper category of the binomial scale and the asso-
ciated 95% confidence interval were calculated to indicate the effect of the train-
ing as reported by the GPs, and the appreciation of the website by its visitors.  
 For the 10 point global rating the mean score and the associated 95%-
confidence interval were calculated to indicate the respondents’ level of apprecia-
tion of the genetics website (the third training module).  
 Website visitor counts were obtained by Google Analytics in the period Sep-
tember 2011 until March 2013. Time series for the Number of visits per month, the 
Number of pages viewed per month, and the Number of pages per visit per month 
were obtained. Where relevant the mean trend in the time series was estimated by 
fitting a straight line (linear regression) to the data, and using the slope of the line 
as indicator of the trend.  
 Data were analysed using SPSS20.  
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Results 
Two oncogenetics CPD modules were developed aimed at improving competences:  
1. A G-eCPD module aimed at improving GPs’ oncogenetics knowledge, and 
2. A four-hour interactive live training module covering oncogenetic clinical 
skills (family history, risk assessment, and efficient referral).13,14  
Two parallel-group pre-post-retention (6-month follow-up for G-eCPD, 3-month 
follow-up for live module) controlled group intervention trials (standardized pa-
tients, checklists and validated questionnaires) were conducted to assess effec-
tiveness of the CPD modules developed. 168 GPs working in the Dutch primary 
care setting responded to an email invitation and were randomly assigned to in-
tervention or control groups, evaluating the G-eCPD module (n=80, 44 GPs com-
pleted all measurements) or the live module (n=88, 56 GPs completed all meas-
urements).  
 Results showed there was a significant follow-up improvement in oncogenetic 
knowledge (G-eCPD) and consultation skills (live module) after the intervention. 
Satisfaction and self-reported applicability was high for both modules.13,14 
GPs self-reported skills and referral 
Participant characteristics 
42 GPs (52%) who participated in the G-eCPD evaluation study and 50 GPs (57%) 
who participated in the live training program, responded to the online question-
naire on long-term effects on Kirkpatrick’s second level of educational outcome. 
88% of the respondents who attended the live training reported to more frequent-
ly consider referral of patients to the Clinical Genetics centers, compared to 64% of 
the respondents who attended the online CPD module. Respectively 68% and 29% 
reported to actually refer patients more frequently (table 2).  
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Table 2. Self reported applicability of an Online Continuing Professional Development (G-eCPD) 
module and a Live training on Oncogenetics by GPs who participated in one of these CPD modules  
Statement/Question Response Online Continuing Professional 
Development 
module (G-eCPD) 
Live Interactive Program on 
Oncogenetics 
 
 Category Total number 
of  
respondents 
% 95%-CI1 Total 
number of 
respondents
% 95%-CI 
    lo hi   lo hi 
I am more alert on 
genetic problems 
Agree, Agree 
completely 
42 69 53 82 50 92 81 98 
I have treated more 
patients with genetic 
problems  
Agree, Agree 
completely 
42 12 4 26 50 46 32 61 
I have more frequently 
considered to refer 
patients to the Clinical 
Genetics department 
Agree, Agree 
completely 
42 64 48 79 50 88 76 96 
I have more frequently 
referred patients to the 
Clinical Genetics 
department 
Agree, Agree 
completely 
42 29 16 45 50 68 53 81 
I am better able to 
explain 
possibilities/limitations 
of genetic tests to 
patients 
Agree, Agree 
completely 
42 50 34 66 50 72 58 84 
How frequent do you 
use the genetics 
website 
Once upto 
Daily 
38 18 8 34 47 47 32 62 
Will you keep on using 
the genetics website  
Yes 31 81 63 93 25 96 80 100 
Did you ever consult 
the genetics website 
when referring patients 
to the Clinical Genetics 
department 
Yes 7 71 29 96 22 91 71 99 
I would recommend the 
genetics website to my 
colleagues 
Agree, Agree 
completely 
7 86 42 100 22 91 71 99 
          
Global rating of the 
genetics website 
10-point 7 7.7 7.0 8.4 22 8.1 7.8 8.3 
1 95%-CI: 95%-Confidence Interval 
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Changes in referral to Clinical Genetics centers 
In table 3 the results of the referral rate from GPs to Clinical Genetics centers 
found through a search in the ICT system at the Clinical Genetics centers in Am-
sterdam and Southern part of the Netherlands are shown for the years 2010-2012. 
No change in number of referrals was seen in the year after presentation of the 
oncogenetic modules and website. 
 
Table 3. GP Referral rates at the Clinical Genetics Medical Centers in the Northern and Southern part of 
the Netherlands the years 2010-2012.  
Site   Year 
   2010 2011 2012 
Maastricht University Medical Center   1549 1590 1508 
VU Amsterdam Medical Center   961 1350 1367 
 
Total   2510 2940 2875 
 
Website interest and satisfaction  
38 visitors (12 (32%) aged 31-40 years, 27 (71%) female) to the website an-
swered the popup questionnaire (results of the questionnaire in table 4). Figure 2 
(upper panel) shows website visitor numbers are steadily increasing each month 
with almost 60 new visitors. The percentage of returning visitors (Figure 2) is 
stable around 20% each month demonstrating sustained interest in the website. 
Website visitor analytics showed a top 10 of most frequently visited webpages: 
drawing family trees, hereditary diseases, family history taking and consanguinity 
and pregnancy wish pages suggest increased application of genetic knowledge and 
consultation skills conceivably reflecting increased genetic health. 
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Table 4. Self reported satisfaction and applicability of the genetics website by general visitors and GPs 
only.  
Statement/Question Response All respondents (resp.) GPs only 
 Category Total 
number of 
resp. 
% 95%-CI1 Total 
number of 
resp. 
% 95%-CI1 
    lo hi   Lo hi 
Is this your first visit to 
the genetics website 
No  38 21 10 37 22 18 5 40 
The content of the website 
is helpful  
Agree, 
Agree 
completely
19 68 44 87 10 70 35 93 
The content of the website 
is up to date 
Agree, 
Agree 
completely
19 68 44 87 10 70 35 93 
The content of the website 
is apprehensible 
Agree, 
Agree 
completely
19 74 49 91 10 70 35 93 
The content of the website 
is up to my expectations 
Agree, 
Agree 
completely
19 63 38 84 10 70 35 93 
The content of the website 
is attractive 
Agree, 
Agree 
completely
19 53 29 76 10 60 26 88 
The content of the website 
is up to professional 
standards 
Agree, 
Agree 
completely
19 74 49 91 10 80 44 98 
The content of the website 
is clearly structured 
Agree, 
Agree 
completely
19 63 38 84 10 70 35 93 
The content of the website 
is simple to use 
Agree, 
Agree 
completely
19 58 34 80 10 70 35 93 
I would recommend the 
genetics website to my 
colleagues 
Agree, 
Agree 
completely
19 68 44 87 10 80 44 98 
Was your current visit 
successful 
Completely, 
or partly 
successful 
19 84 60 97 10 100 69 100 
Global rating of the genetics 
website 
10-point 38 6.3 5.5 7.1 22 7.2 6.5 7.9 
1 95% -CI: 95%-Confidence Interval 
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Figure 2. Website visitor numbers and percentage returning visitors per month 
Discussion 
Self-reported genetic consultation skills increased long-term, including increased 
consideration of referral to Clinical Genetics centers. However, regional GP referral 
numbers did not change accordingly the year after oncogenetic CPD module 
presentation. A reason could be the limited number of GPs who participated in the 
oncogenetic CPD modules. Also, these CPD modules’ topic was specifically onco-
genetics, GPs referral numbers may increase if genetics CPD modules also involve 
other topics such as cardiogenetics, diabetes or reproductive genetic counselling. 
GPs are gatekeepers and play a key role in the Dutch health care system when 
appropriate and timely referral to medical specialists is warranted. Their role 
could be enhanced with increased awareness and alertness if more GPs are effec-
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tively educated.18 There could also be a difference in concept, for improved genet-
ics knowledge and consultation skills should not necessarily result in more refer-
rals. This improvement could also lead to more accurate referrals and could con-
sequently show a decrease in number of referrals. Direct measurement of change 
in referral numbers or efficiency and effectiveness of referral at this time however 
was impossible, since the ICT tools to register family history in the Electronic 
Health Registry is not in place.  
 Although there was only a small number of website visitors who answered 
the pop-up questionnaire, those who did indicated to be interested in and satisfied 
with the supportive website. This converged with long-term website visitor counts 
and percentage returning visitors estimating adequate website user-friendliness 
and usability. Website visitors often looked for application of basic genetics (draw-
ing family trees, family history taking), while initially we had not expected needs 
for these topics. However, at the time no website visitor analytics were available 
from comparable websites. Some website visitor analytics were available from 
websites with information aiming for (non) genetic medical professionals, general 
public, patients, families and others, which is incomparable to the data provided 
on the supportive website huisartsengenetica.nl, which mainly aims to inform GPs. 
With 8747 GPs actively working in the Netherlands, around 1800 visitors (pre-
sumably GPs) returning each month is promising. Updating the website is an on-
going process which should sustainably increase website visitor numbers. Future 
studies could possibly translate the website for GPs internationally and where 
needed (such as specific information on referral and insurance) adapt the infor-
mation to that specific country. 
 The study results presented suggest we have provided an effective framework 
to answer to the need for effective genetic educational programs for non-genetic 
healthcare-providers. The training proved to be a feasible and satisfactory method 
to achieve long-term improvement of applicable oncogenetic knowledge and con-
sultation skills. This educational framework can inform future training activities 
for GPs and potentially other medical professionals to enhance genetics-related 
consultation and decision making with the ultimate aim of improving medical care. 
Comparison with other studies 
A meta-analysis, which examined the effect of moderator variables on physician 
knowledge, performance and patient outcomes showed similar results compared 
to our study. It suggested a larger effect size of CPD outcome in case of interactive 
interventions, using multiple methods, designed for small groups of physicians 
from a single discipline.11 However, the meta-analysis showed a negative correla-
tion between effect size and the outcome assessment time (r=-0.31). This would 
imply, increasing assessment time between CPD intervention and impact evalua-
CHAPTER 6 
132 
tion could impair sustainability of learned genetic competences. Longer-term out-
come assessment of the oncogenetic training program on referral numbers and 
change in organization would need further study to be able to say anything about 
true impact on patient genetic health. Possibly repeating the oncogenetics training 
programs on a yearly basis for local GP groups, may show better outcome effec-
tiveness longer term. Effective impact of new implementations of change in patient 
care is possible to change referral rates or improve outpatient referral appropri-
ateness.19 However, limited rigorous evaluations on referral processes from pri-
mary to secondary care are available to base policy on.20 A few promising inter-
ventions which we incorporated already in our live training were found to posi-
tively influence the referral process, such as local educational intervention involv-
ing secondary care specialists and structured referral sheets. This will need fur-
ther studies in case of referral to Clinical Genetics centers. Clear guidelines for 
referral should be distributed and should be part of training. Genetic counsellors 
may also be beneficial to the referral process for they can provide a second opinion 
before referring to the specialist. Financial compensation to optimize referral has 
been studied, but there is insufficient evidence to draw firm conclusions.20 
Methodological considerations 
A model for the development and evaluation of genetics education programs was 
previously described and was informed by three theories: adult learning theory, 
program logic modeling and evaluation theory.21 In short, adult learning theory 
proposes for an education program to be effective, it should be responsive and 
enable learners optimally. Recognizing a need for learning about a certain topic, 
was previously accomplished.5,6 The first steps towards an effective genetics edu-
cation program were taken involving the GP learners, focusing on the content and 
process, using a range of multifaceted teaching strategies namely experiential and 
interactive.  
 Program logic modelling is a theory useful to define and plan program design 
and possible evaluation, which inspired the previously held Delphi study.6 With 
the use of experts topics for a genetics program were prioritized based on the 
previously held focus group studies.5 The Delphi study was used as a tool to devel-
op our hypothesis that with the use of experts a top ten of genetics topics applica-
ble in daily GP practice could be found which would inform further development of 
effective genetics education. By letting the health professional participate in the 
education program by assessing their learning needs, awareness of the relevance 
of genetics in daily practice was considered to increase and GPs were expected to 
learn best and apply learnt competences accordingly in daily genetic medical care. 
 The evaluation theory rigorously determines impact of the training programs. 
Beneficial effects on process outcomes are usually shown (e.g. increase of genetic 
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competences), however evaluations of patient outcomes (e.g. genetic health care 
improvement) are often lagging behind. Several terms explaining genetic educa-
tional program evaluation apply, to ultimately make evaluation of patient outcome 
possible: formative evaluation (needs assessments by stakeholders involved). The 
second term process evaluation explains the manner in which a genetic educational 
program is implemented in daily practice (i.e. family history taking and registra-
tion in GP computer information system) and whether it reaches its intended au-
dience on time (i.e. pre-symptomatic referral to the clinical geneticist). The last 
term refers to summative evaluation, which sums up the impact of the program on 
the users and audience involved (i.e. improved genetic competences, awareness 
and behaviour in trained GPs and genetic healthcare outcome).21 Results of the 
summative evaluation reported, show that applying the adult learning theory and 
program logic model, in our project assessing the needs and subsequently defining 
the program design, is effective.  
Strengths and limitations 
Voluntary participation by interested GPs could have caused selection bias. How-
ever, similarity of the baseline characteristics of the two groups in the RCTs and 
comparability of the participation rate (previous RCTs 55% (G-eCPD) and 60% 
(live training), for this study 52% (G-eCPD) and 57% (live training)) with that of 
other studies among GPs (60%) indicate that the participants were representative 
of GPs likely to attend oncogenetic training in the future.13,14,22,23 Furthermore, it is 
possible that participating in the genetics training might become part of standard 
training for all GPs. By applying an effective framework for genetics education and 
measuring outcome of education on various levels of Kirkpatrick, we were able to 
initiate a change in organization and find barriers to implementation of genetics 
education.24 Further assessments are necessary however to make additional as-
sumptions on patient health impact. Rigorous assessment of appropriate referrals 
was not feasible within the project, for data were based on self-reported compe-
tencies, increase in referrals and website analytics, not registered referrals in Elec-
tronic Patient Record (EPR). We plan to assess change in referral to the depart-
ments of Clinical Genetics more rigorously by looking at the registered number of 
referrals in the EPR based on added ICPC codes.24 Furthermore, to truly assess 
user-friendliness and usability of our website we plan to assess the website 
through qualitative research methods. 
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Conclusion 
The results presented provide an adaptable and effective framework for genetics 
education of health professionals possibly across national borders. The suggested 
training tools guide future development of curricula that are appropriate to the 
national context, educational system and healthcare setting of the professional 
involved. It is therefore possible, to optimize genetic educational materials as a 
multifaceted approach to implementing the genetic educational needs and priori-
tized topics and genetic education core competences. This educational framework 
therefore has the potential to improve the quality of genetic healthcare for pa-
tients.  
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Online-only text 
Details of background of Materials-Questionnaire to determine self reported 
applicability of an Online Continuing Professional Development 
(G-eCPD) module and a Live training 
An online questionnaire was emailed to those who had previously attended the 
oncogenetics CPD modules determining long-term self reported genetic consulta-
tion skills (i.e. increased awareness of possible genetic predisposition of diseases, 
discuss (possible) familial and hereditary disease risks, management of potentially 
developing hereditary diseases, more frequently consider referral and concrete 
referral to Clinical Genetics centers and explain the possibilities and limitations of 
oncogenetic testing. The questionnaire contained five items (with a 5-point Likert 
scale: 1=completely disagree; 5=completely agree) related to different aspects of, 
self- reported applicability of genetic competences. A global grading of the website 
on a ten-point scale (1: no value; 5: insufficient 6: sufficient; 8: good 10: excellent), 
and a question about the frequency of using the website. The applicability ques-
tionnaire contained two 4-point scale items about the need for the supportive 
website and application of the website on referral in daily practice and a multiple-
choice question about which pages were used to benefit referral to Clinical Genet-
ics center. One question was on whether the participant would recommend the 
website to colleagues (yes/no). 
Details of background of Materials-Website questionnaire determining self 
reported satisfaction and applicability of the genetics website by general 
visitors and GPs only.  
The satisfaction questionnaire contained four items on website content (helpful, 
recent information, understandable language, responding to expectations) and 
four on usability (attractiveness, professional, structure, easy to use) on a 5-point 
Likert scale (1=completely disagree; 5=completely agree) related to different as-
pects of satisfaction, a global grading of the website on a ten-point scale (1: no 
value; 5: insufficient 6: sufficient; 8: good 10: excellent), and a question about the 
frequency of using the website. One question was on whether the participant 
would recommend the website to colleagues (yes/no). The demographic survey 
asked about participants’ general characteristics (male/female; age; professional 
background (GP, midwife, medical specialist, medical student, patient/other). 
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Abstract 
We propose A step-by-step roadmap to integrate genetics in the Electronic Patient 
Record in Family Medicine and clinical research. This could make urgent opera-
tionalization of readily available genetic knowledge feasible in clinical research 
and consequently improved medical care. Improving genomic literacy by training 
and education is needed first. The second step is the improvement of the possibili-
ties to register the family history in such a way that queries can identify patients at 
risk. Adding codes to the ICPC chapters “A21 Personal/family history of malignan-
cy” and “A99 Disease carrier not described further” is proposed. Multidisciplinary 
guidelines for referral must be unambiguous. Electronical patient records need 
possibilities to add (new) family history information, including links between indi-
viduals who are family members. Automatic alerts should help general practition-
ers to recognize patients at risk who satisfy referral criteria. We present a familial 
breast cancer case with a BRCA1 mutation as an example. 
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Introduction 
Public health benefits of advancements in understanding the human genome are 
still to be realized for common chronic diseases such as cardiovascular disease, 
diabetes mellitus, and cancer1. International attempts to integrate and operation-
alize such knowledge into clinical practice are in the early stages, and as a result, 
many questions surround the current state of this translation.1-3 Most physicians 
lack genetic knowledge and skills that might be relevant for decision support in 
daily practice.4 Family history taking and family tree drawing need to be intro-
duced. Oversight of clinical utility of genetic testing should be supported by 
eHealth facilities to bypass unfamiliarity with facts on genetic testing. Shortcom-
ings in registration systems and inadequate implementation of genetics in existing 
guidelines are reported and result in inability to register genetic information in 
Electronic Patient Records. Privacy and risk of discrimination cause concerns 
when registration is considered. Consequently, inadequacy to deliver genetic ser-
vices is reported in literature.1 We present a roadmap to integrate actual genetic 
knowledge into the Electronic Patient Record and into clinical research in Family 
medicine, which would enable urgent operationalization of readily available 
knowledge feasible in daily genetic medical care. 
Evidence for necessary change 
The clinical relevance of integrating genetics in clinical practice was demonstrated 
for several familial diseases such as colorectal cancer and breast cancer. Dove-
Edwin et al. calculated mortality risk reduction up to 80% by identifying and sub-
sequently screening individuals with an increased familial colorectal cancer (CRC) 
risk.5 Cancer risk management options through genetic testing for BRCA mutations 
and subsequent options for preventive surgery after testing positive can empower 
women and can also reduce morbidity and mortality.6 Currently, a large number of 
patients in whom screening would be beneficial, are out of sight or being missed 
by their physicians.7,8  
Barriers to change 
Scheuner et al. identified deficiencies in primary care workers’ basic genetic 
knowledge and ability to interpret familial patterns.1 This is in line with our priori-
tised educational topics, including knowledge of basic genetic principles, the most 
common genetic disorders and family history communication skills.9 Taylor and 
Edwards stated primary care should be encouraged to invest more time and ener-
gy in questioning and registering family history data.10 However, they also 
stressed identified barriers such as time constraints should be encountered. They 
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identified the need to develop strategies to overcome difficulties preventing gen-
eral practitioners (GPs) from routinely obtaining family history information as 
well as strategies to support accurate record keeping in the Electronic Patient 
Record.10  
 
Another identified barrier is the presence of ambiguous referral guidelines to clin-
ical genetics and other medical specialists for patients with a possible high risk at 
familial disease, such as cancer.9 Computerised decision support might be helpful 
in familial risk assessment for common cancers (e.g. breast, ovarian and colon 
cancers) and would render timely genetic risk assessments and consequently sup-
port referrals more consistent with guidelines. These results support the imple-
mentation of genetics education aimed at enhancing effective referral indications 
and options. 
A roadmap for translation 
In order to be able to truly turn useful genetic discoveries from the laboratory 
bench to daily clinical practice, a roadmap is crucial to make urgent translation 
feasible. First, advances in the genomic literacy of health care providers are indis-
pensable. Secondly, innovative and practical ICT tools to apply these newly ac-
quired knowledge and skills are needed, such as registration of family history and 
registry alerts supporting this. 
 
We propose a step-by-step roadmap to effectively integrate genetics in daily family 
medicine to its full potential: 
 
Step 1: Improve basic knowledge of genetics in clinicians and develop skills and 
attitude to obtain and interpret a family history through effective education; 
For example, training on oncogenetics for GPs was recently developed and evalu-
ated in collaboration with The Dutch College of General practitioners. Also, a web-
site on genetics targeted to GPs was developed to easily obtain information on, 
amongst other topics, genetic diseases, referral guidelines and family history tak-
ing (huisartsengenetica.nl, translated “GP and genetics”). Oncogenetic knowledge, 
skills and attitude were effectively transmitted through an accredited online and 
live interactive training and could internationally serve as an example for other 
common topics (i.e. reproductive medicine, familial coronary heart disease and 
diabetes) and possibly other medical specialties provided that they are translated 
to its medical systems. 
 
Step 2: Add relevant International Classification of Primary Care (ICPC) codes and 
other coding strategies for simple registry of family history and develop and sup-
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port coding skills; 
In order to identify and track persons and/or families at risk for hereditary diseas-
es adequate coding is a starting point. We propose to add a number of codes for 
simple registration of family history. This will enable and support adequate case-
finding and decision strategies.8  
Proposal for adding codes to ICPC-2 list in case of oncogenetics 
 
We propose to add a number of codes in order to enable simple but structured 
registry of a family history. In ICPC-2, which is the most frequently used coding 
system for GPs in Western countries, these codes should be included in Chapter A 
(General and Unspecified), under A21 “Risk factor for malignancy”. ICPC-2 was 
developed by the WHO and classifies patient data and clinical activity in the do-
mains of General/Family Practice and primary care, taking into account the fre-
quency distribution of problems seen in these domains. It allows classification of 
the patient’s reason for encounter (RFE), the problems/diagnosis managed, inter-
ventions, and the ordering of these data in an episode of care structure. ICPC-2 has 
a biaxial structure and consists of 17 chapters, each divided into 7 components 
(comp.) dealing with symptoms and complaints (comp. 1), diagnostic, screening 
and preventive procedures (comp. 2), medication, treatment and procedures 
(comp. 3), test results (comp. 4), administrative (comp. 5), referrals and other 
reasons for encounter (comp. 6) and diseases (comp. 7). (see http://www.who.-
int/classifications/icd/adaptations/icpc2/en/index.html)  
 Mapping is available between ICPC and ICD-10, which was also developed by 
the WHO for broad application in healthcare registries. The codes suggested below 
should suit other coding systems such as SNOMED as well. 
 
A21  Personal/family history of malignancy (Existing code) 
A21.1 One or more 1st degree family member(s) with breast cancer 
A21.2 One or more 2nd degree family member(s) with breast cancer 
A21.3 One or more family member(s) with bilateral or multifocal breast cancer 
A21.4 Breast cancer in the family in one or more men 
A99 Disease carrier not described further (Existing code) 
A99.1 BRCA-1 mutation carrier 
A99.2 BRCA-2 mutation carrier 
A99.3  TP53 mutation carrier 
A99.99 Carrier of mutation in other specified gene 
 
Step 3: Improve access to up-to-date and unambiguous referral guidelines; 
For example, in the Netherlands multiple referral guidelines for hereditary cancers 
were developed independently (Oncoline, Foundation for detection of hereditary 
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tumors (In Dutch STOET), clinical genetics centers in University hospitals and The 
Dutch College of General practitioners (NHG)). Limited usable information howev-
er is available for General Practitioners, i.e. only for Diagnostics of Breast Cancer 
and Rectal Bleeding. The guidelines are heterogeneous and difficult to interpret 
We propose to improve this by agreeing on national multi-disciplinary referral 
guidelines and provide synchronized online access to up-to-date and easy to inter-
pret versions.  
 
Step 4: Provide service or online apps to (self) register family history including 
family relations, that can be coupled with routine healthcare registries and the 
EMR used in primary care too; The best way to re-use and expand previously rec-
orded family history information and to view this history from the perspective of a 
different family member is by recording parent-child relations and diagnoses with 
the correct family member. This would require functionality to be added to the 
Electronic Patient Record. In order to overcome privacy issues and an online app 
or website to register family history is recommended (for example: myfamilyhis-
tory.com or familyhealthware.com).  
 
Step 5: Pro-active genetic services integrated in clinical practice facilitated by ICT 
(for example family history registry and registry alerts); 
For example, the GP or nurse practitioners should be able to (periodically) register 
or consult family history information directly into the Electronic Patient Record. 
Accurate and up-to-date treatment and referral guidelines and subsequent auto-
matic alerts should pop up when certain combinations of symptoms and familial 
risk factors indicate referral to a clinical geneticist or other medical specialist. 
Illustration of the proposed roadmap with a familial breast cancer case in clinical 
research and family medicine: 
 
Step 1: Patient name: Angela B., Female, age 35.  
Angela lives in the city with her husband and two daughters aged 13 and 10. She 
works as a hair dresser, has been happily married for a decade and the family just 
bought a new home in the suburbs. She consults the GP on a busy Monday morning 
with the following complaints: Lump in left breast which she noticed during the 
weekend. The 4 cm irregular swelling is not painful but rather sensitive. The skin 
on the swelling is a little red and dimpled. Angela has no medical history, but since 
you followed the oncogenetic training for GPs a few weeks ago you are aware of 
the possible familial risks of breast cancer and decide to take her family history. 
Angela’s mother died of breast cancer when she was only 50 years of age 10 years 
ago. Her mother’s father had an unknown cancer and died at age 55. Angela tells 
you, when you further ask her for her family history, her sister had bilateral breast 
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cancer at age 30 and died of ovarian cancer at age 33, two years ago. Her two other 
and younger sisters seem healthy.  
On father’s side of the family no one has been diagnosed with cancer yet. 
 
Step 2: If proposed codes would be added the following could be registered:  
Two first-degree family members with breast cancer at an early age: mother (died 
at age 50) and sister (age 30, died 33, bilateral breast cancer). : A21.1 and A21.3 
One first-degree family member with ovarian cancer at an early age (sister age 30, 
died age 33). 
 
Step 3: You are alarmed by the family history and the medical complaints of Ange-
la. After checking the referral guidelines for cancer online, you talk with Angela 
about referral to the closest hospital as soon as possible for further diagnostics 
and possibly necessary surgical treatment. You also inform her of the chance that 
she might be a carrier of a DNA mutation which could be further analysed by a 
clinical geneticist. You promise to call the clinical geneticist and discuss the prob-
lem. The clinical geneticist agrees Angela needs further genetic DNA testing based 
on this positive family history and will invite her this week to quickly start DNA 
testing, which may inform further treatment. You call Angela afterwards and she is 
grateful for taking her case so seriously. 
 
Step 4: Angela is alarmed by the fact that her positive family history for breast and 
ovary cancer could mean an added risk to her and her daughters to develop breast 
or ovarian cancer and decides to use the online tool to easily register her family 
history together with her family members during the upcoming family reunion. 
Although it was a little awkward at first to ask her family members for their medi-
cal history, they agreed to do so anonymously online and repeat this every 5 years. 
Angela shows her family tree online to her GP who registers relevant information 
in his Electronic Patient Record and uses this information to build a pdf with only 
initials and years of birth of family members and adds this to her record. Not only 
is she now able to take her family history to her GP, the other family members who 
used the online tool are also able to do so. The whole family is enabled to opera-
tionalize their family history through a snowball effect.  
 
Step 5: Five years later Angela’s daughter Stephany, then aged 18, visits the GP 
with gynaecological problems. She feels a painful swelling. She started to study law 
in a different city and her new GP uploaded her medical and family history into his 
Electronic Patient Record. The Electronic Patient Record has alarmed Stephany’s 
new GP with a pop-up that Stephany is carrier of a BRCA2 mutation since the clini-
cal geneticist not only diagnosed Angela with a mutation, but unfortunately also 
her two daughters. Angela’s daughter is frequently checked with a physical and 
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MRI by a surgeon familiar with familial breast- and ovarian cancer who follows the 
national guidelines for familial cancer. Now that she has these complaints you 
decide to call the surgeon and after careful deliberation you refer her the same day 
to the clinic for further diagnostics. Fortunately, no abnormalities are found 
through the gynaecological and vaginal ultrasound examination. 
 
 
Figure 1: Proposed roadmap to stepwise integration of genetics in family medicine  
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Mrs. A visited her GP because her mother died at the age of 35 of breast cancer. The 
GP referred her to a clinical genetic center, where testing for BRCA mutations was 
discussed. Mrs. A chose to undergo a test and turned out to be a carrier of a BRCA 
mutation. Once she had two children, she decided to go for prophylactic salpingo-
oophorectomy and mastectomy. After some years she tells her GP that although it 
was not easy to decide on the surgical interventions and the physical and emotional 
consequences she has to deal with every day, she is happy cancer is precluded. 
 
More and more patients and physicians will face questions on genetics in their 
own lives and professional career. Genetic core competences for non-genetic 
health care workers have been defined, as a prerequisite for implementing genet-
ics education for general practice.1-5 Continuing Professional Development (CPD) 
modules should be based on an educational needs assessment of general practi-
tioners (GPs) referring to the three domains of educational activities: cognitive 
(knowledge), psychomotor (skills) and affective (attitude).6-8  
 This thesis focused on the exploration and consensus finding of genetic educa-
tional needs and priorities among primary care providers. Furthermore, we devel-
oped and evaluated three modules based on the priorities identified (an online and 
an interactive oncogenetic training for GPs as well as a website (huisartsengeneti-
ca.nl) with supporting genetics information applicable in daily practice for general 
practitioners). This final Chapter starts with a short outline of the background and 
objectives of our studies. Subsequently, the findings will be discussed in relation to 
the research questions. The Chapter concludes with future perspectives on genetic 
education in primary care, both nationally and internationally, including recom-
mendations for changes in the medical curriculum and future research. 
Background and objectives 
Genomics holds great promises to improve human health, although also some-
times short term implications are overestimated.9 GPs are facing a daunting infor-
mational challenge to keep abreast of the expanding body of genomics knowledge 
and attain competencies for informed use of its potential for personalized patient 
care.10 Requests for DNA-based predictive testing could increase in case of a posi-
tive family history and GPs will thus be more involved in preventive check-ups. It 
is therefore important for GPs to be competent to take and interpret a family his-
tory and deal appropriately with patients’ questions and concerns. Lack of genetic 
literacy in GPs is widely recognized; therefore we aimed to explore genetics educa-
tional needs and priorities, followed by determining the effectiveness of organized 
genetic CPD modules for GPs tailored to these needs, taking oncogenetics as an 
example.  
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PART I 
Creating an agenda for effective genetic educational strategies: 
Needs assessment and prioritization in primary care 
In order to successfully implement genetics education in primary care, perspec-
tives on the educational needs and role of genetics were explored (Chapter 2). The 
development of effective education requires a training program with a strong the-
oretical basis and rigorous evaluation which should tailor to the specific settings 
and needs of primary care professionals.8,11 
Educational needs assessment 
The focus group study reported in Chapter 2, indicated that Dutch primary care 
professionals need, and would welcome, more extensive education in genetics.12 
Four major themes emerged in relation to the role of genetics in primary care and 
the related educational needs: (1) basic knowledge, (2) education on family histo-
ry taking and the potential clinical consequences, (3) ethical dilemmas and psy-
chosocial effects related to genetics and (4) insight into the organization of region-
al genetics services for possible referral. There was general agreement that in-
creased genetics knowledge and family history taking results in a better under-
standing of the organization of genetics services in order to promote more appro-
priate and timely referrals. A similar need for genetics education in primary care 
was also found in other studies, in which genetics experts proposed learning out-
comes and core competencies in genetics for non-genetic health care profession-
als.13,14 The results indicated a paucity of knowledge in primary care professionals 
would lead to poor recognition of and unresponsiveness to genetic problems in 
daily patient care.  
 The results presented in Chapter 2 differ from others with regard to the need 
for increased genetics knowledge among midwives.15,16 Midwives in the Nether-
lands, UK and Sweden reported a low confidence with genetic issues in clinical 
practice, and identified psychosocial, screening and risk assessment aspects of 
genetic education as being important to them, rather than technical aspects or 
genetic science. Midwives in our study however, seemed more confident of their 
basic genetic knowledge, did not perceive as strong a need to adapt existing educa-
tional modules for they could have been relatively well prepared on this specific 
topic. This difference could have also been due to differences between master 
programs in midwifery, recent post graduate training programmes for midwives 
on prenatal screening in the Netherlands or differences between health care sys-
tems (UK, Sweden and Netherlands).  
 The focus group study showed GPs recognized the important role of genetics 
in primary care (Chapter 2). Qureshi et al similarly reported that primary care 
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practitioners recognize relevance of genetics in daily practice, such as detecting 
and managing risk of multifactorial disorders and genetic reproductive risk and 
targeted drug therapy.17 This was in contrast to a study conducted by Fetters et al. 
in 1999.18 They found GPs were reluctant to invest in self-education in genetics, 
because genetic problems were believed not clinically relevant. Our study showed 
that today’s primary care providers are aware of a progressive impact of genetics 
on primary care and therefore increasingly conscious of what they don’t know. 
This difference in perspective could be due to time lapse, finishing up of the Hu-
man Genome Project or clinically relevant advances in next genome sequencing 
(NGS).19 The need for attention to genetics in educational modules and thus the 
potential to become an integral part of primary care was recognized.  
Prioritization of educational needs 
Chapter 3 reported the Delphi procedure used to prioritise GPs’ educational needs, 
as identified in focus groups. The results aimed to inform the development of effec-
tive genetics education for GPs as reported in Chapters 4-6 describing Develop-
ment and Evaluation of Genetic Educational Modules for General Practitioners. After 
three Delphi rounds, 29 topics were reduced to 10 priorities (Chapter 3). All eight-
een expert participants completed all three rounds, with many comments per 
round, indicating strong involvement with the study aims. Our study generated 
consensus on a Top 10 of prioritised topics for GPs’ genetics education.20 The 
highest-ranking topics were concerned with skill and knowledge competences 
more so than attitude competence: 
1. “Recognising signals that can indicate a hereditary component of a disease”,  
2. “Evaluating indications for referral to a clinical genetics centre”, and  
3. “Knowledge of the possibilities and limitations of genetic tests”. 
  
This was in contrast to previous research by others into the perspectives of GPs 
and midwives on the educational priorities and attitudes in relation to genetics, in 
contrast to our Delphi study which only involved GPs. In these studies, a need for 
genetics education was revealed in areas like psychosocial issues and screening, 
assessment of the risk for genetic malformations and basic genetics.15,16,18,21-26 
More specific educational needs of primary care providers and their views on the 
role of genetics in daily practice and international efforts to translate these needs 
into education programs were in these previous studies in their early stages of 
investigation.27-29 Our Delphi study made it possible to operationalize the focus 
group results and thus enable further work towards integration of prioritized 
genetics educational topics in GP Continuing Professional Development (CPD) 
modules.  
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The results of the Delphi study differ from those of the Genetic-Educational Priori-
ties (Gen-EP) scale study of 2004 by Calefato et al., the previously discussed focus 
group study and from the American General practitioner Core Educational 
Guidelines, Core Competences in genetics for health professionals in Europe.5,30,31 
Competences relating to attitudes received more attention in these studies, such as 
“ethical, legal and public health issues” and “psychosocial and counselling issues”. 
This difference may be attributed to the fact the Gen-EP study was not limited to 
the Netherlands but encompassed five European countries with differing health 
care systems. Against all odds, our Delphi study results showed genetics education 
should first focus on “knowledge” before moving on to “attitudes”. Some comments 
by experts on this issue were rather ambivalent: “Attitude is not specific to genet-
ics” and “A good attitude should be an intrinsic component of the GP’s role”. Thus, 
although it may seem the “attitude” domain is considered essential for holistic GP 
genetics education (i.e. case based learning with medical ethical problems), effec-
tive implementation of genetics education may be jeopardised if too much atten-
tion would be paid to this area.  
 The results found in part 1 of the project provided the learning outcomes and 
core competences in genetics for non-genetic health care professionals as specified 
by genetic experts.32 This laid a firm foundation, supported by target group and 
expert opinions, for the development of genetics education modules for GPs pre-
sented in part 2 of this thesis. 
PART II 
Development and evaluation of genetic educational modules for 
general practitioners 
The previous Chapters 1, 2 and 3 explained why it is urgent to develop and evalu-
ate oncogenetics CPD modules. CPD seemed to be the obvious vehicle for remedy-
ing deficiencies in practicing physicians’ genetics knowledge and skills. Innovation 
of guidelines incorporating genetics advances and defining responsibilities of non-
genetic healthcare professionals (e.g. when and how to refer or register) should 
follow if appropriate education and tools are in place.8 Two CPD modules were 
developed in collaboration with the The Dutch College of General practitioners 
(e.g. Nederlands Huisartsen Genootschap, NHG) fitting their conference theme 
“Oncology in primary care” for the year 2011- 2012: a Genetic online CPD module 
(G-eCPD) and a live CPD module taking oncogenetics as a model condition.33,34 We 
used the theme “oncogenetics” as a “coincidental” example and fit the adaptable 
multifaceted educational framework to hang on all prioritized topics found 
through the initial explorative Delphi studies building on genetic education core 
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competences and thus made case based genetics education available. An easily 
accessible website on genetics in general practice for daily use in practice was also 
developed in collaboration with the NHG and received a spot on their main web-
site potentially recognizable for all Dutch GPs. The website means to support the 
G-eCPD and live CPD modules, which gives GPs on demand information such as 
information on how to do a family history, how to recognize hereditary diseases, 
basic knowledge of genetics information and how and where to refer.35 The web-
site is not limited to oncogenetics. 
 We aimed to measure the educational outcomes of the CPD modules overall, 
at all four levels of Kirkpatrick’s framework for evaluating educational outcomes 
(satisfaction, knowledge and knowledge retention, behavior, and actual practice 
performance and results).36,37,38 The instruments and data collected are all de-
scribed in table 1, as is the time frame.1  
 
Two randomized controlled trials (RCTs) for the first two modules (eCPD and live 
training) were conducted reported in the second part of this thesis in order to find 
out whether effective, adaptable and sustainable genetics education for GPs can be 
organized and developed.  
Effectiveness of an online G-eCPD module 
The online G-eCPD module aimed at improving knowledge about oncogenetics, 
resulted in positive outcomes at the first two levels of Kirkpatrick’s framework 
(satisfaction and learning). Although evaluation of the educational outcomes of the 
G-eCPD module by questionnaire on the application of new knowledge in daily 
practice closely approached Kirkpatrick’s third level, assessment by observation of 
actual change in clinical genetics behavior and improved patient genetic health 
outcome was currently absent. Studies have reported effectiveness of eCPD mod-
ules on other topics and suggested that course outcomes may benefit when a 
course is designed in accordance with a prior educational needs assessment.39-43 
The advantages of online CPD have been broadly discussed and supported.44  
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Table 1. Description of Instruments to assess genetic CPD outcomes 
Instrument  G-eCPD3,5 
 
Live 
 Training 4,5 
 
Website5  Description of instrument 
measurements 
Demographics 
questionnaire 
Time1 T0 
 
T0 
 
Not 
available 
(n.a.)  
Gender, age, years of 
experience, type of practice, 
degree of urbanization of 
practice area KP level2 n.a. n.a. n.a. 
Satisfaction 
questionnaire 
Time 
 
T1 
 
T1 
 
T3 
 
Recommendation of activity, 
relevance to general practice, 
most appealing topics, grade, 
time spent KP level I I I 
Knowledge test Time 
 
T0, T1 and T2 n.a. 
 
n.a. 
 
Multiple-choice 
Case based Knowledge test  
KP level II n.a. n.a. 
Applicability 
questionnaire 
 
Time T3 T3 
 
T3 Self-reported applicability of 
newly learned knowledge 
(genetic tests, basic genetic 
concepts, information 
sources) and skills (recognize 
and refer sooner) and 
referral behaviour as a result 
of CPD modules and website 
KP level II 
 
II 
 
II 
 
Standardized 
Patients’ checklist
Time 
 
T0, T1 and T2
 
T0, T1 and T2
 
 
n.a. 
 
Standardized 28-item 
checklist assessing 
consultation behavior 
covering the full scope of the 
consultation KP level n.a. III n.a.  
Referral data Time T3 T3 T3 Change in number of 
referrals by GPs   
KP level 
 
IV 
 
IV 
 
IV 
1) Time: The scheduled measurement times of CPD activities are as follows: T0 Pretest, T1 Posttest, T2 
Retention test (G-eCPD 6 months post intervention, live training 3 months post intervention) and T3 
one year post-intervention February 2013); 2) KP level: Kirkpatrick level; Effect evaluation of CPD 
modules is at four levels (I-IV) of Kirkpatrick; 3) Results reported in Chapter 4 of this thesis; 4) Results 
reported in Chapter 5 of this thesis; 5) Results reported in Chapter 6 of this thesis.33,34 
 
Effectiveness of a live oncogenetic CPD module  
Standardized patients were used to measure effectiveness of live oncogenetics 
CPD module in terms of behavioral and organizational changes (Kirkpatrick level 
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3).The needs-based, interactive oncogenetics CPD module aimed at improving 
genetics practice behavior (Chapter 5, third level of Kirkpatrick). The oncogenetics 
CPD module resulted in improved genetic consultation skills. This effect was stud-
ied by using unannounced standardized patients and participants’ satisfaction 
with the training and the reported applicability of what they have learned was 
studied by using online questionnaires. The four-hour training covered oncogenet-
ic skills (family history, oncogenetic risk assessment, and efficient referral), atti-
tude (medical ethical issues relevant to the identification of oncogenetic disease in 
family practice consultations), and clinical knowledge. One of the aims of including 
real patients and simulated consultations in our training was to promote a favora-
ble attitude among GPs to the application of genetic competencies. A study by Car-
roll et al. measured practice intent to use clinical genetics scenarios and increase 
competence due to a multifaceted knowledge translation intervention, but used 
questionnaires and not actual ratings of observed practice behaviors.45 Patient and 
societal perspectives on legal consequences of DNA-based testing results (for ex-
ample being able to find a genetics information source or ability to obtain a mort-
gage or life insurance) however, demand that physicians’ effective use of genetics 
CPD modules be demonstrated by actual performance in health care practice46. We 
therefore deliberately deployed trained and blinded SPs to optimize the value of 
the measurement.  
 Future studies may investigate reproducibility of clinical performance in prac-
tice using incognito standardized patients (SP). Potential oncogenetic problems 
are considered very personal topics to discuss between a patient and their own 
GP.12 This determined why it was not discussed in an incognito setting with a so-
called “new” patient or unannounced, concealed SP.47 Detecting the SPs by the 
participating GPs would become too easy in an incognito setting in the case of 
oncogenetics problems and would have been detrimental to the study. 
 In this study, increase in competences of implementing new consultation 
skills was demonstrated not performance in daily practice. Competency based 
assessments measure what doctors can do in controlled representations of profes-
sional practice; performance based assessments measure what doctors actually do 
in professional practice. Competency is therefore regarded a prerequisite for per-
formance.46 As the assessments took place in GPs’ practices and consultation skills 
in potential oncogenetic situations are frequently encountered, performance may 
closely approach competences in this study. However, real life patients present in 
a wide range of ways which makes sustainably implementing acquired skills in 
different daily practice case scenarios a challenge and requires further studies.  
 Length of the project limited further research on continuous impact on ap-
plicability of the GP oncogenetics CPD modules in daily practice. This requires a 
parallel and ongoing process of exploration of educational needs and priorities. 
Various reviews have pointed to heightened effects on physician behavior of mul-
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tiple interventions compared to single episodic interventions. Multifaceted inter-
ventions can tackle several common barriers to change and this combined opera-
tion may ultimately lead to improved practice performance. These aspects deserve 
further study.  
A practice-based genetics website for GPs: www.huisartsengenetica.nl 
The website huisartsengenetica.nl (GP and genetics) was developed in collabora-
tion with Erfocentrum (Dutch information center on heredity and genetic disor-
ders) and NHG, with on demand supportive information to be able to work on the 
learning tasks and apply competences in daily practice. From the beginning of the 
website, the website was used with visitor numbers (around 350 per week) ex-
pected from a website in a startup phase (personal communication with Erfocen-
trum erfelijkheid.nl). Users of the website reported to be satisfied and reported it 
tailored to their needs with supporting information applicable in daily practice. 
Although, limited number of self-reports showed the website was only visited once 
in a while, the website was also studied if referral was considered and would be 
commended to colleagues.  
 Opportunities for future research should focus on how to increase the website 
visitor numbers. Personal interviews or focus groups research could explore usa-
bility and user-friendliness of the website. It is also possible future genetics CPD 
modules should emphasize better the supportiveness of the website for the mod-
ules attended and potential in daily practice.  
Self-reported change in practice performance and patient referral to clinical 
genetics centers as a result of the oncogenetic CPD modules and website 
Chapter 6 reports sustained effects on professional practice after attending the 
CPD modules and the supportive website. GPs seemed to synthesize and apply the 
newly-learned consultation behaviors. Visitors to the website were highly satisfied 
with and reported the website to be applicable in daily practice. These results 
reflected an increased interest in content of the website and referral possibilities. 
The number of referrals to the clinical genetics centers however did not signifi-
cantly change one year after launch of the modules and website. The reason could 
be because change in referral number is expected after about 10 years of medical 
education innovation and guideline changes (personal communication with Irina 
Stirbu, LINH, 2013). In theory, the same number or rather a decrease in referrals 
could also mean a reduction of unnecessary referrals while the number of appro-
priate referrals increases. The results did not show referral effectiveness and effi-
ciency on a meta-level, for the live training reached only a small part of the total of 
Dutch GPs who attended the regional training. Knowledge acquired by those GPs 
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(in training) who attended the freely offered G-eCPD may not have been sufficient 
enough to have impact on referral. Still, the study results indicate an adaptable and 
effective framework for genetics education for health professionals. 
 Self-reported questionnaires showed us there was a subjective increase in 
applying genetics competences in daily practice as a result of the oncogenetic CPD 
modules. GPs reported they used the website to help them in the referral process, 
were very satisfied with the information applied on the website, especially the 
information on diseases, family history and referral. GPs considered referring pa-
tients possibly affected with oncogenetic diseases more frequently than before-
hand. Self-reported questionnaires are subjective and further objective quantifica-
tion of performance results in actual practice is required to substantiate evidence 
on referral efficacy and effectiveness. Once ICPC codes are in place in GP electronic 
patient records, it would be possible to compare referral numbers in a RCT by 
those who attended the CPD modules and those who did not and retrospectively 
check for efficiency of the referrals to clinical genetics centers involved. 
 
Opportunities for improvement of genetic competences could mean applying ad-
vances in pharmacogenomics in daily medical care and therefore improvement of 
patient safety. As a recent example, aspirin chemoprevention showed to reduce 
cancer risk in Lynch syndrome carriers by ±50% and was recommended as stand-
ard of care.48 Lynch syndrome is the most frequent monogenic subtype of colorec-
tal cancer, on average occurring in 4 patients in every GP practice (of 2000 pa-
tients). What if this information were included in GP guidelines? Are GPs ready to 
recognize healthy family members at risk of Lynch syndrome, refer them for ge-
netic testing, and inform them of this new possibility for prevention? Expanding 
quality of life by early detection in screening modules (e.g. heel prick screening in 
new-borns and timely referral to specialised paediatricians) and personalized 
treatment (e.g. timely referral in case of familial forms of breast cancer) will not 
materialize unless true translation into the primary care workplace and other non-
genetic health care settings takes place. 
PART III 
Summarizing discussion and future perspectives 
In order to create an agenda for effective genetic educational strategies in primary 
care, educational needs were assessed and prioritized. The focus groups identified 
needs in the following categories: genetics knowledge, family history, organization 
of clinical genetics services and ethical dilemmas and psychosocial effects.12 These 
themes reflected a shift in the role of genetics in primary care with implications for 
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education. A Delphi study generated consensus on a top 10 of prioritised topics for 
GPs’ genetics education. The highest-ranking topics were concerned with skill and 
knowledge competences: “Recognising signals that can indicate a hereditary com-
ponent of a disease”, “Evaluating indications for referral to a clinical genetics cen-
tre”, and “Knowledge of the possibilities and limitations of genetic tests”. The pri-
orities resulting from the Delphi study informed the development of oncogenetic 
educational modules, including input for case-based education, to improve GP 
performance in genetic patient care. The GP-specific training proved to be a feasi-
ble, satisfactory and clinically applicable method to improve oncogenetics compe-
tences and could be used as an educational framework to inform future training 
activities with the ultimate aim of improving medical care. 
 
Raising primary care providers’ confidence through better organizational help and 
education would potentially enable them in busy practices to apply these ap-
proaches and makes fully implementing personalized genetic risk assessment 
possible. Future trials to identify barriers are necessary to effectively implement 
decision support systems in the future in real practice. 
 Potentially integrating genetics in daily primary care practice, through effec-
tive CPD modules and operationalization of previously found genetic educational 
priorities should be possible. Murray et al recently reported family health history 
data entered by patients in primary care Electronic Patient Record (EPR) is more 
efficient than standard of care data entered by GPs themselves.49 Determining 
different data portal entries matching patient preference, influence of use on daily 
practice workflow and possible effects on screening and prevention need further 
study. It remains to be explored whether adapting the framework to a topic such 
as cardiogenetics will be as effective and consequently determine changes in refer-
rals and registrations in the EPR. Tools to use to assess these changes in daily gen-
eral practice such as (integration of genetics in existing) guidelines and ICPC codes 
for EPRs however need further development. Agreements on when and how to 
refer on a national basis among clinical geneticists and GPs needs further discus-
sion.50  
Methodological reflections 
Some methodological issues of the studies presented in this thesis should be not-
ed. To assess the educational needs to adapt genetic CPD modules, a qualitative 
research design was used. This explorative study design made it possible to get a 
more complete picture than data obtained by, for example a questionnaire survey. 
Purposive sampling was used to recruit specific groups of professionals for focus 
group interviews in order to obtain rich, relevant and diverse data. The partici-
pants were expected to provide complete and possibly complementary perspec-
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tives on genetics in primary care practice and education. Surveys alone cannot 
disentangle different contributing factors, for it is hard to know whether a survey 
is accurate or whether the terms used are unambiguous. Focus group research 
makes it possible to explore contributing factors and discuss possible defined 
terms. Although focus group studies may have introduced selection bias through 
purposive sampling, further investigation should show whether the results are 
generalizable to real practice and beyond the Dutch health care system.  
 The Delphi prioritization method should be an ongoing process, repeated 
every so many years. For learning needs and priorities may change as clinically 
relevant advances come forward such as preconceptional and prenatal carrier 
screening for inherited genetic disorders for example hemoglobinopathies or cyst-
ic fibrosis through NGS.51-53 We believe the results of this study should be used in 
the near future to guide the implementation of genetics education in the Nether-
lands and perhaps even internationally. Whether the prioritized genetic educa-
tional topics cover genetics-related knowledge, skills and attitudes essential for 
every medical care provider, will have to be determined. Another limitation could 
be that the nature of the sample of selected experts for the Delphi study was 
drawn from the Dutch health care system. Relevance beyond this system remains 
to be investigated. Regression to the mean by adjustment of experts’ opinions as a 
result of this consensus method could have also been a limitation. However, a high 
degree of agreement on the ten accepted topics contradicted this possibility. 
Awareness of previously found focus group results could have caused opinion bias 
limiting the Delphi study results. Validity of the results was checked however 
through triangulation, namely by comparing the focus group with the Delphi group 
procedure results. 
 To our knowledge, this was the first time a series of oncogenetic CPD modules 
was organized based on prioritized genetics topics evaluating educational 
effects.54 Collaboration with the NHG meant recognition and therefore better reach 
of the educational modules by Dutch GPs. Experts in implementation and GP edu-
cation expected if the genetics education module model would be presented as a 
fruit basket (multifaceted format with an online and live training and supporting 
website) usually presented by the NHG, meant better reach to the GP learners 
much more so then when the project team would have tried to have implemented 
the modules on their own. This project therefore aimed for support by a broad 
range of stakeholders, which was previously regarded to be one of important fac-
tors for successful implementations of innovations in patient care.8 Whether the 
results also apply to other possible target groups in primary and secondary care, 
those in training, medical school students or high school biology students needs 
further research. Although there were no significant differences in participant 
characteristics between intervention and control group, the physicians in the stud-
ies presented in chapters 4, 5 and 6 appeared to be more female, younger and less 
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experienced, compared to the general profile of Dutch GPs.55 This possibly reflects 
extra interest in genetics and/or using online learning modules by young female 
GPs who recently graduated. Previously a postal survey among GPs in Northern 
Ireland, suggested that GPs are interested in training courses on genetics and ge-
netic testing. The results indicated male GPs and GPs who have been qualified for 
longer should be specifically targeted.56 Whether the results can be generalized 
within and beyond the Dutch healthcare system, needs further investigation.  
 
A limitation of both the online and live CPD module evaluations is the fairly large 
number of non-responders in the RCTs. The long duration of the studies (i.e. 3- 6 
months) could have been an explanation; the reasons given by physicians however 
were lack of time or illness. Nevertheless, our retention rate (55%) was compara-
ble to those reported for postal surveys among GPs (60%) and much higher than 
the rate found in other RCTs involving GPs.57,58,59 The financial incentives for par-
ticipants may have introduced selection bias. Larger-scale national and interna-
tional RCTs with adequate power are nevertheless warranted to further assess 
how genetics education can improve health care, validity and increase generaliza-
bility. It is well known GPs are busy people with full agendas possibly resulting in 
low response rates in RCTs. RCTs among GPs should therefore try to study topics 
of interest in daily practice for GPs focusing on urgency of the problem. Reasons 
for low-response rate could reflect possible barriers of implementing changes, 
which should therefore be critically studied and possibly be acted on in future 
RCTs studying effectiveness of genetics CPD modules.  
Conclusions 
To organize effective genetics education for GPs, tailoring education to the needs 
and priorities of prospective users seems to be an important factor in order to 
effectively implement genetics in daily practice and potentially improve behav-
ioural competences and performance. Evaluation of genetic training modules can 
be achieved at several levels of Kirkpatrick, including satisfaction, knowledge, 
attitude and behaviour (referral; changing the practice of registering family histo-
ry).  
 A systematic policy of implementation revealed effective promotion and dis-
semination regionally and nationally (NHG) results in sustainable genetics educa-
tion. Reform of existing guidelines and (ICT) tools for pre-symptomatic referral 
and genetic testing is necessary to further integrate pro-active genetic services in 
GP practice. 
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Recommendations for changes in genetic education 
The integration and visibility of genetics in daily medical care and education is still 
very limited.27,60,61,62 Barriers to operationalization of effective genetics education 
in clinical research and daily primary care can essentially be overcome with con-
structive and indispensible collaboration. For truly turning useful genetics discov-
eries from the laboratory bench to daily clinical practice, a roadmap is crucial to 
make urgent translation feasible.50 A few recommendations for further develop-
ment of genetic education can now be suggested. 
1. Involve primary care physicians in identifying their learning goals and priori-
ties, and build effective training modules based on these. 
2. Multifaceted genetics CPD modules should support one another. An online 
genetics CPD module can improve knowledge competences, and thus prepare 
for the live CPD module focussing on genetic consultation skills supported by 
a genetics website with on demand information.  
3. Innovative and practical ICT tools should be developed to support advances in 
genomic literacy of health care providers. Their use in daily practice should 
be trained accordingly.  
4. End-objectives for genetic education in the medical curriculum are not clearly 
defined and agreement upon this would be recommended, although it should 
be recognized that the field is dynamic. Integration of case based genetics 
problems in study methods and therefore increasing clinically relevant genet-
ic knowledge and consultation skills, has now been shown to be efficient and 
should thus be an integral part of the medical curriculum.  
5. The results could contribute to the development of genetics CPD modules in 
general and international. The online and live program and supportive web-
site could potentially reach a large group of physicians in primary and sec-
ondary care provided that it is adapted to the specific target groups. Possibly 
also medical school students and high school biology classes could benefit 
from this framework for genetics education.  
6. It would be challenging logistically to introduce SPs as a routine educational 
activity in daily outpatient practice. In some of the Dutch medical curricula 
however, SPs are already part of routine education to train physical examina-
tion and consultation skills. Also, the SPs are professional actors who were 
very enthusiastic about the oncogenetics training and expressed their motiva-
tion to train GPs on a frequent basis. The GPs themselves were also enthusias-
tic about SPs coming to their practice since it gave them an unexpected train-
ing situation in their own practice. With logistic organization and finances 
well in place, SPs could therefore with minor adjustments be introduced on a 
regular basis.  
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Recommendations for further research 
Further research should focus on the following topics: 
1. There is an urgent need for a clear description of responsibilities in daily 
practice and guidelines to enable effective use of developments in genetics in 
primary care. Especially descriptions of the genetic responsibilities of prima-
ry care providers and their specific role in this area will have to be addressed 
in the future, as was recommended by Baars et al. 63 Consequently, further in-
vestigation is necessary whether the framework designed to deliver genetics 
education for active GPs, is just as effective when it is delivered to GPs in 
training, midwives (in training), non clinical genetic medical specialists (such 
as paediatricians, gynaecologists and other medical specialists potentially 
confronted with genetic problems in daily practice). 
2. Short term, decision support tools to enable integration of genetics in daily 
practice should be developed and implemented for example on oncogenetics, 
such as ICPC codes in GP electronic patient records.50 This would enable time-
ly awareness of possible familial diseases and referral. How to use these tools 
in daily practice should be part of future genetics education.  
3. The number of adequate referrals to clinical genetics departments or timely 
identification of patients with a cancer predisposition syndrome (4th level of 
Kirkpatrick’s framework for evaluation of educational outcomes) should be 
part of further studies. Previous studies have shown that as far as genetics is 
concerned non-genetic healthcare workers require not only education but al-
so clear guidelines and definitions of their responsibilities.12,20,28 Improving 
possibilities to register the family history in such a way that queries can iden-
tify patients at risk as has been proposed, could promote impact. 
4. Also, further research could be done on effective referral when ICPC codes for 
correct family history (self) registration are in place improving genetic con-
sultation by GPs. Insight into the organization of regional genetics services 
and the referral system should sustainably be enhanced through education 
and online supportive information (huisartsengenetica.nl), to promote inter-
disciplinary collaboration. 
5. Long term, further research should focus on effective genetics CPD module 
implementation to increase competences and performance among the rest of 
Dutch GPs and those outside the Netherlands. Possible effectiveness on genet-
ic health care could then be investigated. International health systems may be 
organized very differently. Patients may go to the medical specialist without 
interference of a filter played by the GP for example. We assume different 
health systems may require adaptable content, but a uniform educational 
framework. 
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Training in genetics and genomics 
for primary health care workers 
 
 
 
 
Medical professionals in primary care are increasingly expected to deliver genetic 
services in daily patient care and need to be prepared for patients asking for in-
formation and advice on genetics. This requires appropriate skills and knowledge 
of genetics needed for daily practice. However, postgraduate (physician training) 
and master (midwifery training) programmes in primary care and public health 
are currently failing to meet these perceived educational needs. Improvements in 
genetics education for primary care providers are thus needed to keep up with the 
rapid developments in genetics/genomics. 
 The main objectives of this study project were to reflect on current genet-
ics/genomics developments with primary care workers, to help them identify their 
learning priorities and to evaluate three CPD modules in oncogenetics developed 
in collaboration with multidisciplinary team of general practitioners (GPs), educa-
tionalists and clinical geneticists familiar with genetics in primary care. Key factors 
for successful future training were identified and could make integrating genetics 
step by step in daily genetic primary care possible. 
 
In the first part of this thesis an agenda for effective genetic educational strategies 
was created for which a needs assessment and prioritization of genetic education 
in primary care were studied.  
 
Chapter 2 presents the results of a focus group study, which explored the role of 
genetics in primary care (i.e. family medicine and midwifery care) and the need for 
education in this area as perceived by primary care health workers, patient advo-
cacy groups and clinical genetics professionals. Forty-four participants took part in 
three types of focus groups: mono-disciplinary groups of general practitioners and 
midwives, respectively and multidisciplinary groups composed of a diverse set of 
experts. Four themes emerged regarding the educational needs and the role of 
genetics in primary care: (1) the need for genetics knowledge, (2) taking a family 
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history, (3) ethical dilemmas and psychosocial effects in relation to genetics, and 
(4) insight into the organisation and role of clinical genetics services. The role of 
genetics in primary care was perceived to be unduly limited as a result of care 
providers’ inadequate genetics knowledge and skills. Although all focus group 
participants acknowledged the importance of genetics education, general practi-
tioners seemed to feel this need more urgently than midwives and more strongly 
emphasized their perceived knowledge deficiencies. The study results indicated 
that Dutch primary care providers need, and would welcome, more extensive edu-
cation in genetics, for instance in postgraduate and master programmes.  
 
Chapter 3 presents the results of a Delphi consensus procedure, which aimed to 
operationalize the focus group results and prioritise topics for genetics education 
for general practice. Topics mentioned as learning goals were rephrased in line 
with core competences. The study conducted, consisted of three rounds. A purpos-
ively selected heterogeneous panel (n=18) of experts, comprising six practising 
GPs also engaged in research, five GP trainers, four clinical genetics professionals 
and three representatives of patient organisations, participated. Educational needs 
regarding genetics in general practice in terms of knowledge, skills and attitudes, 
were rated and ranked in a top 10. The entire panel completed all three rounds. 
Kendall’s coefficient of concordance indicated significant agreement regarding the 
top ten genetic educational needs (P<0.001). “Recognising signals that are poten-
tially indicative of a hereditary component of a disease” was rated highest, fol-
lowed by “Evaluating indications for referral to a clinical genetics centre” and 
“Knowledge of the possibilities and limitations of genetic tests”. It was concluded 
that the education priorities resulting from the study could be used to guide the 
development of genetics genetic education to improve GP performance in daily 
practice.  
 
The results described in Chapters 2 and 3 informed the development of genetic 
Continuing Professional Development (CPD) modules, including input for case-
based education, to improve GP performance in genetic patient care. More re-
search into the educational priorities in genetics is needed to design courses that 
are suitable for master programmes for midwives.  
 
The second part of this thesis describes the development and evaluation of three 
training modules: a Genetic online Continuing Professional Development (G-eCPD) 
and live genetic CPD module, taking oncogenetics as an example, supported by a 
website on genetics for GPs (huisartsengenetica.nl or “GP and genetics”). Identifica-
tion of patients at risk for hereditary cancers is considered essential to inform 
decisions about early screening, genetic testing, and pre-symptomatic risk reduc-
ing options. To our knowledge these were the first randomized controlled trials 
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(RCTs) to investigate improvement of GPs’ oncogenetic knowledge and profes-
sional behavior after participation in educational modules. 
 In Chapter 4 an RCT was conducted to evaluate the educational outcomes of a 
G-eCPD module at the first two levels of the Kirkpatrick framework (satisfaction 
and learning). The aim of this G-eCPD module was to provide physicians sufficient 
knowledge and skills through didactic presentations, interactive cases and ena-
bling tools such as information about regional possibilities for referral and consul-
tation. It meant to enable GPs to identify patients with an inherited predisposition 
to cancer; draw a family tree as a tool for identifying patients at risk for hereditary 
cancer; describe the most common types of hereditary cancer (i.e. breast, colon) 
and the likely genetic mutations involved; apply oncogenetics guidelines in identi-
fying patients for whom referral is indicated or not and find relevant information 
online; explain the possibilities and limitations of oncogenetic testing; discuss with 
patients periodic examinations and risk-reducing surgical options that are availa-
ble to patients with hereditary cancer.  
 The G-eCPD module aimed at improving GPs’ knowledge about oncogenetics, 
and was conducted between September 2011 and March 2012. The study method 
was a parallel-group pre-post-retention (six-month follow-up) controlled group 
intervention trial, with repeated measurements. Of the total of 80 Dutch GP volun-
teers (40 intervention group and 40 control group randomly assigned), 44 partici-
pants (20 intervention, 24 control group) completed all the learning activities, 
knowledge tests, and questionnaires For validity reasons, recruitment was limited 
to all GPs practicing outside the two Dutch provinces in the North (Noord Holland) 
and South (Limburg) where GPs could also participate in the live CPD module. The 
findings of the RCT showed that satisfaction with the module was high, with the 
three item’s scores in the range 4.1-4.3 (five-point scale) and a global score of 7.9 
(ten-point scale). Knowledge gains at post-test and retention test were 0.055 
(P<0.05) and 0.079 (P<0.01), respectively, with moderate effect sizes (0.27 and 
0.31). The participants appreciated the applicability in daily practice of knowledge 
aspects (item scores 3.3-3.8, five-point scale), but scores on self-reported identifi-
cation of disease, referral to a specialist, and knowledge about the possibili-
ties/limitations of genetic testing were near neutral (2.7-2.8, five-point scale). It 
was concluded that the educational effects reported in this study can inform fur-
ther development of online G-eCPD aimed at improving physicians’ genetics 
knowledge and could potentially improve patient care. The online CPD module 
with its framework could reach a large group of physicians with a wide variety of 
backgrounds, but adapted to its audience, possibly also medical school students 
and be used in high school biology classes.  
 
Chapter 5 describes whether a live oncogenetics CPD module improves GP consul-
tation skills. In this pragmatic, blinded RCT, the intervention consisted of a four-
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hour training (December 2011 and April 2012), covering oncogenetic consultation 
skills (family history, familial risk assessment, and efficient referral), attitude 
(medical ethical issues), and clinical knowledge required in primary care consulta-
tions. Outcomes were measured using observation checklists by unannounced 
standardized patients and self-reported questionnaires. For logistic reasons, re-
cruitment was limited to all GPs practicing two Dutch provinces in the North 
(Noord Holland) and South (Limburg) who did not participate in the evaluation of 
the G-eCPD. Of 88 randomized GPs who initially agreed to participate, 56 complet-
ed all measurements. Key consultation skills trained equipped the GP to recall 
clinically relevant information about types of hereditary cancer (breast, ovarian, 
colon, skin) including genes associated with oncogenetics syndromes most com-
monly tested for; recognize patients with features suggesting inherited predisposi-
tion to cancer; draw a family tree as a tool to identify patients at risk; discuss (pos-
sible) familial and hereditary cancer risks, management of potentially developing 
hereditary cancer (i.e. surveillance and risk-reducing surgical options) and related 
ethical issues; identifying patients for referral for risk assessment and find rele-
vant information online using oncogenetics guidelines; explain the possibilities 
and limitations of oncogenetic testing; and know when to consult and/or refer to a 
genetics specialist. These key consultation skills significantly and substantially 
improved; regression coefficient post-intervention equal to .34 and .28 at 3-
month-follow-up indicating moderate effect size. The results show sustained im-
provement three months after the training as well as high satisfaction with the 
training and positive perceptions of the practical applicability of training topics.  
 
Chapter 6 aimed to determine long-term (self-reported) genetic consultation skills 
among GPs who participated in the G-eCPD and live CPD modules (i.e. increased 
genetics awareness and referrals to clinical genetics centers), and interests in and 
satisfaction with the website. The genetics CPD modules achieved sustained im-
provement of oncogenetic competencies. Participants reported to be more alert of 
genetic problems. 88% of those who attended the live training reported to more 
frequently refer patients to the Clinical Genetics centers, compared to 29% of 
those who attended the online oncogenetics training. No significant change in re-
ferral numbers however was reported by the Clinical Genetics centers before and 
one year after the training. Moreover, sustained interest in and satisfaction with 
the newly developed GP website were investigated among website visitors who 
completed the pop-up questionnaire. Only a small number (38 visitors, 22 of these 
were GPs) completed the questionnaire during the 1- month study period. Satisfac-
tion with the website and perceived applicability of the website on appropriate-
ness of referrals however were highly scored. Website visitor numbers are in-
creasing; with the page most often consulted “family tree drawing”. 
CHAPTER 9 
176 
Thus, self-perceived genetic consultation skills increase long-term and there is 
interest in and satisfaction with the supportive website.  
 
In Chapter 7 a step-by-step roadmap was proposed to integrate genetics in the 
Electronic Patient Record (EPR) in Family Medicine and clinical research. This 
could make urgent operationalization of readily available genetic knowledge feasi-
ble in clinical research and consequently improved medical care. Improving ge-
nomic literacy by training and education is needed first. The second step is the 
improvement of the possibilities to register the family history in such a way that 
queries can identify patients at risk. Adding codes to the EPR in the International 
Classification of Primary Care (ICPC) in the ICPC chapters “A21 Personal/family 
history of malignancy” and “A99 Disease carrier not described further” and other 
coding strategies for simple registry of family history and develop and support 
coding skills is proposed. EPRs need possibilities to add (new) family history in-
formation, including links between individuals who are family members. Multidis-
ciplinary guidelines for referral must be unambiguous. Automatic alerts should 
help GPs to recognize patients at risk who satisfy referral criteria. A familial breast 
cancer case with a BRCA1 mutation as an example was used for illustration. 
Concluding remarks 
The results of the studies presented in this thesis have provided better insight into 
how non-genetic specialists (e.g. GPs and midwives) perceive the increased role 
for genetics in primary care and consequently recognized the importance of genet-
ics education. The responsibilities of primary care providers with regard to genet-
ics require further study. The GP-specific oncogenetic CPD modules supported by 
the Dutch genetics website huisartsengenetica.nl, suggest to be a feasible, satisfac-
tory and clinically applicable method to improve oncogenetics competences in 
daily practice and suggests to be an adaptable and effective educational frame-
work to inform future training activities with the ultimate aim of improving genet-
ic medical care. 
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Onderwijs over genetica en genomics 
voor eerstelijns zorgverleners 
 
 
 
 
Van zorgverleners in de eerste lijn wordt in toenemende mate verwacht dat zij in 
de dagelijkse praktijk genetische zorg verlenen. Dit vereist een goede voorberei-
ding, vaardigheden en kennis die hen in staat stelt patiënten te helpen die vragen 
om informatie en advies op dit terrein. Er zijn aanwijzingen dat de specialistenop-
leidingen en de hogere beroepsopleidingen in de gezondheidszorg (verloskunde-
opleiding) en de sociale geneeskunde nog niet in staat zijn om aan deze wensen te 
voldoen. Verbeteringen in het geneticaonderwijs voor beroepen in de eerstelijns-
gezondheidszorg zijn dan ook wenselijk, teneinde te kunnen garanderen dat zorg-
verleners op de hoogte zijn en blijven van de snelle ontwikkelingen op het gebied 
van de genetica.  
 
Het eerste deel van dit proefschrift is gericht op het vinden van aanknopings-
punten van effectief geneticaonderwijs. Hiertoe is onderzoek gedaan naar de on-
derwijsbehoeften van eerstelijnszorgverleners en is een prioritering opgesteld 
voor het verder ontwikkelen van geneticaonderwijs. 
 
Hoofdstuk 2 beschrijft de resultaten van een focusgroeponderzoek over de rol van 
genetica in de eerste lijn (huisartsgeneeskunde en verloskundigenzorg) en de be-
staande behoefte aan onderwijs op dit gebied. In totaal namen 44 deelnemers deel 
aan drie typen focusgroepen: twee monodisciplinaire groepen bestaande uit res-
pectievelijk huisartsen en verloskundigen en een multidisciplinaire groep be-
staande uit eerstelijnsopleiders, klinisch genetici en patiëntvertegenwoordigers. 
Uit de resultaten kwamen de volgende behoeften als thema’s naar voren: (1) meer 
basiskennis genetica, (2) vaardigheden in het afnemen van een familieanamnese, 
(3) aandacht voor ethische dilemma’s en psychosociale aspecten op het gebied van 
de genetica, en (4) inzicht in de organisatie en de rol van klinisch genetische dien-
sten. De deelnemers waren van mening dat genetica ongelukkigerwijs een onnodig 
beperkte rol heeft in de eerstelijnsgezondheidszorg, hetgeen samenhangt met de 
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ontoereikende kennis en vaardigheden van zorgverleners. Hoewel alle deelnemers 
aan de focusgroepen het belang van geneticaonderwijs onderschreven, leken de 
huisartsen zich sterker bewust te zijn van de urgentie van onderwijs dan de ver-
loskundigen. De huisartsen legden ook meer nadruk op de ervaren kennistekorten. 
De onderzoeksresultaten gaven aan dat zorgverleners in de eerste lijn in Neder-
land behoefte hebben aan en openstaan voor meer geneticaonderwijs, bijvoor-
beeld in de specialisten- en masteropleidingen. 
 
Hoofdstuk 3 beschrijft de resultaten van een Delphi-onderzoek met als doel con-
sensus te bereiken over de prioritering van onderwerpen voor geneticaonderwijs 
voor huisartsen. Onderwerpen die voorgesteld werden als mogelijke leerdoelen 
werden geformuleerd volgens de kerncompetenties van het medisch onderwijs. 
Het onderzoek bestond uit drie rondes waaraan een heterogeen panel van des-
kundigen (n=18) deelnam, bestaande uit zes praktiserende huisartsen met onder-
zoekservaring, vijf huisartsenopleiders, vier klinisch genetici en drie vertegen-
woordigers van patiëntenorganisaties. Het panel beoordeelde de genetica onder-
wijsbehoeften van huisartsen met betrekking tot kennis, vaardigheden en attitu-
des en stelde een top tien van onderwerpen samen. Alle panelleden namen deel 
aan alle rondes. De Kendall coëfficiënt van concordantie werd berekend om mate 
van overeenstemming over de top tien te bepalen (P<0.001). “Het herkennen van 
signalen die mogelijk wijzen op een erfelijke component van ziekte” stond op 
nummer 1 en werd gevolgd door “het evalueren van verwijsindicaties naar een 
klinisch genetisch centrum” en “kennis van de mogelijkheden en beperkingen van 
genetische testen”. Geconcludeerd werd dat de onderwijsprioriteiten die uit dit 
onderzoek naar voren kwamen als richtlijn konden dienen voor het ontwikkelen 
van geneticaonderwijs gericht op verbetering van het functioneren van de huisarts 
in de dagelijkse praktijk. 
 
De resultaten van hoofdstuk 2 en 3 vormden de basis voor het ontwikkelen van 
nascholingsmodules over genetica voor huisartsen en leverden informatie op voor 
te ontwikkelen onderwijscasuïstiek. [Verder onderzoek betreffende prioriteiten 
voor geneticaonderwijs is nodig voor het ontwikkelen van onderwijs voor de 
masteropleidingen voor verloskundigen.] 
 Het tweede deel van dit proefschrift beschrijft de ontwikkeling en evaluatie 
van drie onderwijsmodules: 1) een online nascholingsmodule (hoofdstuk 4), 2) 
een “live” nascholing (hoofdstuk 5), en 3) een website over genetica voor huisart-
sen (www.huisartsengenetica.nl). Voor beide nascholingsmodules diende de onco-
genetica als voorbeeld. In de huisartspraktijk is het opsporen van patiënten met 
een erfelijke aanleg voor kanker van het grootste belang voor het voorkomen van 
ziekte en sterfte (bijvoorbeeld beslissingen over vroege screening, genetische tes-
ten en risicobeperkende pre-symptomatische maatregelen). In een geran-
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domiseerd gecontroleerd onderzoek (RCT) zijn beide nascholingen geëvalueerd op 
effectiviteit in het verbeteren van de oncogenetische kennis en professioneel ge-
drag van huisartsen. Deze onderzoeken zijn voor zover wij weten de eerste geran-
domiseerde gecontroleerde onderzoeken (RCT’s) naar verbetering van de oncoge-
netische kennis en het professioneel gedrag van huisartsen na deelname aan on-
derwijsmodules. 
 
In hoofdstuk 4 wordt een RCT beschreven betreffende de onderwijskundige uit-
komsten van een online nascholingsmodule voor huisartsen. De uitkomsten zijn 
onderzocht op de eerste twee niveaus van het onderwijsevaluatiemodel van Kirk-
patrick (tevredenheid en leerzaamheid). De module had tot doel artsen te voorzien 
van voldoende kennis en vaardigheden door middel van didactische presentaties, 
interactieve casuïstiek en ondersteunende instrumenten zoals informatie over 
regionale mogelijkheden voor verwijzing en consultatie. Doel van de module was 
dat huisartsen na de module in staat zouden zijn om: patiënten op te sporen met 
een erfelijke aanleg voor kanker; een stamboom op te stellen als instrument voor 
het opsporen van patiënten met een verhoogd risico op erfelijke vormen van kan-
ker en dit te interpreteren; de meest voorkomende soorten erfelijke kanker (borst- 
en darmkanker) te beschrijven, evenals de genetische afwijkingen die daarbij een 
rol kunnen spelen; oncogenetische richtlijnen toe te passen bij het bepalen voor 
welke patiënten verwijzing al of niet zinvol is en te zoeken naar informatie op het 
internet; de mogelijkheden en beperkingen van oncogenetische testen uit te leg-
gen; met patiënten te overleggen over periodiek onderzoek en risicobeperkende 
chirurgische opties voor patiënten met een erfelijke vorm van kanker. 
 Tussen september 2011 en maart 2012 werd de online module gericht op het 
verbeteren van oncogenetische kennis uitgezet en geëvalueerd onder huisartsen. 
Een interventiestudie met een controlegroep werd uitgevoerd met parallelle groe-
pen en dataverzameling door middel van herhaalde metingen met kennistoetsen 
en vragenlijsten voorafgaande (pretest), direct na (posttest) en zes maanden (re-
tentietest) na de interventie. Van de tachtig huisartsen die werden gerandomi-
seerd naar interventiegroep en controlegroep namen 44 (20 in de interventie-
groep en 24 in de controlegroep) deel aan alle metingen. Om de validiteit te verg-
roten werden alleen huisartsen geselecteerd die gevestigd waren buiten de pro-
vincies waarin huisartsen ook konden deelnemen aan de live nascholingsmodule 
(Noord-Holland en Limburg) (zie hoofdstuk 5). De resultaten gaven aan dat de 
huisartsen zeer tevreden waren over de nascholingsmodule. Drie tevredenheids-
items hadden scores van 4.1-4.3 op een vijf-puntsschaal en de totaalscore bedroeg 
7.9 op een tien-puntsschaal. De kennisverbetering gemeten met de post-test en de 
retentietest bedroeg respectievelijk 0,055 (P<0,05) en 0,079 (P<0,01) met medium 
effectgroottes (0,27 en 0,31). De deelnemers waardeerden de toepasbaarheid van 
de kennisaspecten in de praktijk (itemscores 3.3-3.8 op een vijf-puntsschaal). De 
SAMENVATTING 
181 
scores betreffende het zelfoordeel ten aanzien van herkenning van ziekte, verwij-
zing naar een specialist en kennis over de mogelijkheden/beperkingen van geneti-
sche testen waren min of meer neutraal (2.7-2.8 op een vijf-puntsschaal). De con-
clusie was dat de evaluatie van de nascholing informatie opleverde voor de verde-
re ontwikkeling van online modules voor genetische nascholing van huisartsen en 
kunnen zo mogelijk een bijdrage leveren aan het verbeteren van de patiëntenzorg. 
De online nascholingsmodule en het daarvoor ontwikkelde raamwerk kan dienen 
als voorbeeld voor andere specialismen, de basisartsopleiding en het biologieon-
derwijs op middelbare scholen.  
 
Hoofdstuk 5 beschrijft een RCT waarin onderzocht werd of een “live” ongenetische 
nascholingsmodule leidde tot een verbetering van de consultvaardigheden van 
huisartsen. De interventie in dit pragmatische geblindeerde, gerandomiseerde, 
gecontroleerde onderzoek bestond uit een vier uur durende training in: oncogene-
tische consultvaardigheden (familieanamnese, bepaling van familiair/erfelijk risi-
co en doelmatig verwijzen), attitude (medisch ethische kwesties) en klinische ken-
nis voor eerstelijns consulten. De interventie liep tussen december 2011 en april 
2012. De uitkomsten werden gemeten met behulp van scoringslijsten voor geob-
serveerde contacten die door onaangekondigde gestandaardiseerde patiënten 
werden ingevuld en uit zelfbeoordelingvragenlijsten. Om logistieke redenen wer-
den uitsluitend huisartsen geselecteerd die gevestigd waren in twee Nederlandse 
provincies (Noord Holland en Limburg) die niet deelnamen aan het evaluatieon-
derzoek van de online module. Van de 88 gerandomiseerde huisartsen die zich in 
eerste instantie bereid toonden deel te nemen aan het onderzoek, vulden 56 alle 
vragenlijsten in (pre- posttest, en een retentiemeting op drie maanden na de inter-
ventie). De belangrijkste consultvaardigheden die in de training aan de orde kwa-
men, betroffen het herkennen van klinisch relevante informatie over verschillende 
soorten erfelijke kanker (borst/eierstok-, darm- en huidkanker) inclusief de genen 
betrokken bij oncogenetische syndromen en de gerelateerde erfelijkheidstesten; 
het herkennen van patiënten met verschijnselen die wijzen op een erfelijke vorm 
van kanker; het opstellen van een stamboom als instrument voor het opsporen van 
patiënten met een verhoogd risico; het bespreken van een mogelijk risico op fami-
liaire en erfelijke vormen van kanker (b.v. regelmatige controles en risicobeper-
kende chirurgische ingrepen) en daarmee samenhangende ethische kwesties; het 
opsporen van patiënten die in aanmerking komen voor verwijzing voor risicobe-
paling en het zoeken naar relevante online verwijsinformatie online op basis van 
oncogenetische richtlijnen; het toelichten van de mogelijkheden en beperkingen 
van oncogenetische testen; en weten wanneer het zinvol is een klinisch geneticus 
te consulteren en/of daarnaar te verwijzen. Er werd een significante verbetering 
gevonden in deze consultvaardigheden direct na de interventie en na drie maan-
den (regressiecoëfficiënt respectievelijk .34 en .28 met een medium effectgrootte) 
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lieten de resultaten een blijvende verbetering zien. Huisartsen waren tevreden 
over de module en gaven een positief oordeel over de praktische toepasbaarheid 
van de trainingsonderwerpen. 
 
Hoofdstuk 6 betrof een onderzoek waarin met behulp van zelfrapportage werd 
onderzocht wat de lange termijneffecten (een jaar later) waren bij huisartsen die 
hadden deelgenomen aan de online en live nascholingsmodules. Daarnaast werden 
verwijscijfers opgevraagd bij de klinisch genetische centra en werd belangstelling 
voor en tevredenheid met de website huisartsengenetica.nl bepaald. Deelname aan 
de modules leidde tot een blijvende verbetering van oncogenetische competenties. 
De deelnemers gaven aan dat zij alerter waren op genetische problemen; 88% van 
de deelnemers aan de live training gaven aan dat zij patiënten vaker verwezen 
naar een klinisch genetisch centrum, terwijl dit gerapporteerd werd door 29% van 
de deelnemers aan de online oncogenetische training. De klinisch genetische cen-
tra rapporteerden echter dat er een jaar na disseminatie van de onderwijsmodules 
geen significante verandering was in het aantal verwijzingen vergeleken met voor 
de training. Blijvende belangstelling voor en tevredenheid met de nieuwe huisart-
senwebsite werden onderzocht door middel van een “pop-up” vragenlijst voor 
bezoekers aan de website. Slechts een klein aantal van de bezoekers (38 waaron-
der 22 huisartsen) vulde de vragenlijst in gedurende de maand waarin het onder-
zoek plaatsvond. Er werden echter hoge scores gegeven voor tevredenheid met de 
website en de relevantie van de website voor beslissingen over juiste verwijzin-
gen. Het aantal bezoekers van de website nam toe waarbij de pagina over het op-
stellen van een stamboom het meest geraadpleegd werd.  
 
In Hoofdstuk 7 wordt een stapsgewijze route voorgesteld om te komen tot integra-
tie van genetica in het elektronisch patiëntendossier (EPD) voor de huisartsen-
praktijk en klinisch onderzoek. Dit zou de dringend noodzakelijke operationalisa-
tie mogelijk kunnen maken van goed toegankelijke genetische kennis voor klinisch 
onderzoek en daarmee voor verbetering van de gezondheidszorg. De grootste 
urgentie geldt echter voor het bevorderen van genetisch alfabetisme door middel 
van training en onderwijs. De tweede stap betreft een verbetering van de moge-
lijkheden om een familieanamnese zodanig te registreren dat zoekstrategieën 
gebruikt kunnen worden om patiënten met een verhoogd risico op te sporen. 
Voorgesteld wordt om codes aan het EPD toe te voegen uit de hoofdstukken “A21 
Familiegeschiedenis van maligniteiten” en “A99 Ziektedrager niet verder beschre-
ven” in de International Classification of Primary Care (ICPC) en om eenvoudige 
methodes te bieden voor registratie van de familiegeschiedenis evenals het bevor-
deren en ondersteunen van codeervaardigheden. Voor EPD’s zijn mogelijkheden 
nodig om (nieuwe) gegevens over de familiegeschiedenis toe te voegen, zoals rela-
ties tussen personen binnen dezelfde familie. Multidisciplinaire richtlijnen voor 
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verwijzing dienen helder te zijn en geen ruimte te laten voor verschillende inter-
pretaties. Automatische berichten kunnen behulpzaam zijn voor huisartsen om 
patiënten te herkennen met een verhoogd risico die voldoen aan criteria voor 
verwijzing. Ter illustratie wordt een patiëntencasus beschreven met familiaire 
borstkanker met een BRCA1-mutatie.  
Tot besluit 
De resultaten van de onderzoeken die in dit proefschrift zijn beschreven, hebben 
geleid tot een beter inzicht in de inzichten van niet-genetische specialisten, zoals 
huisartsen en verloskundigen, omtrent de toegenomen rol van de genetica in de 
eerstelijnsgezondheidszorg. De bevindingen onderstrepen het belang van gene-
tisch onderwijs. Verder onderzoek is nodig om vast te stellen welke verantwoorde-
lijkheden zorgverleners in de eerste lijn zouden moeten krijgen ten aanzien van de 
genetica. De speciaal voor huisartsen ontworpen oncogenetische nascholingsmo-
dules ondersteund door de Nederlandse genetica website huisartengenetica.nl 
lijken een goede en klinisch toepasbare methode om de oncogenetische competen-
ties voor de dagelijkse huisartspraktijk te versterken en tevens een flexibel en 
doelmatig raamwerk te bieden ter ondersteuning van de ontwikkeling en uitvoe-
ring van trainingsactiviteiten die uiteindelijk kunnen leiden tot een verbetering 
van de genetische zorgverlening. 
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“Success.  
I am fascinated by people who make work look seamless. Take Usain Bolt for 
example, you look at him run and you see greatness. You see that he looks noth-
ing like the other sprinters. His face, his muscles are relaxed, whereas other 
sprinters are cringing - you can feel their tension just by watching. But even for 
Bolt, being talented alone was not enough to win. To win he had to train hard, 
despite his self-admitted distaste for hard work. The similar concept applies in 
professional world, as it is impossible to succeed on talent alone anymore – 20 
years ago, maybe, but not anymore. Nowadays, success lies at the crossroads of 
talent and work ethic. And sure, everyone has different amount of talent, but few 
actually work hard enough to realize the talent they do possess. Therefore, I am 
inspired by the prospect of realizing my full potential and achieving “seamless-
ness” at whatever I do.” 
Artour Samsonov on inspiration, London Business School, MBA2011 
interview on Impact 
 
Wat is een Dream team? Samen roeien met de riemen die je hebt, met de neuzen 
dezelfde kant uit en met een hart vol passie voor waar je mee bezig bent. Ik mag 
mijzelf gelukkig prijzen dat ik met zoveel zeer talentvolle, gepassioneerde, sportie-
ve, lieve, inspirerende, ambitieuze mensen, collega’s, vrienden, ouders, man en 
kinderen nu zover ben dat ik mijn proefschrift mag verdedigen. Ik had dit NOOIT 
alleen kunnen doen! Dit betekent voor mij absoluut geen einde maar een continue-
ring van waar ik al jaren mee bezig ben: doen wat ik leuk vind en er met de volle 
100% voor gaan! There is so much more to come! 
 
Als je als huisarts wilt promoveren, twee kleine kinderen hebt, een man hebt die 
ook graag en goed academisch werkt als Cardioloog, graag wilt blijven rennen en 
roeien, ook soms nog eens wilt afspreken met vrienden en familie, dan moet je 
prioriteren en dus grenzen stellen. Dit wordt je niet altijd in dank afgenomen. Er 
wordt aan je getrokken en geloof in jezelf en wat je doet wordt dan wel eens op de 
proef gesteld. Maar ik ben iemand die sterker wordt door tegenwind en doorgaat 
als het nodig is. Dit project kon en wilde ik dus ook niet alleen doen en met alle 
hulp en steun is het gelukt! Een dankwoord is dus ook in mijn proefschrift onmis-
baar, ook al bestaat deze uit vele pagina’s.  
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“We tillen de boot uit het water. We trekken een doek over de cederhouten huid 
om hem af te drogen, brengen ‘m naar binnen en gaan de riemen halen. En dan, 
terwijl we samen naar de loods lopen, ieder een riem in de hand, slaat David 
heel even een arm over mijn schouder. Niet vriendelijk, maar vriendschappelijk. 
Niet spottend, maar gemeend. Ik ben zo moe. Ik knijp in het hard hout van de 
riem en voel mijn spieren nog een keer spannen. Er golft een diep geluksgevoel 
door mijn handen, mijn armen, mijn schouders, mijn borst en mijn benen. Ik ben 
moe en gelukkig.” 
H.M. van den Brink, Over het water. 1998. Uitgeverij Meulenhof. 
 
Ten eerste zou ik het Centre for Society and the Life Sciences (CSG) willen danken 
voor hun steun. Onze CSG dagen zijn na de CSG Academy ook na de promotie door-
gegaan. De financiële bijdragen en jullie steun, ook vanuit het Center for Medical 
Systems Biology (CMSB) en Netherlands Genomics Initiative (NGI), maakten het 
mogelijk om te doen wat we wilden doen: goed onderwijs opzetten, implemente-
ren en vervolgens gedegen evalueren. De eerstelijns zorg (maar hopelijk ook 
tweedelijn en medisch/biologie/middelbare school studenten) kan zo weer een 
hele stap vooruit zetten en samenwerking binnen de eerste en met de tweedelijn 
verbeteren op het gebied van genetica en genomics, maar belangrijker nog de ge-
zondheidszorg vooruit helpen. Daarnaast natuurlijk ook al mijn collegae bij de 
afdeling klinische genetica van het VU medisch centrum en sectie Community Ge-
netics en de vakgroep Huisartsgeneeskunde in Maastricht. Als flex-er en parttime 
dokter/onderzoeker heb je niet altijd mogelijkheid om meer tijd in de sociale rela-
ties met collegae te steken. Dat heb ik wel erg jammer gevonden en ik hoop dan 
ook na mijn promotie nog lang met jullie samen te mogen werken. Ik heb de tijd 
die we wel samen hebben gehad erg gezellig gevonden. De NHG congressen, 
NACGG dagen en ESHG congres in Parijs waren een stuk minder gezellig geweest 
zonder jullie! 
 
Ik zou ook graag al mijn collegae huisartsen, praktijkondersteuners en assistenten 
willen danken. In Medisch Contact stond (23 mei 2013) een stuk over gebrek aan 
wetenschappelijk onderzoekers onder huisartsen. Collegae zoals jullie maken het 
mogelijk te doen waar onze passie ligt: combinatie praktijk met onderzoek en zo 
de huisartsgeneeskunde op een hoger niveau brengen. Ook de patiënten wil ik 
graag bedanken: ook jullie hebben me op dagen gezien dat ik nachten had moeten 
doorwerken aan mijn onderzoek en met wallen op het werk met koffie in de hand 
er stond. Ik heb menigmaal een hart onder de riem gekregen door opmerkingen 
hoe belangrijk het is dat je als arts leert praten over genetica (een Klinefelter pati-
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ent), drie generaties aan dames die met elkaar in gesprek gingen over borstkanker 
in hun familie en hun DNA lieten onderzoeken. Heel veel dank! 
 
Ik wil het Nederlands Huisartsen Genootschap bedanken voor hun ondersteuning 
bij de duurzame ontwikkeling van het genetica onderwijs en de samenwerking 
tijdens het onderzoeksproject. Martina en ik gingen in de zomer van 2010 enthou-
siast praten met Rob Dijkstra (toen nog directeur implementatie bij het NHG, nu 
bestuursvoorzitter en directeur NHG) over het ontwikkelen van onderwijs over 
genetica. Kanker bleek het thema voor 2011. Jullie omarmden met jullie team en-
thousiast het onderwerp, hoewel het ook jullie veel tijd kostte en kanker bleek 
natuurlijk een goede kapstok te zijn om genetica aan op te hangen. Ik wil met name 
noemen: Rob Dijkstra, Dorry Cox, Shyama Sewpersad, Florijn Jonkers, Vroon Pig-
mans, Liesbeth van der Jagt, Mireille Ballieux en Els Bakker. Maar er zullen waar-
schijnlijk velen zijn die ik nu niet noem, maar op de achtergrond een grote rol heb-
ben gespeeld. Jullie vertrouwen en inzet heb ik erg kunnen waarderen. Wij hopen 
dan ook dat het niet alleen bij “Kanker en genetica” blijft, maar dat we ook verder 
kunnen gaan met samenwerken, andere onderwerpen, buiten onze landsgrenzen, 
de huisartsen in de rest van Nederland en mogelijk ook andere zorgverleners in 
eerste en tweede lijn. We zijn al begonnen om verdere uitbreiding van het onder-
wijs op te zetten zodat niet tientallen maar honderden huisartsen bereikt kunnen 
worden.  
 Annemieke van Dijk, Petra Elders, Bestuursleden Huisartsenkring Amster-
dam, 1e Lijn Amsterdam, WDH HOZL, ZIO (RHZ Heuvelland) en WDH Meditta (Guy 
Schulpen, Jan van Rooij, Merijn Verburg, Roger Eurelings, Esther van Engelshoven, 
Frank Soomers, Safira Quick, Mischa van der Graaff, Irmgard Rietbroek, Guyonne 
Boskamp, Brigitte Paulissen): als collega huisartsen actief betrokken bij opzetten 
nascholingen en als medewerkers betrokken bij de regionale organisaties voor 
huisartsen in Limburg en Noord Holland hebben jullie mijn verzoek om ons on-
derwijs te ondersteunen met enorm veel enthousiasme opgepakt. Jullie hebben 
ons blijvend ondersteund waardoor huisartsen in staat waren geïnformeerd te 
worden over de nascholingen via jullie bij hen bekende websites en locaties. Maar 
ook de manier van communiceren heb ik erg prettig gevonden en hoop dan ook 
dat jullie bereid zijn dit in de toekomst te blijven doen: want we gaan door met 
regionaal genetica onderwijs! 
 
Onze website www.huisartsengenetica wordt goed bezocht, met de samen opge-
zette webredactie (Lidewij Henneman, Marloes Brouns, Klaas Dolsma, Kristel van 
Asselt, Martijn Sijbom, Cecile Janssens, Petra van Overveld, Martina Cornel, Florijn 
Jonkers) willen we de kwaliteit hoog houden zodat huisartsen ook in de toekomst 
weten waar zij hun informatie over genetica kunnen blijven vinden. Marloes: heeft 
veel dank voor onze gezellige samenwerking en onze goede gesprekken.  
DANKWOORD 
189 
 
“Persistence. It is the greatest lesson I learnt, and I learnt it from my college 
rowing coach (Harry Parker, Harvard University). Before every race, he would 
tell us to be patient. The thought was that you might not be able to break your 
competition right away but wear them down over the course of the race. The 
danger of trying to break your competition in a race is that if you are not able to 
achieve it quickly, you end up breaking yourself. By focusing on being patient, 
the focus remained on the process of preparing for a race and racing rather than 
the desired result (winning). After 4 years of racing in college, I started to ap-
preciate the point that results often take time, and if you focus on the process 
rather than result, the results will always come out much better than the other 
way around.” 
Artour Samsonov (Harvard alumnus, Olympic rower and married to one of my best 
friends Sue) on his greatest lesson learnt 
 
Ik weet niet of ik een goede volgorde aanhoudt met iedereen bedanken, maar ja 
dan grijp ik weer terug op roeien: iedereen in de boot is belangrijk, je steunt elkaar 
en je moet samenwerken, de cirkel moet als het ware rond zijn en de roei haal 
moet als een machine lopen als ware het de ketting van een fiets. Sommige roei 
team leden zullen beter zijn in de eindsprint, anderen in het schoonhouden en 
verzorgen van de boot en de etentjes, anderen zullen de stuurtjes vragen om te 
komen naar de trainingen. Maar iedereen is onmisbaar. Van boeg tot slag en stuur-
vrouw of man. De Dames 8+ van MWC: Ik kon de afgelopen jaren niet veel mee-
doen, meedrinken, meelachen, etc etc, maar ik hoop dat ik na het afronden van de 
promotie weer vaker kan instappen en het team weer compleet kan maken!;))) 
Heb jullie gemist en onze borrels op het terras aan de Maas zijn heerlijk in de zon. 
De BBQ in onze tuin zit hier net ver vandaan! Hans onze roeisessies om 6u ’s och-
tends gaan ook door! 
 Dé VNVA kadertrainingen van Ina Vader heb ik ook als een bevrijding ervaren. 
Ongelooflijk de teamspirit en dat we nog steeds bij elkaar komen op de mooiste 
plekken in Nederland, lekker decadent! Ik had meer contact willen houden en 
hoop dat dat nu weer wat makkelijker gaat. Jullie zijn zulke sterke dames en heb-
ben me er echt doorheen getrokken, een voorbeeld voor elkaar. Ina, ik hoop dat je 
nog lang door zult gaan met de trainingen, vrouwelijk artsen ontberen steun om 
zichzelf verder te ontplooien en jij doet dat op zo’n respectvolle manier waar je je 
veilig bij voelt om nooit te vergeten en direkt te gaan toepassen in de praktijk. Heel 
veel dank! Prof . dr. Henriette van der Horst attendeerde mij op deze training en 
werd vanuit de VNVA mijn coach de afgelopen jaren om werk en prive op heel 
persoonlijk niveau te bespreken. Heel veel dank daarvoor Henriette! 
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Ook wil ik graag de Working-Ladies (annex borrelclub) en de Oudervereniging van 
OBS Binnenstad bedanken voor jullie steun. Je brengt als ouder relatief veel tijd 
door op school en wat is er dan leuker als je dan ook nog leuke, interessante, lieve, 
ondersteunende dames/ouders/vrienden en vriendinnen tegenkomt die je be-
staan als ouder combi huisarts combi promovenda kunnen ondersteunen? Marieke 
deed mee aan de avond 4 daagse, twee avonden werd ze opgehaald door Ghislaine, 
mama Jip. Je merkt dan hoe je elkaar steunt. Ja ja, je bent de avond 4-daagse ser-
vice . Het is een hectisch jaar geweest, van zieke vader ver weg in Amsterdam, 
verkoop oude huis met heen en weer fietsen en dan verhuizen naar ons prachtige 
huis aan de Aylvalaan, Marieke die tussendoor ook nog moest leren lezen en mijn 
hoofd dat bepaald niet naar fantasievol lezen stond en naar woordjes samen puz-
zelen om 19u ‘s avonds…. (Oh ja even voor de duidelijkheid, ik ben super trots: ze 
leest nu super!). Samen koffie op de woensdagmiddag bij de ene moeder om de 
een weg te brengen en dan hups naar de andere moeder op de bank om de ander 
op te halen, maken het leven soms wat lichter als het even niet zo licht is. Het zijn 
vaak die parels die het leven mooi maken. 
 
Promoveren is net als wonen in Maastricht, 
je moet het voortdurend aan iedereen uitleggen. 
Amy Jonk, Maastricht in NRC, 04-01-2012 
 
Voordat ik schrijf over mijn onderzoeksteam/groep, eerst alle aandacht voor de 
assistentes/secretaresses/secretaris: Marianne Hardonk en Wilma IJzerman in 
Amsterdam, Frits Ruijters en Ine Siegelaar in Maastricht: Jullie hulp en luisterend 
oor maakt het daadwerkelijk mogelijk om te doen wat ik doe en wat ik wil blijven 
doen: combineren van huisartsgeneeskundige zorg met onderzoek. Heel veel dank! 
 Ook wil ik Dr Irina Stirbu-Wagner van het LINH- NIVEL instituut danken voor 
onze samenwerking. We hebben de afgelopen jaren een aantal keren uitgebreid 
overlegd over verwijzingen van de huisartsen naar specialisten. Jouw ervaringen 
en enthousiasme hielpen mij erg te leren begrijpen hoe ingewikkeld dit proces is 
en hoeveel tijd het kost voordat er veranderingen in verwijsgedrag in de vorm van 
cijfers kunnen worden opgemerkt. Ik hoop dat we elkaar nog vaak zullen vinden! 
 I would also like acknowledge my inspirational research bosses in the USA: 
prof Carol Warner (Northeastern University, Boston, MA: you started the spark), 
prof McDonough (Medical College of Georgia, Augusta, GA: you made it possible for 
me to combine rowing in the Olympics team on the Savannah river with working 
in the laboratory a few hours a day) and dr Carolyn Schanen (UCLA, Los Angeles, 
CA: for making me understand how inspirational it can be to work on translating 
genetics into the clinic as a physician). Thanks! 
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Tja, maar waar zou ik zijn zonder mijn dream team OVOGG ( Onderzoek van On-
derwijs over Genetica en Genomics om volledig te zijn) vergaderingen (in Maas-
tricht) en OVO (Onderzoek van Onderwijs) team vergaderingen (in Amsterdam)? 
Deze vergaderingen werden altijd enthousiast bezocht met altijd een heerlijke 
lunch. Ik wil jullie toch allemaal noemen: prof Connie Stumpel en prof Albert 
Scherpbier: heel veel dank voor jullie hulp met name bij de opzet van het project 
en me blijven aansporen om door te gaan, ook na het afronden van mijn promotie. 
Alle begin is moeilijk, jullie ervaring, expertise en enthousiasme heeft veel bete-
kent. Heel veel. Dr Denhard de Smit, jouw aanwezigheid maakte dat we als een 
groot team konden samenwerken. Als ik aan jou denk, denk ik aan toekomst en 
aan samen met het NHG duurzaam onderwijs opzetten voor huisartsen en huisart-
sen in opleiding. Dr Scheltus van Luijk, Amsterdam blijft trekken, maar Maastricht 
geeft ook veel ruimte! Ik ben blij dat ook jij inziet dat Amsterdam-Maastricht 
daadwerkelijk bereisd kan worden met de trein! Jouw hulp als voorzitter tijdens 
de focusgroepen gaf een goed beeld van de inventarisatie en duidelijkheid en 
maakte dat we in staat waren binnen afzienbare tijd een mooi artikel te publice-
ren. Maar ook later bleef je met je steun en aanwezigheid erg belangrijk. Jouw ex-
pertise in het onderwijs gaf mij vaak helderheid over hoe je met veel plezier goed 
onderwijs kunt opzetten. Mereke Gorsira, wat geweldig dat je ondanks je drukke 
werkzaamheden ook nog de tijd hebt gevonden om mijn teksten na te kijken. Ac-
ceptatie van de artikelen is ook dankzij jouw hulp voorspoedig gelopen. Dank! 
 
Overige leden van de promotie- en leescommissie:  
 Prof Gerda Croiset, ik leerde jou kennen tijdens de cursus van prof Albert 
Scherpbier in Utrecht: Onderzoek van Onderwijs. Jouw bevlogenheid is erg aan-
stekelijk en je bent als vrouwelijk hoogleraar een groot voorbeeld voor mij maar 
ook voor anderen. Bedankt voor je enthousiasme en onder jouw leiding heerlijk 
gegeten en zeer interessante discussies met de arts assistentes in Maastricht! 
 Prof Joep Geraedts, wij kennen elkaar al jaaaaaren! Vlak nadat ik terug was uit 
Amerika van roeien en onderzoek mocht ik al een presentatie houden over mijn 
Rett onderzoek en resultaten. Ik heb deze aandacht zeer positief ervaren en uw 
aanhoudende enthousiasme werkt lang door. Nog steeds zijn we regelmatig in 
gesprek over hoe we het genetica onderwijs binnen de geneeskunde opleiding en 
opleiding voor medisch specialisten/huisartsen/aios kunnen implementeren. 
 Prof Hanne Meijers-Heijboer, beste Hanne, jouw enthousiasme tijdens de 
nascholingen voor huisartsen is zo aanstekelijk geweest. Met jouw ervaring als 
klinisch geneticus, opleider en contacten met huisartsen over de jaren weet jij als 
geen ander de zaal mee te krijgen. We hebben elkaar ook erg persoonlijk leren 
kennen en hoop dan ook dat we na mijn promotie nog contact houden. Maastricht 
is een heerlijke Bourgondische stad waar je altijd welkom bent! 
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 Prof Mattijs Numans, ik heb jou via Annet Sollie leren kennen en als bevlogen 
collega huisarts en hoogleraar op het gebied van Vernieuwen en verbeteren kwali-
teit eerstelijns zorg natuurlijk degene waarvan ik hoopte dat hij in de promotie-
commissie wilde plaatsnemen. Ik voel me dan ook echt vereerd dat je dit wilde 
doen en hoop nog lange tijd met je te kunnen samenwerken. 
 Prof Onno van Schayck, dank dat ook jij in mijn promotiecommissie wil deel-
nemen. Als hoogleraar preventieve geneeskunde en befaamd wetenschapper kon 
ik u natuurlijk niet missen, maar ja dat had ik natuurlijk al een paar jaar daarvoor 
met uw vrouw Cornel van Schayck besproken! Zij sprak tijdens de simulatiepatiënt 
trainingen in Maastricht hartstikke trots over u en nadat ik u een paar keer had 
gesproken en uw werk had gelezen hoopte ik dat u niet zou ontbreken. Heel veel 
dank! 
 Prof Connie Stumpel, ook jou ken ik natuurlijk al erg lang, zolang als prof Joep 
Geraedts in feite. Ja, het proefschrift is er eindelijk, na al mijn jaren werk aan Rett 
syndroom, maar goed, het leven is dan ook een weg die je mag bewandelen en 
meestal is de weg interessanter dan het doel op zich. Nu hoop ik op meer en verde-
re verbetering en vernieuwing van het onderwijs. Ik hoop dan ook dat we nog 
lange tijd zullen samenwerken. In Parijs tijdens het ESHG kwam je na mijn praatje 
erg enthousiast naar mij toe. Jouw steun aan het begin, maar dus ook aan het eind, 
van het project was onmisbaar, een goede basis betekent alles (maar goed daar 
weet je als klinisch geneticus en kinderarts natuurlijk alles van). Heel veel dank. 
 Dr Alan Guttmacher, we also met a long time ago and when we met I was very 
inspired by your enthusiasm to truly implement genetics in main stream medicine 
and making it possible to register family diseases. We have been in touch over the 
years and you have definately been able through our mails, publications and inter-
views to re-spark my enthusiasm to proceed with genetics education in primary 
care. Thanks! 
 
Deelnemers aan de focusgroepen, Delphi studie, PIN, nascholingen, ECWO studen-
ten, simulatiepatiënten jullie steun is onmisbaar geweest. Woorden kunnen niet 
uitdrukken hoe ontzettend dankbaar ik ben voor jullie steun en deelname aan dit 
onderzoek. Jullie hebben het mogelijk gemaakt om genetica onderwijs vorm te 
geven. 
 
Sarah, Jouke en Steven: jullie hulp is hard nodig geweest! Ik weet niet hoe ik jullie 
kan bedanken. Mijn dagen lijken te kort, zou zo een paar uur extra willen. Maar 
misschien zijn ze juist zo kort zodat je leert om met zulke geweldig getalenteerde 
studenten en (toekomstig) collegae samen te werken en te begeleiden. Ik hoop dat 
ik jullie ook wat heb kunnen leren en in de toekomst kan blijven spreken. 
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En dan mijn OVO Dream team:  
Prof Cees van der Vleuten, Cees, als copromotor en als wereldberoemd expert op 
het gebied van onderzoek van onderwijs was jij mijn Maastrichtse wereldbegelei-
der. Wat een dream team lid. Jouw positiviteit gleed als een warme deken over het 
project. Je was altijd zo snel in je antwoorden en altijd positief. Mocht ik ooit een 
psycholoog nodig hebben dan hoop ik bij jou langs te kunnen komen ;-)) 
 Dr Lidewij Henneman, Lidewij, wij kennen elkaar eigenlijk ook al langer dan 
vandaag.  Ik zal niet zeggen hoe, maar toen ik dat wist dacht ik: dat komt wel 
goed. Jouw steun is super geweest. Bloed zweet en tranen, tja daar weet jij nu met 
mij alles van. Ik denk altijd: no limits! Jij denkt altijd: stay in the moment! Een su-
per combi lijkt me zo. Ik hoop dat ik nog lang op je mag rekenen en jouw ervaring 
als klankbord mag gebruiken. 
 Prof Geert Jan Dinant, is het nu Geert-Jan, Geert Jan, GeertJan of GJ? ;-))), heel 
veel dank dat je mijn promotor wilde zijn in Maastricht. Als collega huisarts en 
hoogleraar huisartsgeneeskunde, kwam jij met al je ervaring vaak met zeer inno-
verende en enthousiaste ideeën naar voren. Als gedetacheerd huisarts-promotie-
onderzoeker moest ik mijn draai vinden op de derde verdieping in Maastricht. 
Heel veel dank met je hulp daarbij. Jouw mooiste en beste advies aan mij was dat 
ik bij mijn kern moet blijven: “Jouw ideeën zijn goed, probeer niet nu al te veel te 
differentiëren!”. Ik hoop dat we nog lang samen kunnen blijven werken! 
 Prof Martina Cornel, Martina jij bent meer dan alleen een promotor. We heb-
ben de afgelopen jaren al heel wat meegemaakt samen. Je bent integer en hebt je 
hart op de goede plek zitten. Ik weet nog toen we begonnen aan dit project, ik je al 
bij voorbaat heb gezegd dat eerlijk zijn bij mij een voorwaarde is om goed samen 
te werken. Helaas heb ik door schade en schande ook andere ervaringen. Martina 
heeft mij daarin absoluut niet teleurgesteld en ik heb dan ook zoveel van je ge-
leerd. Dank dat je mij het vertrouwen in de wetenschap weer hebt teruggegeven. 
Ik hoop dat ik je naast mijn promotor ook dierbare vriendin mag blijven noemen 
na alles wat we hebben besproken en meegemaakt. Het is echt een eer om binnen 
jouw sectie mijn promotieproject te hebben mogen afronden. Ik hoop dat we nog 
lang zo doorgaan. Je bent met de sectie en je familie altijd welkom in Maastricht, 
het lekkere eten, de wijn en de logeerverdieping staan klaar! 
 
LEF 
Breek de regels.  
Volg nooit de uitgestippelde paden.  
Probeer wat anders te doen, ook al vertellen mensen dat je gek bent.  
Alles wat je kunt dromen is mogelijk, het enige wat je nodig hebt is lef.  
 
Vrij naar Paulo Coelho, Dagblad De Pers, Maandag 26 mei, 2008 
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Vrienden (Angele, Michiel, Carina, Vincent, Carijn, Rob, Bjorn, Marian, Hans, Lana, 
Buckley, Sue (can’t wait to hold the BLOB in my arms, Artour (thanks for your 
quotes! Rowing is truly inspirational and taught me so many lessons as well. It is 
great to have both of you as our friends and find we are on the same wavelength. 
Thanks for reminding me :))), Esther, Annet, Pieter, Rachel, Paul, Ghislaine, Ste-
phan, Annemieke, Joel, Ingrid, Marije, Michiel, Simone, Leon, Lonneke, Pieter, Pe-
ter, Anke, Bea, Esther, Hafida, Swee, Blandine et Hakim, Susan en Hans, Kim, Robin, 
Renate, Narender, Ineke, Bram, Jola, Kathleen, Bianca, Iris, Jolanda, Thea en Yuri, 
To en die vrienden die belangrijk zijn en zijn geweest op alle leuke en minder leu-
ke momenten in ons leven. Vrienden zijn voor mij en voor ons echt onmisbaar 
gebleken in de afgelopen jaren. Sommigen zie ik vaker dan anderen, anderen zie ik 
door de afstand bijna nooit. Maar altijd weet ik dat we op jullie kunnen rekenen. 
Can’t wait to see you again and have some great laughs! 
 
I would really like to stop here and also thank my sisters in Long Beach California 
for being there for me in good times and in bad. If it was not for you, this thesis 
would not have been here. You know why. I hope we can soon meet again. Your 
warm hugs, smiles, prayers, emails, calls and welcome back party at Ann’s house 
are unforgettable: I love you!  
 
Maar ook onze nieuwe buren op de Aylvalaan. In een enerverend jaar als dit jaar, 
voelt het als een warm bad waar we in terecht zijn gekomen. Het klinkt misschien 
gek om ook de buren hier te noemen. Maar met ouders en soms ook vrienden ver 
weg is het voor ons echt bijzonder om jullie dichtbij altijd klaar te hebben staan als 
we de babyfoon even willen afgeven voor een spoeddienst, rennen op de berg, 
wielrennen sorry mountainbiken met buurvrouw en eten in restaurantje in de 
buurt. Jullie zijn altijd welkom en wij bij jullie. Ondanks onze drukke levens staan 
we altijd klaar voor elkaar en is het drinken van een wijntje samen dan net wat 
gezelliger (lekker snel thuiskomen ;).  
 
Mijn paranimfen: Annet en Angele. Beiden gepassioneerde moeders, vriendinnen, 
artsen en onderzoekers (volgorde nog nader te bepalen;). Jullie blijven mij inspire-
ren en ik hoop ik jullie. Dank voor al jullie hulp en ondersteunende gesprekken. De 
toekomst roept en de logeerverdieping in Maastricht staat natuurlijk ook voor 
jullie klaar! Gezelligheid kent geen tijd… 
 
TO “LET GO”
Is not to cut myself off, 
It is the realization 
I can’t control another 
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Pa en ma. Jullie zijn mijn hele leven heel belangrijk geweest bij het ondersteunen 
van alles waar ik mee bezig ben geweest. Maar ik denk ook dat jullie vaak hebben 
gedacht: waar is ze mee bezig? Ik herinner me hoe mijn vader bij de USA Nationaal 
roei team trainingen in Augusta, Georgia, met zijn cowboy hoed op stond met zijn 
lange regenjas aan, handen in de zakken, waarschijnlijk met krullende tenen en 
ons zag trekken aan die ergometers als bezetenen. Je zag hem denken: is dit nu 
leuk? Ja dat was leuk, en we waren trots, net als nu! Het afgelopen jaar heb ik met 
heel mijn hart en ziel zitten huilen aan je bed, angst dat ik je zou verliezen. De 
angst dat wij zonder jouw passie voor het leven door moesten was zo groot. Wij 
hebben als gezin ons best gedaan om vanuit Maastricht zo vaak mogelijk in Am-
sterdam jou en mama te ondersteunen. Wij zijn zo gelukkig dat je nu weer kunt 
genieten van het leven en met mama en vrienden naar Noordwijkerhout, camper, 
bootje op de Amsterdamse grachten, Ibiza, Frankrijk en Spanje kunt en daar kunt 
genieten van zon, zee, drank en spijzen. Ga hier nog lang mee door! Mama en papa: 
jullie liefde voor onderwijs, het huisartsen vak en jullie praktijkteam zullen me 
blijven inspireren.  
 
Lieve Bas, Marieke en Joppe: jullie zijn mijn Dreamteam thuis en zijn onmisbaar bij 
alles wat mij bezighoudt! Bas onze gezamenlijke passie voor elkaar, de weten-
schap, rennen, skiën en lekker eten waren onze eerste aanzet voor onze relatie. We 
kenden elkaar natuurlijk al 10 jaar toen we elkaar (weer) tegenkwamen in de Per-
roen tijdens de carnaval in Maastricht, maar wetenschap is wat onze liefde uren-
lang op de bank (ja echt) heeft aangewakkerd en dit nog steeds doet. Wij houden 
samen alle ballen in de lucht en mogen er trots op zijn dat we dit (meestal) met 
plezier blijven doen. Werk is ook maar werk, sport is ook maar sport, vrienden en 
familie zijn… nou ja. Jullie zijn meer dan de icing on the cake, zonder jullie heb ik 
geen zin in die cakejes. Een glimlach, zoen, knuffel zorgen voor het relativeren van 
alle ups en downs.  
 Ik hou van jullie, met heel mijn hart en ziel hou ik van jullie! 
 
Liefde is…
 
… onze eigen koers naar het geluk varen. 
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Isa Houwink was born on December the 13th 
1973 in Haarlem, the Netherlands. After she 
received secondary education at the Barlaeus 
Gymnasium in Amsterdam, the Netherlands, 
she successfully passed the Propadeutics in 
Health Sciences. In 1994 she started studying 
medicine at Maastricht University and graduat-
ed March 2003. Her interest in science started 
during her science rotation in Boston with Prof. 
Dr. Carol Warner, Northeastern University, 
Massachusetts, USA, for which she won the 
Student Science Award in 1998 (“Aspects of 
preimplantation embryology and sex- related growth rate differences in mouse 
preimplantation embryos in the Ped fast and Ped slow strain in vivo.”). During her 
internship she rowed in Boston early mornings and early evenings at the Union 
Boat Club on the Charles River, where she was scouted and asked to row in the 
National team in Augusta, Georgia. She then decided to postpone the rest of her 
rotations and work on her dream to be part of the Olympic team for Sydney in 
2000. Her interest in genetics and science led her to the Department of Human 
Genetics, UCLA, Los Angeles, California, where she was able to work with Dr. Car-
olyn Schanen on Rett syndrome research and methyl CpG binding protein MECP2 
mutations.  
 
Maastricht University was kind enough to let her fulfill her combined sports and 
scientific dreams and helped her to come back in 2001 and she successfully fin-
ished her internships in 2003. After obtaining her medical degree she started 
working as a resident at the departments of Obstetrics and Gynecology both in 
Amsterdam and in Heerlen. She then decided to become a General Practitioner to 
be able to be in a more personal relationship with her patients and started her 
residency in Maastricht in 2005. Since March 2008, Isa is a part-time practicing 
General Practitioner, where she is still able to show she is a family doctor with 
special interests in gynecology. In 2006 she published an accredited written Ac-
credidact CPD module on pre- and postnatal screening together with prof.  Martina 
Cornel. In 2010, together with prof. Martina Cornel, she also published a book on 
“Genetics in general practice” published by Elsevier in the series of Praktikum 
Huisartsgeneeskunde. From 2008 until 2013 she participated in a PhD project at 
the section Community Genetics, Department of Clinical genetics (VU University 
Medical Center Amsterdam) under the supervision of prof.  Martina Cornel and 
prof.  Geert Jan Dinant (Department of Family Medicine in Maastricht). Her project, 
funded by CSG Centre for Society and the Life Sciences /Centre for Medical Sys-
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tems Biology, aimed to reflect on current genomics developments with primary 
care workers, and to help them identify their learning priorities.  
 
In her free time she loves to row, yoga, run and ski with her husband Bas and is a 
mother to their children Marieke and Joppe, travel, read, enjoy her hobby photog-
raphy and spend as much time in her house and garden with friends and family as 
possible. 
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Stille engel  
 
Isa Houwink 
 
Huisartsen moeten zich voorbereiden op snelle ontwikkelingen in de genetica van complexe ziekten. 
Collega’s zeggen wel te weten dat diabetes, depressie, kanker en acute hartdood binnen families voor-
komen, maar helaas vergeten ze vaak deze kennis toe te passen in de dagelijkse praktijk. Zeker 1 op de 
10 patiënten komt met een klacht waarbij erfelijke belasting een rol speelt. 
 
Nadat ik 3 jaar genetisch onderzoek in Amerikaanse laboratoria had gedaan, kwam ik in 2001 terug om 
mijn coschappen af te maken. In Californië werkte ik mee aan genetisch onderzoek naar een stukje 
erfelijkheidsmateriaal dat het syndroom van Rett veroorzaakt. Meisjes met dit syndroom worden na 
twee jaar autistisch, verliezen het vermogen om woordjes te zeggen, zoals ‘mama’. Dat is toch het 
woord dat je moederhart doet smelten als je dat de eerste keer hoort. Ouders die ik zag, konden niet 
geloven dat hun kind dat opeens niet meer kon en zo’n zeldzame aandoening had. In het laboratorium 
gingen wij op zoek naar dat foutje dat ervoor zorgde dat hun kind een ‘stil engeltje’ werd. Ik werd direct 
gebiologeerd door het feit dat zo’n kleine afwijking zulke desastreuze gevolgen kan hebben. Van heinde 
en ver werden wij gevraagd het DNA te onderzoeken van kinderen die mogelijk het rettsyndroom 
hadden. 
 
Genetica werd een levenslange verslaving, want mijn kennis en kunde blijft niet onbenut. Ik werd mij 
bewust van het feit dat er een brug geslagen moet worden tussen de laboratoriumkennis en de toepas-
sing hiervan in de kliniek. Tijdens mijn opleiding huisartsgeneeskunde in Maastricht stapte ik af op 
prof.dr. Geert Jan Dinant (vakgroep Huisartsgeneeskunde Maastricht), die mij in contact bracht met 
prof.dr. Martina Cornel (sectie Community genetics, VUmc, Amsterdam). Samen werkten we verder aan 
een promotieproject om deze brug mogelijk te gaan maken. Het Center for Society and Genomics (CSG) 
was bereid om het project in te bedden in haar programma en te steunen met alle multidisciplinaire 
contacten. Experts uit verschillende geledingen, waaronder patiëntenverenigingen, onderwijskundigen, 
collega’s uit de eerste en tweede lijn zijn onmisbaar voor een succesvolle en duurzame implementatie 
van het onderwijs. Huisartsen blijken behoefte te hebben aan onderwijs over genetica, maar dan wel 
gericht op de praktijk. Geen taaie stof, maar problematiek aansluitend bij de dagelijkse praktijk. 
 
Zo is de patiënt van 42 jaar met darmklachten voor mij nu niet meer zomaar iemand die in de tropen 
iets verkeerds heeft gegeten, maar blijkt iemand die zich zorgen maakt omdat zijn vader met dezelfde 
klachten op dezelfde leeftijd darmkanker bleek te hebben. Dit laatste is het puzzelstukje dat ik nodig 
heb om de waarschijnlijkheidsdiagnose te stellen en na een coloscopie blijkt hij op 10 cm van het rec-
tum (verder dan mijn wijsvinger kan reiken) een ingroeiende tumor te hebben. Gelukkig kan hij snel 
worden geopereerd en daarna nog volop van het leven genieten. Genetica is niet ver weg en ook niet 
ingewikkeld. 
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Topsport  
 
Isa Houwink 
 
Willen wij als niet-genetici meegaan met de snelle ontwikkelingen in de genetica, dan is het noodzake-
lijk ons te laten onderwijzen om onze patiënten beter te kunnen informeren. Alleen op die manier zijn 
alle mogelijkheden en beperkingen van de genetica anno 2011 in dagelijkse praktijk te brengen. Voor 
succesvol geneticaonderwijs zijn experts en ‘stakeholders’ nodig, zoals huisartsen en andere eerste-
lijnszorgmedewerkers die betrokken zijn bij onderwijs, klinisch genetici, vertegenwoordigers van 
patiëntenverenigingen, onderwijsontwikkelaars en beroepsverenigingen. Onderwijs ontwikkelen is net 
topsport, je moet er voor kunnen samenwerken en gecoacht kunnen worden. 
 
Dat samenwerken stimuleert om tot goede prestaties te komen, werd mij duidelijk tijdens het meetrai-
nen in het Amerikaans nationaal roeiteam in 1998-2000. Het doel was immers een wedstrijd te winnen 
door samen te werken in een optimale sfeer waarbij de roeislag werd gevolgd. Je staat als roeier nooit 
alleen, je vult elkaar aan en staat voor elkaar klaar. Er zijn dagen dat je beter presteert dan andere, 
maar altijd ga je voor het beste. 
 
Bij het voorbereiden van het geneticaonderwijs voor de eerste lijn heb ik precies hetzelfde gevoel. In de 
focusgroepen die wij hielden als voorbereiding, zaten niet alleen huisartsen of verloskundigen die hun 
behoeften over geneticaonderwijs uitten, maar ook experts die vanuit patiënten- of onderwijsperspec-
tief vertelden wat zij belangrijk vonden. De focusgroepen waren geen afzonderlijke discussiegroepen, 
nee, zij vulden elkaar aan en completeerden elkaar. Het werd ons als onderzoekers en ontwikkelaars 
van onderwijs duidelijk dat er vanuit de verschillende geledingen behoefte is aan geneticaonderwijs en 
dat wij elkaar hierbij vooruit willen helpen. Nu moeten we nog in hetzelfde tempo leren roeien. Eerder 
onderzoek liet zien dat huisartsen te weinig kennis over genetica hebben. Dat is hetzelfde als te zeggen 
dat die ene roeier misschien wel competent is om mee te peddelen, maar dan geen opbouwende feed-
back te geven om er samen voor te gaan. Voor dat laatste blijkt veel meer nodig te zijn. 
 
De sfeer van elkaar op een stimulerende wijze feedback geven om zo tot prestaties te komen, heb ik ook 
ervaren in de kadertraining van de Vereniging Nederlandse Vrouwelijke Artsen, die werd gecoacht 
door Ina Vader. Ons team van 12 vrouwelijk artsen deed aan ‘topsport’. Gedurende 3 keer 2 dagen 
kwamen wij als team van vrouwen bijeen om te leren hoe elkaar feedback te geven en deze te krijgen, 
vergaderingen te leiden, te leren waar je grenzen liggen en deze duidelijk te maken. Mij werd feedback 
gegeven over mijn kwaliteiten en minder goede kanten. Ik hoorde dat ik daadkrachtig ben, maar dat ik 
daarin kan doorschieten en wat flexibeler zou moeten zijn. Niet helemaal onherkenbaar… Maar goed, 
als promotieonderzoeker en huisarts in een medisch centrum, ben ik blij met mijn kennis over mijn 
kwaliteiten, allergieën, uitdagingen en valkuilen. Zo heb ik handvaten gekregen hier beter mee om te 
gaan. Of, zoals Loesje zegt: ‘Waarom moeilijk doen, als het samen kan?’ 
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Een passend puzzelstukje  
 
Isa Houwink 
 
Isa Houwink is huisarts en promotieonderzoeker bij de afdeling Klinische Genetica, sectie Community 
genetics VUmc, Amsterdam, en bij vakgroep Huisartsgeneeskunde in Maastricht. Ze schrijft 4 weekboe-
ken over het belang van genetica voor niet-genetici (e.houwink@vumc.nl). 
 
Sommige huisartsen worden steeds meer subspecialisten binnen hun vakgebied. Er worden kadertrai-
ningen georganiseerd bijvoorbeeld op het gebied van hart- en vaatziekten, ouderenzorg en diabetes. 
Experthuisartsen of kaderartsen zogezegd. Of ik nu ook opper om een kadertraining ‘Genetica’ op te 
zetten? Nee, daar heb ik geen behoefte aan, want genetica is generalistisch. De gehele eerstelijnszorg 
zou zich bewust moeten zijn van het belang daarvan. Bij de veelvoorkomende multifactoriële, ook wel 
complexe ziekten is kennis over genetische aspecten belangrijk. Denk maar aan kanker, alzheimerde-
mentie, diabetes mellitus type 2 of familiaire hartproblemen. Genetica is relevant, omdat in de com-
plexe etiologie soms één gen een grote rol speelt, en het soms de multifactoriële etiologie handvaten 
voor (be)handeling geeft. Al deze ziekten vallen binnen de bestaande kadertrainingen voor huisartsen; 
nóg een nieuwe kaderopleiding is dus overbodig. Met het voorbereiden van onderwijs over genetica 
voor huisartsen zouden we onze huisarts subspecialisten onderwijs kunnen bieden binnen hun kader-
opleiding. Genetica zou daarmee echter een kennisdomein worden voor alleen die huisartsen die deze 
trainingen volgen op dat ene specifieke vakgebied, en ik denk niet dat dat de goede weg is. Genen zitten 
in álle organen en nieuwe kennis speelt in álle levensfasen, daarom kan kennis over genetica de ge-
zondheidszorg voor iedereen verbeteren. 
 
De huisarts in Amsterdam Zuid bekommert zich om sommige van zijn Joodse patiënten die binnen de 
gemeenschap met elkaar trouwen. De plattelandsdokter wordt door het boerengezin met een kind met 
downsyndroom gevraagd of het iets is waar de broer van vader van het kind zich ook zorgen over moet 
maken. Genetica komt heel dichtbij. Voor iedere arts, ook die zonder kadertraining. Daar is bewustwor-
ding voor nodig en onderwijs voor iedere arts. 
 
Er wordt gezegd: hebben al die ontwikkelingen op het gebied van het genoom wel zin gehad? Heel veel, 
maar ook heel weinig. Met name op het gebied van zeldzame aandoeningen zie ik veel directe toepas-
singen voor de klinisch geneticus. Voor de huisarts zijn de puzzelstukjes bij complexe aandoeningen 
van belang voor het maken van de ingewikkelde puzzel voor gevorderden. Dat zijn namelijk de artsen 
die bij uitstek vaker met het bijltje hakken als het gaat om het diagnosticeren en behandelen van de 
complexe aandoeningen zoals diabetes of astma. 
 
Een patiënte vertelt dat zij iets geks in haar borst voelt, en vertelt over haar angst voor kanker, wellicht 
iets engs in de familie waar eigenlijk nooit over gepraat mag worden, ja waarschijnlijk bij vader, maar 
ook bij een zus. In de familieanamnese vind ik als het ware een toverstokje: de puzzelstukjes vallen als 
een spannend verhaal naadloos in elkaar. In haar rechter borst voel ik een nauwelijks palpabele massa. 
Ik verwijs haar voor een mammografie en echo van de mammae. Helaas blijkt dat er sprake is van 
borstkanker, waarschijnlijk één van de erfelijke varianten. Patiënte is mij erkentelijk voor het feit dat ik 
snel heb gehandeld. Zo heeft de ontdekking van het genoom toch zin gehad! 
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Perfectie als maatschappelijk fenomeen  
 
Isa Houwink 
 
Isa Houwink is huisarts en promotieonderzoeker bij de afdeling Klinische Genetica, sectie Community 
genetics VUmc, Amsterdam, en bij vakgroep Huisartsgeneeskunde in Maastricht. Dit is haar laatste 
weekboek over het belang van genetica voor niet-genetici (e.houwink@vumc.nl). 
 
Mijnheer Jansen (50 jaar) is al enige tijd niet fit. In zijn familie krijgen mensen kanker als ze rond de 50 
jaar zijn. Hij komt mijn spreekkamer binnen en eist: ‘Ik wil genetisch onderzoek!’ Heeft hij ook een 
verhoogde kans op kanker of is alles goed? Mij bekruipt het gevoel dat wij als maatschappij bezig zijn 
een droom te verwezenlijken van perfectie, alsof we alles kunnen voorspellen. Een genetische test zou 
kunnen vertellen of alles goed is, zelfs blijft, en de angst voor imperfectie kunnen wegnemen. 
 
Het Centre for Society and Genomics (CSG), waarbinnen ons project ‘Onderwijs over genetica voor 
huisartsen wordt uitgevoerd, ‘...beschrijft, analyseert en verbetert de relatie tussen de samenleving en 
genomics-onderzoek. Daarmee draagt het CSG bij aan de aansluiting van genomics-onderzoek op de 
verwachtingen en vragen van de samenleving.’ De samenleving heeft dus verwachtingen van de geneti-
ca. Het CSG sluit hierbij aan. 
 
De huisarts houdt zich volop bezig met preventie. Onlangs lanceerden NHG en LHV het preventiecon-
sult. Daarin is de rol van genetica helaas gering. Terwijl de maatschappij wel van ons als arts verwacht 
dat we de genetica betrekken bij het voorkómen van aandoeningen zoals acute hartdood, kanker en 
diabetes mellitus, liefst al in een presymptomatisch stadium. Uit onderzoek bleek dat 9 van de 10 ziek-
ten waar Amerikanen het vaakst aan overlijden een genetische component hebben. Zaaien wij dan 
angst en wekken wij verwachtingen die wij niet kunnen waarmaken? Via internet kan de individuele 
patiënt een DNA-test bestellen. Al voor enkele honderden dollars kun je je genoom laten screenen op 
allerlei aandoeningen. Maar wat doe je ermee, als patiënt en – niet onbelangrijk – als huisarts? Wat is 
de klinische bruikbaarheid als de patiënt daar met zijn formuliertje zit? Hoe nu verder? 
 
De ogen zijn op mij gericht en ik wil de patiënt niet teleurstellen of nog erger: bang maken. Ik weeg mijn 
woorden, gelukkig heb ik even tijd. Genen hebben geen haast, geen ambulance die afkomt op een ziek-
makend gen. Nee, ik kan een familieanamnese afnemen, vragen waarom de patiënt de test wil laten 
doen en wat de verwachtingen zijn, en zeker zo belangrijk: overleggen met een klinisch geneticus. 
 
Als huisarts vormen wij de brug tussen de kliniek (ofwel het genomics-onderzoek) en de samenleving. 
Er wordt van ons verwacht deze brug te slaan. Kortgeleden zijn door Eurogentest competenties voor 
niet-klinisch genetici geformuleerd, waaruit blijkt waaraan huisartsen zouden moeten voldoen. Een 
uitdaging, maar zeker niet onmogelijk. Zoals ik eerder schreef in de vorige 3 weekboeken: genetica 
toepassen in de dagelijkse praktijk is niet moeilijk, als we genetica als puzzelstukje gaan zien bij het 
oplossen van de diagnostiek en behandelingen van de vaker voorkomende aandoeningen. Zo wordt 
genetica wellicht nog eens ‘perfect’ toegepast! 
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